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Abstract
As the major mitogen in serum, platelet-derived growth factor (PDGF) has been
implicated in many fundamental proliferative processes such as growth,
development, wound healing, atherosclerosis and neoplasia. While earlier studies
had mapped PDGFA to 7p22.1-pter, the location of the gene relative to other loci,
cytogenetic landmarks such as the chromosome telomere was not known. Deletions
of chromosome 7p are associated with craniosynostosis which has been mapped to
two regions: 7pl3-15 and 7p21-22. At the start of this project it was not known
whether the location of PDGFA on chromosome 7p overlapped with the more distal
of these two regions. This project undertakes genetic and physical mapping studies
on the A-chain gene of PDGF to refine the location of the gene on chromosome 7p.
To further describe the structure of the gene and to develop polymorphic markers for
linkage analysis, 7.3kb ofgDNA from PDGFA was sequenced. This sequencing
project identified polymorphic loci including a minisatellite and two dimorphic
markers. This minisatellite, which is in intron 3 of the gene, lies less than 300 bp
upstream from another minisatellite, in intron 4, which has been described
previously (Bonthron 1992). The intron 3 minisatellite described in this project has a
heterozygosity of about 56% however some alleles are refractory to PCR
amplification making it unsuitable for the large scale typing of data required for the
linkage analysis. For this, the two dimorphisms were used. The linkage analysis
placed PDGFA as the most distal locus in chromosome 7p, about 10 to 16 cM distal
to the nearest proximal markers. Two maps using different sets of markers are
presented.
Pulsed-field restriction mapping identified a CpG island at the 5' end of PDGFA but
excluded close physical linkage to the nearest linked locus, MS31 (D7S21). This
PFGE restriction map has been extended as far as possible with the probes available.
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YAC and PI clone libraries were exhaustively screened for clones spanning PDGFA
however, no positive clones were identified. The paucity of clones may reflect the
difficulty of cloning subtelomeric regions. Candidate telomere YACs for
chromosome 7p were screened for PDGFA but were also negative. End cloning of
these clones showed that they contain repetitive sequence around their cloning site,
no single copy probes are available from these YACs at present.
RARE (RecA-assisted restriction endonuclease) cleavage experiments showed that
PDGFA lies about 630 to 679 kb from the telomere. Analysis using a probe from
exon 7 ofPDGFA with four different individuals, indicated that there may be size
variation in this distance. Polymorphic length variation in the subtelomeric regions
has also been described for other chromosome telomeres. A telomeric location for
PDGFA, which is a growth factor gene, is interesting since the loss of chromosome
telomeres is associated with both ageing and malignancy. Loss of telomere repeats
results in instability of the chromosome ends and may explain the increase in
chromosome rearrangements seen in malignant cells. Such telomere rearrangements
can have dramatic effects on the expression of nearby genes; for example truncation
of the 16p telomere can silence expression from the nearby a-globin cluster.
Expression of the gene has been shown to be silenced even when the gene itself is
intact. The consequence of similar rearrangements involving chromosome 7p and
the expression ofPDGFA are open to speculation.
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Abbreviations used in this report
ADP adenosine 5'-diphosphate
ATP-y-S adenosine 5'[y-thio] triphosphate
bp base pairs














EDTA ethylenediaminetetra-acetic acid disodium salt
EGTA [ethylenebis (oxyethylenenitrilo)]-tetraacetic acid
FISH fluorescent in-situ hybridisation
gDNA genomic DNA
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PBS phosphate buffered saline
PCR polymerase chain reaction
PDGF platelet-derived growth factor
PDGFA platelet-derived growth factor A-chain gene
PDGFB platelet-derived growth factor B-chain gene
pdgfra platelet-derived growth factor a receptor
pdgfrp platelet-derived growth factor p receptor
PEG polyethylene glycol
PFGE pulsed field gel electrophoresis
PMSF phenylmethylsulfonylfluoride
RARE recA-assisted restriction endonuclease cleavage
RFLP restriction fragment length polymorphism
RNA ribonucleic acid
rpm revolutions per minute
SAM S -adenosylmethionine
S.cerev Scicchciromyces cerevisiae
SDS sodium dodecyl sulphate
SSV simian sarcoma virus
STS sequence tagged site
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1. Chapter 1: Introduction
1
1.1 Aims of this project
The aims of this project were to develop genetic and physical maps for the platelet-
derived growth factor A-chain (PDGFA) gene. Mapping projects were undertaken
at all scales: to provide more structural and sequence data from the gene, a linkage
map and a physical map in the form of a clone contig. To put into context the work
in this project and to explain the reasons for studying this gene, the protein (PDGF),
its constituent chains (A and B genes),- its receptors and physiological role are
discussed. The work in this project provided further information about the A-chain
gene sequence and structure, this is presented along with a discussion of the
implications of these findings. Importantly, this work has shown that the PDGF A-
chain gene is located in a subtelomeric position on chromosome 7p. The
implications of such a location for a growth factor gene are discussed.
1.2 Platelet-derived growth factor (PDGF)
As the major mitogen in serum and a potent growth factor secreted by many cell
types, the platelet-derived growth factor protein has been extensively studied.
PDGF has been implicated in many important processes such as growth,
development and wound healing as well as in the development of pathologies such as
neoplasia and atherosclerosis.
The existence of PDGF was realised with the observation that material released from
platelets was the principal source of mitogens present in serum and was responsible
for the growth in culture of many serum dependent cells (Kohler 1974, Ross 1974).
PDGF was initially purified from the a-granules of human platelets (Heldin 1979,
Antoniades 1979), although it is now known to be secreted by a range of cell types
which are discussed below (section 1.3).
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PDGF from human platelets is a 30 kDa cationic glycoprotein comprised of two
disulphide-bonded polypeptide chains. The PDGF heterodimer is comprised of two
chains: A and B which are encoded by two separate genes which are described in
sections 1.4 to 1.6 below. All three possible isoforms (AA, AB and BB) have been
described and are functionally active for cells carrying the appropriate a and/or (3
receptors. This project concentrates on the A-chain gene, with specific interest in
the detailed mapping of its sequence, structure and chromosomal location.
1.3 Expression ofPDGF
PDGF is secreted by platelets and by a variety of different cells such as vascular
endothelial cells (Bowen-Pope 1984, Collins 1985, 1987), vascular smooth muscle
cells (Seifert 1984, Walker 1986, Majesky 1988), uterine and placental smooth
muscle cells (Taylor 1988, Mendoza 1990, Holmgren 1991), neurons and glial cells
(Sasahara 1991, Yeh 1991), macrophages (Shimokado 1985) and transformed cells
such as osteosarcomas (Heldin 1986), embryonal carcinoma cells (Rizzino 1985),
SSV and SV40-transformed cells (Bowen-Pope 1984).
The PDGF-AB and -BB isoforms were found to constitute about 70 and 30%
respectively ofPDGF purified from human platelets (Hammacher 1988) although the
relative proportions of each isoform appears to depend on the isolation procedure
used (Hart 1990). The homodimer PDGF-AA is produced by normal cells such as
fibroblasts (Paulsson 1987), as well as by tumour cell lines such as osteosarcomas
(Heldin 1986). The secretion ofPDGF isoforms by a cell line stably transfected with
PDGF-A and B implied that the formation of each isoform ofPDGF is dictated by
the relative abundance of each transcript and is not directly controlled by the cell. It
has been proposed that there may be a difference in the secretory behaviours ofthe
PDGF isoforms. PDGF-BB remains associated with the producer cell and is not
secreted (Ostman 1988), this retention ofPDGF-BB is based on the basic amino
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acids in the C-terminal ofthe protein (Ostman 1991). The A-chain is produced as
two splice variants (see section 1.5.3). It has been proposed that the longer variant,
which carries a motif similar to the C-terminus ofthe B chain remains bound to the
cell or the extracellular matrix while the shorter variant is secreted (Raines 1992).
However, a major control over the functional activity ofPDGF is clearly the
expression of the PDGF a and (3 receptors by the target cells (discussed in section
1.7).
Normal human plasma contains undetectable levels ofPDGF. Experiments based on
intravenous injection ofPDGF into baboons to measure the half-life of the protein
found it to be less than two minutes (Bowen-Pope 1984). The binding ofPDGF by
heparan sulphate glycoproteins in the extra-cellular matrix has been demonstrated and
the presence ofplasma has been shown to reduce the ability ofPDGF to bind to
cultured cell receptors which implies that the serum contains proteins which bind
PDGF.
Homology between the PDGF A and B-chain genes
The PDGF heterodimer comprises of two chains, A and B, which are encoded by
two separate genes. The A-chain gene has been mapped to human chromosome 7
while the B-chain gene is located on chromosome 22. The PDGF B-chain shows
homology to the simian sarcoma virus gene v-sis. Characterisation of the two genes
has shown them to be very similar in their structure; both genes span 23 - 24 kb and
have 7 exons. The exon/intron boundaries correspond to similar domains in the
polypeptide chains and are comparable between both human genes and the v-sis gene
(see diagram 1.1). Exon 1, in addition to an unusually long untranslated region,
encodes the signal peptide. Exons 2 and 3 encode the N-terminal propeptide,







Diagram1.1:HomologybetweenPDGFA,DGFBndv-sisge . Schematicrepresentationoftplatel t-derivedgrow hfa torA-cha n,B- aianv-sisg n s,comparingthex n/intros ructuresof thereegen s.BoxinPDGFgerep es nto s,nbox :untranslatedsequ nc ,ch ck dbox :lead rsequ nc s, hatchedboxes:sequencesencodingprop pti es;fill dboxes:mat rePDGF.LTR:l gter inalrep t.Thfigur sv raxo representitsnumb rwhereasthosbe ntexonsrepr tsizoftin ronkilobase .FrWestermark(1990a).
included or skipped by alternate splicing generating proteins with different C-termini.
(section 1.5.3). This exon shows a much lower level of homology to the PDGF B
exon 6 than other exon pairs. Exon 7, which is very large, encodes almost entirely
untranslated sequences. The amino acid sequence of mature proteins from the two
genes show about 56% homology (Betsholtz 1986). This high level of homology
between the two genes suggests that they are both derived from a common source.
1.5 PDGF A-chain gene: sequence and structure
Complementary DNA (cDNA) clones encoding PDGFA were first isolated from
human glioblastoma cDNA libraries (Betsholtz 1986). Three transcripts of 1.9, 2.3
and 2.8 kb were identified, of which the 2.3 kb form was the most abundant.
Subsequent isolation of human genomic clones, DNA sequencing and
characterisation of its structure showed that the gene has 7 exons and spans 24 kb
(Bonthron 1988). The chromosomal localisation of PDGFA to 7p21-22 is discussed
below in section 1.5.4. As described above in section 1.4, PDGFA shows strong
homology to the PDGF B-chain gene.
Sequencing of PDGFA identified a TATAA consensus promoter element in a GC
rich promoter region and a AATAAA polyadenylation consensus signal in exon 7
(see section 1.5.2). The exon/intron boundaries were identified and all splice
junctions were found to conform to the GT/AG rule (Bonthron 1988). Alternative
splicing, omitting exon 6, has been described and is discussed below in section
1.5.3.
Sequencing of PDGFA has revealed a number of unusual features. At the start of
intron 3 a 41 bp sequence is directly repeated while intron 4 begins with a
minisatellite repeat. This structure starts within exon 4 and each repeat includes the
splice donor site, it is described below in section 1.5.1. Analysis of the 3' region of
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the gene found that it is poorly conserved outside the protein coding regions,
however a 32 bp sequence near the middle of intron 6 is perfectly conserved.
Another well conserved region in intron 6 is a 100 bp sequence which is repeated in
human DNA but not in the mouse. The functional significance of these elements is
not known (Bonthron 1992).
1.5.1 Polymorphisms within PDGFA
To achieve one of the major aims of this project, that is to map the PDGFA locus by
linkage analysis, polymorphic markers were required. Two polymorphic loci which
had been identified within PDGFA prior to the start of this project are described
below. Unfortunately neither of these were suitable as markers for linkage analysis
and the search for useful markers is described in Chapter 3.
1.5.1.1 The minisatellite in intron 4
The minisatellite mentioned above is shown in diagram 1.2. As the diagram shows,
the minisatellite comprises an 80 bp monomeric repeat which is repeated three times
(Bonthron 1992). The first repeat includes the last 29 bases of exon 4, as a result
there four copies of the splice donor site for exon 4. It is not known whether this
repetition of the splice donor site has an effect on splicing patterns. At the centre of
the first three repeat elements are, respectively, 18, 7 or 3 copies of the pentamer
'CCTCC'. Within the first repeat element which contains 18 copies of the pentamer
there is some subunit sequence variation and some repeats have the sequence
'TCTCC'. A polymorphic variant which carries only 16 pentamers in the first repeat
element has been described, however this allele is rare and the polymorphism is not
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Diagram1.2:ThePDGFAminisat lliteintron4.
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1.5.1.2 An uncharacterised Styl RFLP
Ferns (1990) described a Styl RFLP detected by a PDGFA cDNA probe. Southern
blot analysis gave a complex pattern of hybridisation with one band appearing to be
multiallelic. The molecular basis of this RFLP was not known at the start of this
project, however the distribution of Styl sites in the genomic sequence suggested
that the polymorphic band was due to hybridisation to exon 4 (Bonthron 1992).
Unfortunately identification of this reported polymorphism using Southern blotting
proved difficult to replicate. Thus, in this form, the polymorphism was not a useful
marker and needed further analysis to develop a useful marker.
1.5.2 Transcriptional control of PDGFA
The transcriptional regulation of the PDGF A-chain gene is independent of that of
PDGFB. The 5' region of the A-chain gene is very GC rich (78.6%), thus at the
sequence level this region fits the criteria for a hypomethylated CpG island (Bonthron
1988). The nature and extent of this putative CpG island is investigated in Chapter
5: Pulsed-field restriction mapping. A single transcriptional start was identified by
primer extension analysis and SI nuclease mapping and is located about 36 bp
downstream of a TATAA consensus promoter element (Bonthron 1988). A more
recent report identified a second putative promoter downstream of the original
promoter site however, it lacks a TATA-box and seems to be comprised of several
GC-elements (Rorsman 1992).
The promoter region of the A-chain gene contains multiple copies of the consensus
binding sequence for the transcription factor Spl (GGGCGG), several copies of the
putative binding site for AP2 (CCCCAGGC) and three putative binding sites for the
zinc finger binding protein WT1 (Gashler 1992). Mutations in the WT1 binding
protein gene lead to the development ofWilm's tumours. These kidney tumours,
which develop in childhood have been shown to over express PDGFA. For this
reason the role ofWT1 hi the transcriptional control ofPDGFA was investigated. It
was found to repress transcription (Gashler 1992).
The alternative spbeing of exon 6 which is discussed below (section 1.5.3) does not
cause a large enough variation in transcript size to explain the three different sized
transcripts which have been described. It is thought that these different sized
mRNAs reflect the use of alternative poly(A) sites which have been identified in the
3' end of the gene (Bonthron 1988, Rorsman 1992). Of these only one, the first
described (Bonthron 1988), matches the consensus sequence for polyadenylation
signal sites (AATAAA). Transcripts isolated from a human U-2 OS cell line were
analysed and at least one used an atypical polyadenylation signal with the sequence
AATTAAA (Hoppe 1987). This signal site was located 470 bp downstream from
the usual consensus signal site. It is thought that this product corresponds to the
largest (2.8 kb) product and that the smallest transcript ofPDGFA uses a third,
upstream, polyadenylation signal. These three sites may explain the different
transcript sizes however, the functional significance of these alternative adenylation
sites is unknown.
1.5.3 Alternative spbeing ofPDGFA
Alternative splicing ofthe PDGF A-chain cDNA clones in human glioma and
endothelial cell lines produces mRNA transcripts which differ by 15 amino acids at
the C-terminus (Collins 1987, Tong 1987, Rorsman 1988). The two species are
identical in their sequence before and after the insert which corresponds to the 69 bp
exon 6 (Bonthron 1988, Rorsman 1988). The omission of exon 6 creates a
structure which is 15 amino acids shorter, removing a highly basic carboxy-terminal
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region. This alternative splicing has been shown to be conserved through evolution
which implies that the two forms have an important functional role (Mercola 1988).
Initially it was speculated that the longer mRNA form, which includes exon 6, is
expressed only by malignant cells (Collins 1987), however the differently spliced
mRNA products have been shown to be normal cellular proteins (Matoskova 1989,
Young 1990). It has been proposed that the exon 6 sequence and the corresponding
sequence in PDGF-B allow the protein to be bound by the cell and that the shorter
protein may be secreted. However, PCR analysis detected similar levels ofthe two
splice variants in a wide range ofmouse tissues (Young 1990). These findings do
not support the hypothesis that exon 6 encodes a targeting sequence.
A third PDGFA transcript which carries an extra 110 bp insert at its C-terminus has
been described in rabbit vascular smooth muscle cells. Expression of this transcript
is induced by angiotensinll (Nakahara 1992). The insert has been found to be a
sequence in intron 6 which is well conserved in human gDNA (D.T. Bonthron pers.
comm.). It is not clear why this sequence is so well conserved or whether it has any
functional role in human PDGFA expression.
1.5.4 Chromosomal localisation ofPDGFA
PDGFA was initially assigned to the region 7q22-7pter, using a mouse-human
somatic cell hybrid panel (Betsholtz 1986). Subsequently, conflicting assignments
ofPDGFA to 7p21-p22 (Bonthron 1988) and to 7qll.23 (Stenman 1988) were made
using in situ hybridisation studies. More recently additional somatic cell hybrids
containing fragments of chromosome 7 were analysed using in situ hybridisation,
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these results confirm the assignment ofPDGFA to the tip of chromosome 7p
(Bonthron 1992). The first two in situ hybridisation studies used cDNA clones
differing only in the presence or absence ofthe alternately spliced exon 6. The third
study used a genomic probe consisting largely of intronic sequences, thus the results
of this third study may be viewed as independent ofthose obtained using the cDNA
probes.
The panel of somatic cell hybrids used in this third study (Bonthron 1992) were also
analysed for the presence ofPDGFA by PCR. The expected PCR product was seen
using those cells known to contain the distal portion of chromosome 7. These
hybrids include one (0044 Rag 1-15) which contains only a very small distal portion
of chromosome 7 (7p22. l-7pter), which further refines the localisation ofPDGFA
on chromosome 7p. The conflicting assignment ofPDGFA to 7qll.23 was
subsequently retracted by the authors (Stenman 1992) and there is no evidence for a
second locus for the PDGFA gene.
Speleman (1989) reported a dysmorphic patient DSE who had been shown to carry a
de novo, and apparently terminal, deletion of 7p22.1-pter. Unexpectedly, in situ
hybridisation studies showed that DSE had retained the PDGFA locus at the tip of
chromosome 7p. The location ofthe PDGFA is therefore confined to two relatively
small cytogenetic regions: (i) between the breakpoint in 0044 Rag 1-15 and the
proximal breakpoint in DSE or (ii) between the distal breakpoint in DSE and the
chromosome 7p telomere. These two possible locations for the gene are summarised
in diagram 1.3. The second possibility would imply that the deletion in DSE is not
truly a terminal deletion and that some interstitial DNA has been retained from the tip
of the chromosome which has been healed with its own telomere. This would give a
subtelomeric location for PDGFA. More refined mapping required linkage studies
and physical mapping at the molecular level, this refined mapping ofthe PDGFA






Diagram 1.3: Localising PDGFA.
Two possible locations for PDGFA at the start of this project were inferred from the
information available from cytogenetic landmarks. The hybrid cell hue 0044 Rag 1 -
15 indicated that PDGFA was located in 7p2 l-7pter, while the apparently terminal
deletion in the patient DSE narrowed the location ofPDGFA to 7p21 or the
subtelomeric tip of 7p.
1.6 The PDGF B-chain gene
The PDGF B-chain was isolated from platelets and initially sequenced at the amino
acid level. This partial sequencing showed that PDGFB is strongly homologous to
p28s,s, the transforming protein of the simian sarcoma virus (Waterfield 1983,
Doolittle 1983). The strong homology between the two proteins suggested that the
virus had acquired the cellular sequence which encodes PDGFB. This was the first
demonstration of a link between an oncogene (v-sis) and a cellular growth factor (c-
sis). Comparison of the DNA sequence shows that v-sis encompasses all of exons 2
to 6 and the 5' part of exon 7. The signal peptide encoded by exon 1 in c-sis is lost,
but it is compensated for by the 5' flanking env gene in the viral genome (reviewed in
Westermark 1990a). The simian sarcoma virus only transforms cells which are
responsive to PDGF, by stimulating cell growth via PDGF using an autocrine
feedback mechanism (Westermark 1990b).
Subsequent sequencing of PDGFB at the DNA level showed that the gene has seven
exons and includes an unusually long 5' untranslated region which has been shown to
inhibit translation (Collins 1985, Rao 1986). The exon/intron structure of the gene
is reviewed in comparison to the PDGFA gene in section 1.5. The transcriptional
control of PDGFB is independent to that for PDGFA. The PDGFB gene has been
mapped to human chromosome 22ql2.3-13.2 using a panel of cell lines with stable
translocations involving chromosome 22 (Zhang 1990).
1.7 The PDGF a and (3 receptors
Two PDGF receptor proteins have been described, the a-receptor (pdgfra) binds all
three isoforms with high and equal affinities. The (3-receptor binds only PDGF-BB
with high affinity, PDGF-AB is bound to the (3-receptor at a lower affinity and
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PDGF-AA is not bound at all. Like PDGF, the receptor is only functional as a
dimer and it is thought to dimerise on binding of the ligand (Heldin 1989).
Pdgffa has homology with the (3 receptor, c-kit, colony stimulating factor I receptor
(CSF-IR) and fibroblast growth factor receptor (FGFR). Together these proteins
form a subfamily of receptor kinases (Yarden 1986). Each receptor consists of an
extracellular section with five immunoglobin-like domains and an intracellular part
containing a kinase domain with a characteristic inserted sequence which is unique to
this subfamily of receptors (reviewed in Heldin 1992). Pdgffa and c-kit have been
localised to a common 630 kb fragment on mouse chromosome 5 (Smith 1991) and
to the same cytogenetic band on human chromosome 4ql 1-12 (Stenman 1989,
Gronwald 1990). Interestingly pdgfrff and CSF-IR are syntenic on mouse
chromosome 18 (Wang 1988) and human chromosome 5q31-32 (Yarden 1986). On
human chromosome 5 the two genes are found in a head-to-tail arrangement
separated by only 500 bp (Roberts 1988).
1.7.1 The Patch mutant mouse
Deletion of the pdgffa gene has been shown to produce the Patch mutant mouse
model which has been used to evaluate the developmental consequences of this
mutation (Smith 1991, Stephenson 1991). Patch heterozygotes are relatively
normal although they show an abnormal increase in the width of the prefrontal bone
and an absence of functional melanocytes from much of their torso. This
abnormality of melanocytes causes the white patching of their coat from which their
name is derived.
Patch homozygotes are much more severely affected and do not survive to birth.
Retardation of proliferation of mesenchymal cells is seen throughout the body of the
embryo: they fail to develop cartilage to form a skeleton, the dermis layer of the
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skin is missing and organs such as the oesophagus fail to develop their smooth
muscle layer. A second set ofdefects is seen in tissues which develop from the non-
neurogenic subset ofneural crest cells, thus the embryos fail to develop thyroid or
thymus tissue and the septation ofthe cardiac outflow tract into aorta and pulmonary
artery fails to occur. Pdgfra is also expressed by derivatives of the ectoderm, thus
development ofthe choroid plexus and the optic lens is abnormal (reviewed in
Bowen-Pope 1991). It is not clear whether these defects are due to lack of
expression ofpdgfra in the defective tissues and reflect an ongoing requirement for
PDGF or are the secondary consequences of earlier defects.
1.8 The function ofPDGF
1.8.1 Mitogenic activity
PDGF was identified as the element in serum which is required for serum dependent
cells in culture to divide (Ross 1974, Kohler 1974). A major function ofPDGF is to
induce mitosis in target cells such as fibroblasts, arterial smooth muscle cells and
endothelial cells. All three isoforms ofPDGF have been shown to exert equal
mitogenic activity on 3T3 cells and human dermal fibroblasts in culture (Hosang
1989).
An ordered sequence of events is required before a quiescent cell will undergo
mitosis. PDGF alone does not promote optimal stimulation for cell division or the
synthesis ofDNA, rather it appears to induce modulators which make the cell
competent to progress into the second stage of division which has been shown to be
mediated by substances found in platelet poor plasma (Ross 1974, Pledger 1978).
Cells have been shown to respond to stimulation by PDGF with an increase in the
levels of c-fos and c-myc mRNA levels. This increased transcription has been
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described in high passage senescent fibroblasts which are terminally growth arrested,
confirming that the control of the progression of cells into mitosis is controlled by
factors other than PDGF (Paulsson 1987).
1.8.2 Chemotaxis
Chemotaxis is the directed movement of cells along a chemical gradient. Unusually
for a growth factor, PDGF is a potent chemoattractant for cultured fibroblasts,
vascular smooth muscle cells monocytes and neutrophils (Seppa 1982, Grotendorst
1982, Deuel 1982, Senior 1985). PDGF has been shown to exert its chemotactic
ability at physiological levels (Westermark 1990b) and all three isoforms have been
shown to exert a stimulus (Hosang 1989, Hammacher 1989). The chemotactic role
of PDGF is of obvious importance for a role in recruiting inflammatory cells to the
site of injuries to promote wound healing (discussed below in section. 1.9.2).
1.8.3 Vasoconstriction
PDGF has also been shown to cause vasoconstriction. In vitro studies using strips of
rat aorta smooth muscle found PDGF to be more potent than angiotensinll (Berk
1986). It has been suggested that vasoconstriction is an important factor in
atherosclerosis which may suggest that the role of PDGF in atherosclerosis is
extensive (Ross 1986, discussed below in section 1.9.3).
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1.9 The physiological role of PDGF
The dual role of chemotactic recruitment and mitogenic stimulation of cells such as
fibroblasts suggests that PDGF may play an important role in normal proliferative
responses such as development and wound repair, and also in pathological processes
such as atherosclerosis and neoplasia.
1.9.1 Development
The mitogenic role of PDGF suggests that it would be involved in growth and
development. The two PDGF chains and the a and (3 receptors show distinct and
specific differences in their expression during development. The PDGF-AA isoform
and the a receptor are expressed very early in the embryo, before implantation. The
importance of the expression of the a receptor is shown by the developmental
abnormalities seen in the patch mouse. By comparison PDGFB and the (3 receptor
are not expressed in the mouse embryo until day 8 of development.
1.9.2 Wound repair
Following injury an inflammatory response is seen in the affected tissue. Neutrophils
and platelets migrate to the wound area, followed by macrophages and fibroblasts.
As the fibroblasts proliferate and lay down an extracellular matrix, new capillaries
start to develop. This provisional or granulation tissue is formed over 2 -3 weeks.
Remodelling of the wound, forming permanent scar tissue continues for up to a year.
The ability of PDGF to induce migration and proliferation of connective tissue cells
would suggest that it has an important role in wound repair.
18
PDGFB and PDGF(3 receptor have been shown by in situ hybridisation to be
expressed by epithelial cell and fibroblasts in wounded tissue 1-2 days after injury.
The expression levels in the wounded site were highest during the initial stages of
wound repair and then declined by 5 - 9 days after the injury (Antoniades 1991).
These findings were surprising since normally epithelial cells do not express PDGF or
its receptor. They provide strong evidence for a role for PDGF in normal wound
repair.
In vivo studies in rats have shown that local application ofPDGF-BB to the site of
injury can enhance would healing by stimulating an earlier influx of cell into the
wound area. However the beneficial effects ofPDGF-BB are not seen beyond two
weeks and longer term treatment with PDGF-BB is no more effective (Grotendorst
1985, Lawrence 1986, Pierce 1988, 1991). Impaired wound healing is seen in
conditions such as diabetes where a marked delay in cell infiltration is seen.
However once the cells arrive in the area normal development ofgranulation tissue is
seen. The application ofPDGF to wounds in diabetic rats restored the rate of
wound repair to that ofnormal animals (Grotendorst 1985, Greenhalgh 1990). The
results of a human clinical trial also showed a stimulatory effect of recombinant
PDGF-BB on topical application to chronic pressure ulcers (Robson 1992).
1.9.3 Atherosclerosis
Atherosclerosis is characterised by focal plaques in the intima ofthe artery wall. The
lesions contain a core of deposited lipids surrounded by an abnormal proliferation of
arterial smooth muscle, macrophages and an excessive deposition of connective
tissue. It is thought that the lesions arise as the result of an abnormal response to
minor injuries to the vascular endothelium, simulating processes similar to those seen
in wound repair.
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PDGF is the principal mitogen implicated in the proliferation seen in atherosclerosis.
It has been shown that under normal conditions PDGF is produced by vascular
smooth muscle (Seifert 1984, Majesky 1988), fibroblasts (Paulsson 1987),
macrophages (Shimokado 1985) and vascular endothelium (Bowen-Pope 1984,
Collins 1985,1987) all ofwhich are involved in the development of atherosclerotic
plaques. Thus PDGF has the potential to be involved in this pathological process.
Confirming this, increased secretion ofPDGF by plaque tissue has been
demonstrated (Libby 1988, Barrett 1988).
The pattern ofproduction ofPDGF by the cells in the atherosclerotic plaque is
complicated. Evidence from in situ hybridisation studies and dissection ofthe
plaques tissues suggests that increased PDGFB is transcribed by macrophages (Ross
1990) and vascular endothelial cells (Barrett 1988, Wilcox 1988) while smooth
muscle cells increase PDGFA transcription (Barrett 1988, Majesky 1990). This
complicated pattern of expression ofthe PDGF isoforms is further confused by the
different expression ofPDGF receptor genes seen in each tissue (Majesky 1990).
Each receptor isoform will bind the different isoforms ofPDGF with different levels
of affinity and thus the effect of secretion ofPDGF on the secreting cell and the
surrounding tissues will depend on the combination of ligand and receptor isoforms.
The effect ofPDGF as a vasoconstrictor has also been mentioned, it has been
suggested that arterial spasms occur predominantly at the site of atherosclerotic
lesions and that atherosclerotic lesions increase the basal tone ofthe artery walls
(reviewed in Berk 1986). This would suggest an even greater role for PDGF in
atherosclerosis although its effect remains to be clearly established.
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1.9.4 Neoplasia
,/ The finding of homology between PDGFB and the SSV v-sis gene suggested that the
abnormal expression of PDGF may lead to malignant transformation (Doolittle 1983,
Waterfield 1983). The v-sis oncogene has been shown to be required for the
transformation of human fibroblasts by SSV and a wide range of human malignant
cell lines express one or both PDGF genes. It is thought that naturally occurring
human tumour cells express both the c-sis gene and the P receptor allowing an
autocrine stimulation of cell growth. Transfection studies using the c-sis gene have
produced inconsistent results, thus it is not clear where the role of PDGF in the
development of human malignancy lies. It has been suggested that PDGF may be
involved in the later events of malignancy such as the development of growth
autonomy, local tumour expansion and perhaps metastasis (reviewed in Silver 1992).
Thus the role of PDGF in the development and propagation of human malignancies
needs further investigation.
1.10 Abnormalities associated with chromosome 7p
One of the major aims of this project was to develop genetic and physical maps for
the region surrounding PDGFA. As discussed above (section 1.5.4), PDGFA had
been mapped to 7p22. l-7pter prior to the start of this work. The function of a gene
and its location within a chromosomal region may be indicated by the finding of
chromosomal rearrangements such as deletions or translocations in dysmorphic
patients.
At least 32 cases of deletions of chromosome 7p have been identified and
characterised. Of these, 14 were associated with craniosynostosis. The association
between chromosome 7p deletions and craniosynostosis is discussed below. The
familial craniosynostosis syndromes Greig cephalopolysyndactyly and Saethre-
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Chotzen syndrome have also been linked to chromosome 7p (see sections 1.10.2 -
1.10.3). A number ofpatients with ring chromosome 7 have been described Ring
chromosome arises from fusion of the two chromosome termini to each other. Since
one ofthe two possible locations for PDGFA at the start ofthis project was in the
subtelomeric region of chromosome 7p, this syndrome is also discussed below
(section 1.10.4).
1.10.1 The Craniosynostosis Syndromes
There are a wide range of syndromes which affect the development of the bones of
the skull (craniosynostosis). The mutations causing a number of these defects have
now been described. Four ofthese syndromes, Pfeiffer, Crouzon, Jackson-Weiss
and Apert syndromes, have been found to be due to mutations in the fibroblast
growth factor receptor 2 gene (FGFR2) (Jabs 1994, Reardon 1994, Wilkie 1995,
Rutland 1995, Lajeunie 1995). In addition, mutations causing Pfeiffer syndrome
have also been found in the FGFR1 gene (Muenk 1994). The description of these
different mutations is an important reminder that the categories of dysmorphology
syndromes are often based on clinical findings and that distinct clinical syndromes
may arise from different mutations in the same gene.
For chromosome 7p, at least 32 cases ofvarying deletions have been identified and
characterised. Of these, 14 are associated with craniosynostosis although there is
considerable variation on the size and location of the deleted segment. Inspection of
the deletions in these patients has identified two regions, 7p 13-15 and 7p21-22,
which appear to be consistently associated with craniosynostosis (Schomig-Spingler
1986, Kikkawa 1993, Chotai 1994). At the start of this study the more distal of
these two regions, 7p21-p22, overlapped with the assigned location for PDGFA.
Molecular studies have been conducted using DNA from a subset of 6 patients with
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chromosome 7p deletions and craniosynostosis (Chotai 1994). Unfortunately this
study did not include PDGFA, however all of the patients studied were found to be
heterozygous for MS31 (D7S21). The importance of this finding in relation to the
location of PDGFA is discussed in the light of the results of the linkage analysis in
Chapter 4.
1.10.2 Greig Syndrome
Greig cephalopolysyndactyly (GCPS) is an autosomal dominant disorder which
affects limb and craniofacial development. The genetic locus for this syndrome was
identified as 7pl3 by balanced translocations associated with GCPS (Tommerup
1983, Kriiger 1989, Drabkin 1989) and by linkage analysis (Brueton 1988). From
the in situ hybridisation data the location of PDGFA on chromosome 7p appeared to
be more distal in 7p22-7pter (Bonthron 1988), thus PDGFA was not a good
candidate gene for GCPS. Around the time of the start of this project this
impression was confirmed when two of the three translocations described above were
shown to interrupt the zinc-finger gene GL13 (Vortkamp 1991). This suggests that
mutations arising in the GL13 gene account for the development of GCPS which is
compatible with the role of zinc-finger binding proteins in the regulation of
transcription during development.
1.10.3 Saethre-Chotzen syndrome
The Saethre-Chotzen syndrome shows a wide variety in symptoms and severity. The
main presenting feature is craniosynostosis although this may be mild. Other
symptoms typical of the syndrome include facial asymmetry, ptosis, hypertelorism,
hearing impairment and vertebral column defects. Partial syndactyly is seen, usually
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affecting the second interdigital space. The hallux is often abnormally broad and
may show a valgus deformity (Reardon 1994).
Two reports have described Saethre-Chotzen syndrome in association with
translocations of chromosome 7p. Reardon (1993) reported a breakpoint at 7p21.2
while Reid (1993) found the breakpoint in their patient to be at 7p22. This
discrepancy between the two reports may due to the limits of cytogenetic resolution
or it may be reflect an underlying genetic heterogeneity. The finding of a
translocation breakpoint as far distal as 7p22 meant that this syndrome mapped to the
same region as PDGFA.
An early linkage analysis study linked Saethre-Chotzen syndrome to the region
between D7S10 and D7S370. Importantly in this study there was no evidence for
linkage to MS31 (D7S21) (Brueton 1992). More recently this assignment has been
refined, narrowing the candidate region to between D7S513 and D7S516 (Lewanda
1994a) although two further linkage studies have defined separate regions within this
interval (Lewanda 1994b, van Herwerden 1994). For clarity, the results from these
later, comparable linkage studies are summarised in diagram 1.4. Importantly both
linked regions he proximal to D7S513.
It is interesting to note that the patient DSE who has been shown to have retained
PDGFA (see section 1.5.4) shows no signs of craniosynostosis. At the start ofthis
project PDGFA had not been placed on a linkage map so its location relative to these
markers was not known. Loci D7S21 and D7S513 are both included in the linkage
analysis in Chapter 4, the relationship ofthat data to the search for candidate genes
for Saethre-Chotzen craniosynostosis syndrome is discussed.
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Diagram 1.4: Linkage analysis in Saethre-Chotzen craniosynostosis
These linkage maps are summarised from the linkage analysis in Lewanda (1994a,
1994b) and van Herwerden (1994), distances are in centiMorgans (cM). The
hatched lines indicate the chromosomal regions to which the Saethre-Chotzen
syndrome was mapped in each of these studies. These regions are not overlapping
but they do all lie proximal to the marker D7S513.
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1.10.4 Ring Chromosome 7
As discussed in section 1.5.4, the retention ofPDGFA in the apparently terminal
deletion in DSE gives two possible locations for the gene: in the subtelomeric region
of 7p or between the breakpoint in DSE and cell line 004 Rag 1-15. Ifthe location
ofPDGFA were subtelomeric than it would be expected that it may be deleted in a
ring chromosome 7.
Ring chromosomes result from the deletion ofvarying quantities of the telomeric
regions ofboth the long and short arms of the same chromosome followed by fusion
ofthe two arms to each other. To date, 10 cases of ring chromosome 7 have been
reported (DeLozier 1992, Tsukamoto 1993). The phenotype of affected patients is
very variable but all show growth retardation and have a wide range of skin lesions
including cafe-au-lait spots, haemangiomas and pigmented naevi. In one girl a
malignant melanoma developed from one ofthese lesions (Vollenweider 1993). The
presence of such skin lesions is interesting since the patch mutant mouse (section
1.7.1) also shows abnormalities ofmelanocytes in its coat colouring. One report of a
patient with ring chromosome 7 was a severely affected boy who died at 20 months
(Tsukamoto 1993). A neuropathological autopsy reported abnormalities including
fusion ofthe anterior cerebral hemispheres, agenesis of the olfactory bulbs and
tracts, absence ofpigmentation within brainstem pigmented neurones and severe
hypomyelination of the whole brain. Such developmental abnormalities are
interesting when considering the chromosomal location ofPDGFA since PDGF has
been shown to be expressed during neuronal development. This may mean that the
PDGFA gene was deleted in this patient however such conclusions can only be
speculative given the unfortunate absence of any molecular studies in this report.
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1.11 Approaches to gene mapping
Classically chromosomal rearrangements identified in dysmorphic patients were used
to map genes to cytogenetic regions. This approach has been immensely useful for
mapping many genes, however its usefulness is limited by its dependence on
identifying individuals carrying suitable chromosomal rearrangements.
Rearrangements of chromosome 7p and their association with disease are discussed
above in section 1.10, unfortunately these are not useful for mapping PDGFA.
Thus further mapping ofPDGFA required approaches which would provide
information at a much higher resolution.
Linkage mapping can be used to map genes both to chromosomes and relative to
other loci within a defined chromosomal region. Linkage mapping is discussed
below in section 1.12, it was used in this project to map PDGFA (see Chapter 4).
This approach to mapping has the advantage that it can provide information at a
much higher resolution than cytogenetic mapping however linkage mapping cannot
provide physical data or clones from the region.
To relate the information from a linkage map to the physical landmarks seen on the
chromosome and to allow a more detailed study of the region, physical mapping
must be undertaken. Physical mapping is the cloning of a chromosomal region by
the collection of a series of stable, easily manipulated, ordered and overlapping
fragments. A number of cloning systems containing different sizes of fragments can
be used. Yeast artificial chromosomes (YACs) are now a widely used cloning
system. These clones can contain large fragments of human DNA allowing a large
area to be mapped. The cloning vector is described below in section 1.13.2 and
screening of YAC libraries for clones spanning PDGFA is described in Chapter 6.
While YAC clones provide a huge advantage for the construction of physical maps
some regions of the genome appear to be unclonable in YACs. Regions which are
unclonable in YACs may be cloned using other systems such as PI clones which are
discussed below in section 1.13.3 and are used in Chapter 7. Other approaches such
as BACs (bacterial artificial chromosome) and MACs (mammalian artificial
chromosomes) are being developed. It is hoped that these systems will overcome
some of the problems associated with YAC clones. Unfortunately these alternative
systems are not yet available.
Since the DNA inserts in clones such as YACs may be rearranged it is important to
compare the information from the clone contig back to genomic DNA. This is often
done by comparing the pattern of restriction maps of rare cutting enzymes such as
NotI derived from the YAC clone contigs and from human gDNA. This approach
requires long range restriction mapping by pulsed field gel electrophoresis (PFGE)
which is discussed below and undertaken for the region surrounding PDGFA in
Chapter 5.
Each of these approaches to mapping genes is discussed below, along with the
resources and information about chromosome 7p21-pter and PDGFA which was
available at the start of this project.
1.12 Linkage analysis
Linkage analysis measures the natural occurrence of recombination or 'cross-overs'
between a pair of chromosomes during meiosis. When traced through generations of
the same family using a suitable marker, these recombinations events can be used to
statistically infer the distance between two sites: the further apart two sites are the
greater number of cross-overs will occur between them. Linkage analysis therefore
has two major requirements: (i) DNA must be available from suitable families to
allow the events of meiosis to be traced, (ii) Polymorphisms or markers which can
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be used to identify sites along the chromosome of interest and to distinguish between
the two chromosomes are required.
Classically, linkage analysis has been used to identify regions of the genome which
may contain disease causing, mutated genes using DNA collected from families
suffering from the disease in question. However, large numbers of random
polymorphic markers are now available and these are being used to produce linkage
maps for each chromosome. This approach uses linkage analysis to determine the
relative order of the markers on the chromosome and to measure the genetic distance
between each marker. Since these mapping projects are not attempting to identify
linkage between a marker and a disease locus, they can be undertaken using normal
families such as the CEPH panel of families (Dausset 1990). The panel of CEPH
families which were used for the linkage analysis in this project are described in
Chapter 4: Linkage analysis ofPDGFA.
1.12.1 Maximum likelihood calculations and lod scores.
Two loci on different chromosomes will cosegregate, on average 50% of the time
whereas two loci physically close together on the same chromosome will be inherited
together more frequently. The frequency with which two loci do not segregate
together is termed the recombination fraction (denoted 0). The selected
polymorphic markers are used to type all the individuals from the selected families
Using this data, the likelihood of linkage between each pair of markers is calculated
using a range ofvalues for 0 from 0.5 (no linkage) to 0 (no recombination).
Frequently the phase of the haplotypes in crucial individuals cannot be determined
and thus which individuals are recombinant will be unknown. This means that the
likelihood calculation has to be made for each of the possible phase orientations of
the markers. Since the likelihood value would depend on the size of the family being
studied, a likelihood ratio is calculated comparing each possible value for 0 against
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the null hypothesis that there is no linkage (9). This ratio is the oddsfor linkage, it
indicates whether the two markers are more likely to be linked or unlinked. For
convenience the logarithm of this odds ratio is used. The log of the odds or lod
score for each family in the study can be added together. The mathematical and
statistical details of linkage calculations are described fully in Ott (1991).
In very simple situations the maximum lod score may be calculated by hand,
however the increasing complexity of a larger number of families and complicating
factors such as missing information, unknown phase and unequal male and female
recombination frequencies usually requires the aid of a computer for the calculations.
1.12.2 Statistical significance of linkage
The maximum lod score gives a measure of the statistical significance of the result.
For autosomal loci a value greater than +3 is usually accepted as demonstrating that
linkage is present. This corresponds to odds for linkage of at least 1000:1. As
mentioned above, linkage analysis is increasingly being used to develop multipoint
genetic linkage maps for whole chromosomes. When comparing alternative orders
for two loci odds of greater than 1000:1 are generally used before the loci are placed
on the map.
1.12.3 Mapping functions and genetic distance
In order to construct a genetic map, distances as measured by the recombination
fraction (9) are converted, using a mapping function, into map distances which are
measured in centiMorgans (cM). Recombination events do not happen truly
randomly since the occurrence of one-cross will inhibit a second cross-over occurring
nearby. This phenomenon, termed interference, means that maps derived from
nearby. This phenomenon, termed interference, means that maps derived from
functions which do not account for it tend to overestimate genetic distance. The
most commonly used mapping function, Kosambi's mapping function, is designed to
account for interference (Ott 1991).
1.12.4 The relationship between genetic and physical distance
Recombination fractions and genetic distance do not bear a direct relationship with
physical distance since the frequency of recombination differs between male and
female and varies with location in the genome. However, the order of the loci is the
same on genetic and physical maps. Recombination is generally higher in females
than in males so linkage maps for autosomal loci are usually calculated separately.
As a result the female linkage map is generally longer than the male although in the
telomeric regions of the chromosomes the reverse is seen. Recombination frequency
has been shown to increase dramatically in some regions, termed recombination 'hot-
spots', and also at the telomeres of the chromosomes (e.g. Alhto 1990, Burmeister
1991).
To allow rough estimations ofthe correlation between genetic and physical distance,
the concept of a sex averaged map ofthe genome was introduced. Historically the
length of such a map of the human genome was calculated to be 33 Morgans or
3,300 cM. As a rough guide, the haploid genome is estimated to be 3 x 109 bp,
lcM is therefore equivalent to 1 Mb. However this comparison between physical
and genetic distance is only a rough guide and may be misleading in some regions
such as the chromosome telomeres (discussed further in Chapter 4).
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1.12.5 Linkage maps available for Chromosome 7p
At the time of writing this thesis a number of linkage maps of chromosome 7p were
available, details from four of these maps are summarised in diagram 1.5. At the
start of this project, the first of these maps, Mishra (1992), was the most recently
published. Four loci from this map (.D7S21, D7S108, D7S89 and D7S103) were
used in the linkage analysis in Chapter 4. The second and third maps, Mishra
(1994) and Hill (1994), were both published as 'provisional framework maps' in the
report from the 1993 International Workshop on Chromosome 7 (Grzeschik 1994).
However one of these maps (Hill 1994) is based on unchecked data which may result
in some inaccuracies. These three maps were all constructed using the program Cri-
Map. The fourth map (Gyapay 1994) is from the genome wide 1994 Genethon
human genome linkage map. It was constructed using the LINKAGE program.
It is difficult to determine whether published maps use data which has been
independently obtained since all of these maps use the CEPH panel of families for
which databases are available. This is of interest especially since some of the maps
are based on data from a small subset of the CEPH families, in the maps published by
Gyapay (1994) only 8 out of the 40 families had been typed. More recently, a
further two sets of linkage maps of the human genome have been published (Buetow
1994, Matise 1994). These maps are also based on collated data and do not provide
any further information for the chromosome 7p region.
The two loci, D7S21 and D7S531, at the telomeric end of the 7p map were found to
be of particular interest in the mapping analysis in this project. Of the six linkage
maps referred to above, five included both loci (Mishra 1994, Hill 1994, Gyapay
1994, Buetow 1994, Matise 1994). Two of these maps placed D7S531 telomeric
to D7S21 (Hill 1994, Buetow 1994) while the other three could not place the two
loci relative to each other (Mishra 1994, Gyapay 1994, Matise 1994). Thus it is
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data which is available. The relative position of these two loci was found to be
important in the linkage analysis of PDGFA, this is discussed further in Chapter 4.
Locus D7S5I3 is also of interest since it was used in the linkage analysis of the
craniosynostosis syndromes which is described above in section 1.10. The two
regions which were identified as candidates regions for Saethre-Chotzen syndrome
were both proximal to D7S5J3. Two of the four maps in diagram 1.5 include
D7S513. This locus is also included in the Eurogem chromosome 7p linkage map
(diagram 4.8, Badbanchi 1994). Thus the location of PDGFA is mapped relative to
the candidate regions for Saethre-Chotzen craniosynostosis in this project.
1.13 Physical mapping
The different approaches to physical mapping which were used to map PDGFA are
listed above in section 1.11, the approaches of PFGE restriction mapping, the YAC
cloning vector and library screening and P1 clones are described below.
1.13.1 Long range restriction mapping
Long range restriction mapping uses 'rare-cutting' restriction enzymes to produce a
map. The average ffagment sizes produced by such 'rare-cutting' enzymes are
generally in the range 100 - 1000 kb. Such fragments are too large to be resolved by
conventional agarose gel electrophoresis which uses a static electrical field and can
separate fragments up to 20 - 30 kb in size. Periodically changing the direction of
the electrical field in pulses during electrophoresis has been found to allow the
resolution of much larger fragments ofDNA (Schwartz 1984). Changing the
direction of the electric field during electrophoresis forces the DNA molecule to
change its conformation and reorientate in the direction of the new electrical field
before it can migrate in the new direction. The time required for the molecule to
reorientate is dependant on the size of the molecule, thus separation of DNA
molecules on the basis of their size is possible.
The PFGE work described in this project was produced using the CHEF (contour
clamped homogeneous electric field) system which separates the DNA in straight
lanes in contrast to the curved lanes produced by earlier systems (Chu 1986). This
is achieved by dividing the voltage from the power supply between 24 electrodes in
an hexagonal array, creating a voltage which is constant across the gel. Earlier
apparatus, such as that originally used by Schwartz and Cantor (1984), used a
gradient electric field which caused the lanes of DNA to run at an angle. It has been
found that a 90° reorientation angle results in a large increase in the mobility of the
DNA molecules causing a decrease in their resolution. The hexagonal array of
electrodes in the CHEF apparatus is selected to create a 120° reorientation angle.
1.13.2 Restriction enzymes used for pulsed-field mapping
The majority of'rare-cutting' restriction enzymes have recognition sites that contain
the dinucleotide CpG. The dinucleotide CpG is strikingly rare. It is present in the
genome approximately 5 times less frequently than would be expected on a random
basis. This rarity of CpG dinucleotides is thought to be a consequence of
methylation: cytosine is prone to deamination and when methylated this gives rise to
thymine. DNA repair mechanisms appear to fail to recognise and correct this
mutation. About 60 -90% of CpG dinucleotides are methylated and this high level of
methylation in vertebrate DNA seems to have led to the evolution of a genome which
is depleted for this dinucleotide (reviewed in Bird 1985, 1986).
The pattern of methylation of CpG dinucleotide in the genome is not uniform. A
specific site may be only partially methylated and different regions of the genome are
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methylated to different degrees. An unusually low frequency of methylation is often
found in the region at the start or 5' end of many genes. These hypomethylated
areas are referred to as CpG islands and are defined as having a high G and C content
(>50%). In contrast to the rest of the genome, the dinucleotide CpG is found to be
present at a level which would be expected on a random basis. It is thought that the
low level of methylation in these regions is responsible for the high CpG content by
avoiding the mutation of cytosine to thymine. CpG islands are found at the 5' end of
many gene including all 'housekeeping' genes. The region is often large (500 - 2000
bp) and may include the first few exons of the gene as well as upstream sequences
(Bird 1986, Larsen 1992).
The functional effect of these islands on restriction mapping projects is two fold.
These regions may be useful, an area with a high frequency of unmethylated CpG
dinucleotides may indicate the start of an unknown gene (reviewed in Bird 1987).
However their presence may also frustrate restriction mapping projects around
known genes. If the CpG island contains restriction sites for all enzymes in a cluster
at the 5' end of the gene it may not be possible to extend the restriction map. For
this a probe which lies beyond the island will be required.
1.13.3 The YAC cloning vector
The yeast artificial chromosome (YAC) vector comprises the basic functional units of
yeast chromosomes: a centromere, telomeres and a replication origin (ARS) (Burke
1987). The most widely used vector is pYAC4 (diagram 1.6). Itwhich allows the
direct cloning of fragments produced by EcoRI partial digests into the cloning site in
the sup4 gene (Burke 1987). Restriction of the vector with EcoRI and BamHI
generates three fragments, two of these fragments form the arms of the YAC vector.
The BamHI ends are recognised by S. cerevisiae and are 'healed' into functional
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Diagram 1.6: The YAC cloning vector pYAC4
The yeast artificial cloning vector pYAC4. Restriction sites used for the
construction ofYACs and the structure of the final artificial chromosome are shown.
Singles lines represent pBR322-dervived sequence while the boxed regions are yeast-
derived. Adapted from Riley (1992).
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The recombinant vector is transformed into yeast cells where it is maintained as a
single copy artificial chromosome. Large DNA fragments, up to 1 Mb, can be
cloned using YACs. This major advantage means that they are now the most widely
used vector for large scale mapping projects. The large clone sizes mean that YAC
vectors have been used to develop a series contigs spanning the entire length of
human chromosome 21 (Chumakov 1992). However the isolation ofvector DNA
from the yeast genome is difficult in comparison to the easy isolation of cloned DNA
of plasmids This makes the subsequent analysis of the cloned fragments much more
difficult.
YAC clones have been used to develop several human genome clone libraries, these
are described below in section 1.14. To identify YAC clones which span PDGFA,
these libraries were screened using probes and PCR assays from the gene. The YAC
libraries and the screening experiments are described in Chapter 6 of this thesis.
1.13.4 Telomere YAC vectors
Several modified vectors have been developed incorporating different cloning sites
and selectable markers. One of these vectors, pTYACl has been developed to
clone telomere specific fragments (Riethman 1989). This telomere YAC vector has
a single yeast telomere and cannot function as a linear chromosome in the yeast host
cell until it is complemented with a second telomere acquired during the cloning
procedure. The telomere YAC vector, pTYACl, consists of one vector arm which
carries the essential elements for cloning and replication such as selectable marker
ura3 , the ARS, a telomere and a functional centromere. The second arm of the
recombinant artificial chromosome is provided by the cloned DNA insert. The aim
of the cloning procedure is that this DNA insert will consist of the telomere and
subtelomeric sequence of the genome being cloned.
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However, yeast is capable of'healing' chromosomes by the addition of telomeric
repeat sequences. This means that sequences which are not telomeric in origin can
be cloned, healed and function as telomeres in the yeast cell. Thus it is important to
screen colonies for the presence of the human telomere repeat (TTAGGG)n before
the YAC can be confirmed as a telomere clone. Typically 1-5 % of transformants
will hybridise to human telomere probe and contain DNA which may be oftelomeric
origin (reviewed in Dobson 1992).
Following the results ofthe linkage analysis and from screening the YAC libraries,
YAC clones for the chromosome 7p telomere were sought. The telomere YAC
library and the analysis of the candidate clones for 7p is described in Chapter 8:
Telomere YACs.
1.13.5 The P1 cloning vector
The cosmid cloning vector has a high cloning efficiency and the cloned DNA is easy
to isolate. However it is limited by the small size ofDNA inserts (up to 40 kb)
which the vector can carry. The development ofyeast artificial chromosomes
(YACs) allowed DNA inserts up to 1 Mb to be cloned (Burke 1987), however the
YAC cloning system suffers from a number of inherent problems: its cloning
efficiency is low, the cloned DNA is more difficult to isolate and many clones
contain chimeric cloning artefacts. The bacteriophage PI cloning system can carry
DNA inserts ofup to 95 kb (Sternberg 1990) and can be analysed using conventional
techniques avoiding the laborious techniques required for YAC clones, thus it
complements these two widely used cloning systems.
The original PI cloning vector was pAdlO, which was developed by Sternberg
(1990). However it is the second generation vector, pAdlO-sacBII, which is the
vector of choice (Pierce 1992). It carries the normal vector features such as a
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selectable kanamycin marker to allow positive selection of recombinants. The ICRF
human P1 clone library is described below. It was screened for P1 clones spanning
the PDGFA locus (described in Chapter 7).
1.14 Physical mapping resources
At the start of this project there was very little physical mapping information available
for the short arm of chromosome 7. The majority of mapping projects had
concentrated on 7q which carries CFTR, the gene responsible for cystic fibrosis.
A somatic cell hybrid panel of cell lines containing fragments of chromosome 7 was
available (Vortkamp 1991). A subset of cell lines from this hybrid panel had been
used to map PDGFA to 7p21-pter as discussed above in section 1.5.4. The most
distal breakpoint known in chromosome 7p is the breakpoint of the X;7 translocation:
46,XX,t(X;7)(q21 ;p22) in the cell line GM 1696. A series of 148 probes were
mapped to a panel of translocated chromosomes including GM 1696, of these probes
only 2 mapped to the distal region defined by this breakpoint (Vortkamp 1991).
This cell line was not included in the panel of hybrids which were screened for
PDGFA (Bonthron 1992) so at the start of this project it was not known whether
PDGFA was retained on chromosome 7 in GM 1696.
A number of whole genome YAC clone libraries have been developed and are
available for screening. Those libraries which were screened for PDGFA in this
project are described below. One YAC library, the CEPH YAC library has been
used to develop a genome wide physical map of YAC contigs (Cohen 1993). This
mapping project found particularly poor coverage of YAC clones in the telomeric
regions of the chromosomes and unfortunately this map does not cover the region
7p21-7pter to which PDGFA has been localised. Thus this library was not screened
for PDGFA.
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1.14.1 The ICIYAC Library
The ICI YAC library (Anand 1990) contains about 35 000 YAC recombinants whose
average insert size is 350 kb. This gives a theoretical coverage of 3.5 copies ofthe
human genome. The presence of chimeric clones has been estimated to be about
10%. The library is available both gridded onto nylon filters for screening by
hybridisation and as a series ofpooled clones which can by screened by PCR. The
gridded filters have the individual clones laid out on 40 nylon filters of 12 x 8 cm. In
contrast the PCR screening approach uses 40 master or primary pools which contain
864 clones each.
The gridded filters were supplied as a gift from the Human Genome Mapping Project
(HGMP) Resource Centre, London. Two sets ofprimary pools for PCR screening
were also obtained, one set were a kind gift from K. Dry and A. Wright (MRC
Human Genetics Unit, Edinburgh), the other set were a gift from J. Warner
(Edinburgh University Human Genetics Unit, Edinburgh).
1.14.2 The CEPH 'megaYAC' Library
The CEPH 'megaYAC' library contains 23 808 recombinants with a much larger
average insert size of 918 kb. It has a significantly higher level of chimeric
recombinants at 30 - 40 % although this level is thought to be regionally dependent.
This library was supplied as a set ofpooled clones for screening by PCR as a kind gift
by M. Jones (Cambridge).
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1.14.3 The Washington University total human DNA YAC library
This human total genomic DNA YAC library was described by Brownstein (1989).
It contains an estimated 60 000 clones with an average insert size of 275 kb. This is
smaller than the average insert size of other libraries such as the ICI library (Anand
1990). The frequency of chimeric clones is higher at 40 -50 %. Primer pairs for
STS's in the PDGFA gene were sent by E. Green (National Centre for Human
Genome Research, NIH, Bethesda, USA) who screened this library.
1.14.4 Chromosome 7 YAC libraries
The first report of the international workshop on human chromosome 7 in 1993
reported the development of two human chromosome 7 specific YAC libraries
(Grzeschik 1994). Obviously these were of great interest in the attempts to identify
clones for the region surrounding PDGFA.
1.14.4.1 The Toronto human chromosome 7 library
The Toronto chromosome 7 YAC library was initially developed using a
chromosome 7 somatic cell hybrid cell line (Scherer 1992, 1993). However in the
course of the development of the YAC library the human chromosome 7 in the cell
line was found to have been rearranged. This involved the duplication of a segment
of 7q which had been inserted into the short arm of the same chromosome. As a
result the chromosome was deleted for part of the short arm of chromosome 7. A
second chromosome 7 hybrid cell line was used in an attempt to generate more YAC
clones from 7p, however this cell line was also found to have lost a portion of
chromosome 7p (Kunz 1994). Thus this library is relatively depleted for the distal
region of short arm of chromosome 7 (see diagram 1.7).
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This is not ideal for screening for clones of PDGFA since this depleted region is the
region of the chromosome to which the gene has been mapped. The library contains
over 1000 clones with an average insert size of about 475 kb. Over 750 of these
YAC clones have been mapped to chromosome 7 using fluorescent in-situ
hybridisation (Kunz 1994).
1.14.4.2 The Washington University human chromosome 7 YAC library
The second chromosome 7 library which was screened for PDGFA was constructed
using YACs derived from a human chromosome 7 somatic hybrid cell line and
chromosome 7 enriched YACs from the CEPH 'megaYAC' library with the addition
of a small number of other YACs known to be from chromosome 7 (Green 1994).
The library has an estimated coverage of chromosome 7 of 6.5 - 7.5 times. Using
this library, 117 genetic markers have identified 650 YACs which are contained in 80
contigs which are estimated to cover 60 - 85 % of chromosome 7. A integrated map
has been constructed which compares the 1993 Genethon linkage map of
chromosome 7 (Gyapay 1994) to contigs constructed from YACs in this library
(Green 1994) this is shown in diagram 1.8. As can be seen in the diagram, the YAC
clone coverage of chromosome 7 is heavily concentrated on the long arm of the
chromosome. The distal region of the short arm which contains the PDGFA gene is




Diagram 1.8: YAC clone contigs from the Washington University YAC library
The 1993 Genethon linkage map of human chromosome 7 is depicted (Gyapay et al),
the dashed line brackets indicate where markers on tills map are placed with <100:1
odds. On the far right the vertical brackets indicate the YAC contigs which have
been developed from the Washington university chromosome 7 YAC library. The
thin brackets indicate where a single YAC has been shown to link two or more STSs.
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1.14.5 The ICRF human gDNA PI Library
The ICRF PI library was constructed using genomic DNA from the human
lymphoblastoid cell line GM1416B (Human Genetic Cell Repository, Camden,
N.J.), karyotype: 48XXXX, using the vector pAd 10SacBII which is described
above in section 1.13.5. (Francis 1994). The library was constructed and supplied as
a gift by F. Francis (ICRF, London). As for many YAC libraries, the human gDNA
used for cloning was prepared and digested (using Mbol) in agarose and size-
fractionated by pulsed-field electrophoresis. Handling the DNA in agarose reduced
the risk of damage from shear forces, optimising the size of cloned inserts. The
average size of the cloned inserts in the library is about 75 kb.
The library contains about 47 000 clones, giving a theoretical genome coverage of at
least one times. It is gridded onto two sets of duplicate filters, thus four filters of 21
by 21 cm were supplied. The two filters which contained duplicate copies ofthe
clones were not gridded in the same order so matches between the two sets of filters
could only be identified by the scientists at ICRF. Each filter contained an array of
144 x 144 clones arranged in 48 x 48 boxes each ofwhich contained 9 PI clones in a




At the start ofthis project a number of objectives were established. They were:
1) To further sequence the PDGFA gene looking for useful polymorphic markers and
information on the structure ofthe gene in the light of the unusual features which
have been described.
2) To map PDGFA by linkage analysis using new polymorphic markers identified in
the sequencing project. A location for PDGFA relative to other markers in the distal
regions of chromosome 7p may provide further information about the disease
syndromes associated with this region and the function ofPDGFA in processes such
as neoplasia.
3) To develop a long range restriction map ofthe region spanning PDGFA using
pulsed field gel electrophoresis. Such a map would be important for the
development of a YAC clone contig and would provide further information about the
region surrounding the gene.
4) To screen human YAC chromosome and PI libraries for clones spanning PDGFA
and to use these to develop a clone contig. An aim of such a physical mapping
project would be to physically link PDGFA to other landmarks in the region such as
flanking loci or the telomere. The development of a physical map was also of
interest since such information about this region is sparse in comparison to, for
example, the long arm ofchromosome 7.
5) In the light of developments as this project proceeded, a further aim became
increasingly important. That was to provide a measure ofthe physical distance
between PDGFA and the chromosome 7p telomere using Rec-A assisted restriction
endonuclease (RARE) cleavage technique.
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2. Chapter 2: Materials and methods
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2.1 Suppliers of chemicals and enzymes
The companies which were routinely used for supplies of chemicals and enzymes are
detailed in appendix I.
2.2 Bacterial cell culture: Media and additives
Luria Bertani (LB) medium.
LB medium consists of 5 g/L Bacto yeast extract, 10 g/L Bacto tryptone, 0.17 M
NaOH adjusted to pH 7.0. It was used routinely for the culture of plasmid
containing E.coli. In addition, LB agar plates contained 15 g/L agar which was
added to the media prior to autoclaving.
Terrific Broth.
Terrific broth (24 g/L Bacto yeast extract, 12 g/L Bacto tryptone, 4 g/L glycerol,
10 mM KH2PO4, 72 mM K2HP04) is a richer medium which was used to give high
yields of plasmids from overnight culture for large scale isolation of plasmid DNA.
The 'terrific' broth and the potassium phosphate buffer were prepared and autoclaved
separately, the buffer was added to the broth immediately before use
TYM Broth
TYM broth contained 5 g/L Bacto yeast extract, 12 g/L Bacto tryptone, 100 mM
NaCl and 10 mM MgCl2. It was used for cell culture during the preparation of
calcium competent cells.
SOC medium
SOC medium was used to resuspend electro-competent cells after transformation
with plasmids. It contains 5 g/L Bacto yeast extract, 20 g/L Bacto tryptone,
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8.5mMNaCl, 2.5 mM KC1 and 20 mM glucose, adjusted to pH 7.0. The media
and glucose were autoclaved separately and mixed prior to use.
2YT medium
2YT medium (10 g/L Bacto yeast extract, 16 g/L Bacto yeast tryptone, 85 mM
NaCl pH 7.0) was used to culture the PI clones described in Chapter 7.
Media was sterilised by autoclaving for 20 minutes, at 121°C. Where appropriate,
ampicillin, at 100 pg/ml or kanamycin at 50 pg/ml was added to media immediately
before use. E.Coli were grown at 37°C, on a shaker for aeration of liquid cultures.
Stocks were stored at -80°C in 15% (v/v) glycerol.
2.2.1 Plasmid cloning vectors
pBluescript II KS(+/-) (Stratagene)
This 2961 bp phagemid derived from pUC19 was used to produce the plasmid
pACY7 which was used in the sequencing project described in Chapter 3. The KS
designation indicates that the polylinker in this plasmid is orientated such that lacZ
transcription proceeds from the Kpnl restriction site to the SacI site.
pPCRH
The vector supplied in the TA cloning kit (Invitrogen) carries single 3' T overhangs.
The procedure used in this kit for cloning PCR products takes advantage ofthe non-
template dependant activity of Taq polymerase which adds a single deoxyadenosine
to the 3' end of all duplex DNA molecules produced in the PCR reaction. This kit




This cloning vector, which is supplied in the PCR cloning kit (Stratagene), is based
on pBluescript II SK(+). The SK multicloning site has been modified to contain an
Srfl restriction endonuclease target sequence. This kit was used to clone telomere
YAC ends rescued by Vectorette PCR
2.2.2 Yeast cell culture
YPD medium
YPD medium (10 g/L Bacto yeast extract, 20 g/L Bacto tryptone, 20 g/L glucose)
was used to culture S. cerevisiae strain YP148. This strain of cells was a gift from
Dr F. Richards, Cambridge. It was used as a size marker in the pulsed field gel
electrophoresis experiments since it carries an additional chromosome of 75 kb which
provides a useful additional size marker.
Ura" medium
A medium which lacked uracil was used for the selective growth ofYAC
recombinants. It contained 6.7 g/L Bacto yeast nitrogen base, 20 g/L glucose, 55
mg/L adenine, 14 g/L casaminoacids. The tyrosine, glucose, adenine and
casaminoacids were autoclaved separately and mixed with the YNB (yeast nitrogen
base) after the liquid had been allowed to cool.
Agar plates also contained 15 g/L agar which was added to the medium prior to
autoclaving. All yeast were grown at 30°C, with aeration on a shaking platform for
liquid cultures.
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2.3 Transformation and propagation ofplasmid DNA
2.3.1 Preparation of competent cells
To prepare calcium competent cells for transformation, 100 ml of fresh TYM was
inoculated with 1 ml of an overnight culture ofDH5a cells and incubated at 37°C,
300 rpm for 2-3 hours, until the optical density at 550 nm was between 0.5-1.0.
The cells were recovered and then resuspended in 30 ml of Tfbl (30 mM KC2H302,
50mMMnCl2, lOOmMKCl, 10 mM CaCl2, 15% (v/v) glycerol, pH 5.8). This
was left on ice for 10 minutes, centrifuged to recover the cells and resuspended in 4
ml of Tfbll (10 mM MOPS pH 7.0, 75 mM CaCl2, lOmMKCl, 15% (v/v)
glycerol) divided into 200 pi aliquots and stored at -80°C.
2.3.2 Transformation of calcium competent cells
The 200 pi aliquots of competent cells were thawed on ice with up to 100 ng of
plasmid DNA. The plasmid/cell mixture was left on ice for 30 minutes and then
placed in a 37°C water bath for 120 seconds to heat shock the cells. To this, 800 pi
ofpre-warmed TYM were added, mixed gently and the cells were incubated at 37°C
for 45 to 60 minutes. The bacteria were then plated out on LB agar plates
containing ampicillin.
2.3.3 Preparation of electro-competent cells
Electro-competent cells were prepared using a method adapted from Dower (1988).
A litre ofLB was inoculated with 10 ml of a fresh overnight culture ofDH5a cells.
This culture was incubated at 37°C with vigorous shaking until the optical density at
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600 nm was in the range 0.5 to 0.7. The culture was chilled on ice, the cells were
recovered and then resuspended in 1 litre of 10% (v/v) glycerol at 4°C. The cells
were washed in successively decreasing volumes of 500 ml, 60 ml and finally 2 to 3
ml of 10% glycerol. Aliquots of 40 pi were dispensed, frozen in a dry-ice/methanol
freezing bath and stored at -70 °C.
2.3.4 Electro-transformation of competent cells
The 40 pi aliquots were thawed on ice and mixed with about 1 ng ofDNA. They
were transferred to a pre-cooled cuvette (0.2 cm) and placed between the electrodes
in the Gene Pulser (BioRad). Pulses were delivered at 2.5 kV using a 25 pF
capacitor and a 200 O resistor. Immediately after pulsing, 1 ml of SOC was added.
The cell suspension was incubated at 37°C, 200 rpm for an hour and then spread
onto LB/ampicillin agar plates.
2.4 DNA extraction and preparation
2.4.1 Small scale preparation ofplasmid DNA
Three different methods were used for the small scale isolation ofplasmid DNA from
LB medium cultures:
2.4.1.1 Alkali lysis extraction ofplasmid DNA
Small scale preparations ofplasmid DNA were extracted using the alkali lysis method
described in Sambrook (1989). The cells were recovered from 2 ml of an overnight
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culture and resuspended in 100 pi Solution I (50 mM glucose, 25 mM TrisHCl, 10
mMEDTA, pH 8.0). To this, 200 pi of Solution II (0.2 M NaOH, l%SDS)were
added and the tube was mixed well. On ice, 150 pi Solution III (3 M potassium,
5 M acetate) were added, the sample was mixed and left on ice for 5 minutes. The
lysate was centrifiiged, the supernatant was recovered and the DNA was extracted
with phenol/chloroform and precipitated in an equal volume of isopropanol (IPA).
The DNA pellet was resuspended in TE (10 mM TrisHCl, 1 mM EDTA pH 8.0)
containing RNase at 20 pg/ml.
2.4.1.2 Promega Magic Minipreps
A Promega 'magic minipreps' kit was used as an alternative miniprep method on
occasions. DNA extraction using this kit is based on the alkali lysis method above to
lyse the bacterial cells. The DNA is extracted from the lysate by binding it to a resin
column, purified in a salt/ethanol wash while bound to the column and then eluted in
dH20 or TE.
2.4.1.3 Phenol/chloroform extraction of small scale DNA preparations
Cells from 1.5 ml of an overnight culture were suspended in 100 pi TE. To this,
100 pi buffered phenol/chloroform in a 1:1 ratio were added and the mixture was
vortexed at high speed to lyse the cells. The phenol was buffered in 0.1 M TrisHCl
(pH 8.0) with the addition of0.1% hydroxyquinoline. After centrifugation, the
aqueous layer was recovered and precipitated in 0.25 volumes 10 M ammonium
acetate and 2 volumes of ethanol. The DNA pellet was then suspended in 50 pi
TE/RNase (20 mg/ml).
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2.4.2 Large scale preparation of plasmid DNA
For large scale cultures, the plasmid DNA was incubated overnight at 37°C in 500ml
'Terrific' broth. The DNA was extracted by alkaline lysis (section 2.4.1) using 10 ml
Solution I, 20 ml Solution II and 15 ml Solution III per 500 ml starting culture.
The plasmid DNA was purified further with LiCl and PEG (polyethylene glycol). To
remove high molecular weight RNA, 0.33 volumes 5 M LiCl at 4°C was added to
the DNA and the sample was centrifuged at 14 000 rpm for 10 minutes at 4°C. The
supernatant was transferred to a fresh tube, the DNA was precipitated in an equal
volume of IPA, resuspended in TE/RNase (20 mg/ml) and then mixed with an equal
volume of 1.6 M NaCl containing 13% PEG. The DNA was recovered by
centrifugation, resuspended in TE and extracted with phenol/chloroform.
2.4.3 Total yeast DNA extract
An extract of total yeast DNA including the YAC was prepared from the
recombinant clones in liquid form for analyses in which large DNA fragment size was
not critical.
A streak of yeast colonies were used to inoculate Ura" medium and were incubated at
30°C on a shaking platform until the OD6oo was in the range 0.8 to 1.4. The cells
were harvested, resuspended in 0.9 M sorbitol, 0.1 M EDTA, 0.4 mg/ml
Zymolyase (20T) and then incubated at 100 rpm, 37°C for 1 hour. The cells were
pelleted, washed by resuspending in lysis buffer (0.9 M sorbitol, 50 mM TrisHCl pH
7.4, 50 mM EDTA) and recentrifuged. The cell pellet was suspended in lysis buffer
with 1% SDS, 0.13 mg/ml Proteinase K, and incubated at 37°C overnight. The
total yeast DNA was extracted from the lysed cell suspension by phenol/chloroform
extraction.
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2.4.4 PI clones DNA extraction
The PI clones were supplied as a gift by F. Francis (ICRF, London). A single
colony was used to inoculate 25 ml 2YT, 50 pg/ml kanamycin and was incubated at
200 rpm, 37°C overnight. This was used to inoculate 800 ml 2YT/Kanamycin and
the incubation was continued for 1 hour. IPTG was added to a final concentration
of 1 mM and the cells were incubated for a further 4 hours. The cells were
harvested and the DNA was extracted by alkali lysis (see section 2.4). The PI lytic
replicon in the plasmid is regulated by the lac operon promoter which is repressed in
cells containing the lac Iq repressor. The addition of IPTG releases this repression
and allows the copy number of the plasmid to increase. This method yielded 115 to
150 pg of DNA from 1 litre of medium.
2.4.5 Geneclean
To remove PCR primers and unincorporated nucleotides from PCR products and to
extract DNA from agarose the 'Geneclean' method was used (Vogelstein 1979).
DNA in agarose was diluted in 3 to 4 volumes of 6 M Nal and incubated at 55°C to
melt the agarose. Usually 5 pi of'Glassmilk' was added to the suspension, mixed
well and left on ice for 20 minutes to allow the DNA to bind to the silica matrix.
The glassmilk/DNA mixture was pelleted by centrifuging and then washed three
times by resuspension in 0.2 M NaCl, 20 mM TrisHCl pH 7.2, 2 mM EDTA, 50%
ethanol, finally the DNA was eluted in dH20.
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2.4.6 Extraction ofgDNA from whole blood
The unclotted blood samples were mixed with 3-4 volumes of'blood buffer' :
155 mM NH4C1, 10 mM KHCO3, 0.1 mM EDTA (pH 8.0) and left at 4°C for at
least an hour to lyse the red blood cells. The lymphocytes were collected and washed
by resuspending in BB If the pellet was red in colour, the cell lysis was repeated.
The cell pellet was then washed in 75 mM NaCl, 25 mM EDTA (pH 8.0), pelleted
and suspended in 0.2 volumes of 10 mM TrisHCl pH 8.2, 0.4 M NaCl, 2 mM
EDTA with 0.3 mg/ml Proteinase K and 0.67% SDS. This was incubated overnight
at 37°C.
The sample was then mixed well with 0.33 volumes of saturated (~ 6 M) NaCl and
centrifuged at 5 000 rpm for 15 minutes. The supernatant was collected and mixed
gently with two volumes of ethanol. As the sample was mixed the DNA precipitated
at the interface and was spooled out using a sealed glass pipette.
2.4.7 Preparation ofDNA agarose blocks for PFGE
Generally when undertaking a restriction digest the size of starting DNA should be 3
to 5 times larger than the desired restriction fragment. Pulsed-field gel
electrophoresis (PFGE) generally aims to separate DNA fragments sized from 50 kb
to 5 Mb. However, conventional methods such as pipetting and vortexing introduce
shear forces which damage the DNA. These methods produce DNA molecules
which are on average 200 to 300 kb in length, thus DNA prepared in solution is not
suitable for PFGE. To protect DNA from mechanical breakage it is prepared by
embedding the cells in agarose followed by enzymatic digestion of the non-DNA cell
components.
A pellet of lymphocytes was prepared in 'blood buffer' from a 50 ml fresh blood
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sample (see section 2.4.6), and then suspended in 5 ml PBS (phosphate buffered
saline). The cell concentration was estimated by counting in a haemocytometer and
adjusted to give a final concentration of 2.5 x 107 cells/ml. The PBS suspension of
lymphocytes was warmed to 31°C, mixed with an equal volume ofpre-warmed 2%
molten LMP agarose in PBS and pipetted into the mould wells. The agarose blocks
were allowed to set and were then pushed into 0.5 M EDTA, 1% SDS, 1 mg/ml
Proteinase K The blocks were incubated at 55°C for at least 48 hours, the buffer
was changed after 24 hours. This digests virtually all the unwanted cell components
leaving the DNA suspended in the agarose block.
To remove all traces ofthe SDS and Proteinase K, the agarose blocks were washed
at least 10 times in 10 volumes of TE (pH 8.0) for 30 minutes at room temperature.
Since the blocks were washed extensively it was not found to be necessary to use
PMSF to inactivate the Proteinase K The washed agarose blocks were stored for
several weeks in 10 to 20 volumes ofTE at 4°C. For longer term storage the blocks
were stored in 0.5 M EDTA, before these blocks were used they were washed 10
times in 10 volumes ofTE.
2.4.8 Preparation ofyeast and YAC chromosome DNA for PFGE
The yeast chromosomal DNA was prepared according to the same principles as for
human gDNA, however before the yeast cells were suspended in agarose they were
treated with Zymolyase to remove the cell wall which cannot be digested by
Proteinase K. A 100 ml culture was incubated until the optical density at 600 nm
was in the range 0.8 to 1.4. The cells were harvested, suspended in 5 ml 1 M
sorbitol, 2 mg/ml Zymolyase (20T) and incubated for 1 hour at 37°C, 100 rpm.
The cells were collected by centrifuging (2 500 rpm for 10 minutes), and
resuspended in 1 M sorbitol, 100 mM EDTA (pH 8.0) to a final concentration of 1 x
109 cells/ml. This cell suspension was used to make agarose blocks (section 2.4.7).
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2.5 Restriction endonuclease digestion
Digestion ofDNA in solution with restriction endonucleases was conducted using the
buffer and temperature recommended by the supplier. Plasmid DNA and PCR
amplified DNA were incubated for 1 to 4 hours using 2 to 6 units/pg DNA, gDNA
was digested overnight using 4 to 8 units of enzyme/pg DNA. The reactions were
stopped by the addition of 0.1 volume of 10 x BPB loading buffer (see section 2.6.2).
2.5.1 Restriction endonuclease digestion ofgDNA for PFGE
Agarose blocks for PFGE were 80 pi in volume, containing about 10 pg ofgDNA.
Before digesting the DNA the blocks were equilibrated at room temperature by 3
washes of 45 minutes in 2 ml of the appropriate buffer (at lx concentration).
Restriction digests were incubated overnight in 200 pi of 1 x buffer using 80 to 100
units of restriction enzyme. For each buffer that was used a negative control,
containing no enzyme, was set up.
2.6 Separation ofDNA molecules by electrophoresis
2.6.1 Solutions and buffers
Tris acetate EDTA (TAE) Buffer: The majority of agarose gels were prepared and
run in lx TAE buffer (0.04 M Tris acetate, 0.02 M EDTA pH 8.0).
Tris borate EDTA (TBE) Buffer: TBE buffer (lx: 0.09 M Tris borate, 0.02 M
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EDTA pH 8.0) was used at lx concentration to run polyacrylamide sequencing gels
and at 0.5x concentration for pulsed field gel electrophoresis.
2.6.2 Loading buffers
10 x Bromophenol blue (BPB): The majority ofDNA samples which were
separated in agarose were loaded into the wells of the gel using a simple
bromophenol blue loading buffer. A lOx concentrate contained 0.25% bromophenol
blue and 30% glycerol. On occasions the marker dye xylene cyanol was added, also
to a final concentration of 0.25%.
Ficoll orange: Bromophenol blue dye absorbs UV light and may mask the
presence ofDNA fragments with which it comigrates, thus when very small DNA
fragments were expected, 0.25% orange G in 15% Ficoll was used as a loading
buffer.
2.6.3 Size markers
1 kb ladder (Gibco-BRL): This size marker was used routinely for the majority of
agarose gels. It contains 23 bands which range in size from 75 bp to 12.2 kb.
S. cerevisicie strain YP148: This cell line was a kind gift from Dr F Richards.
Whole chromosomes suspended in agarose were used as size markers in pulsed field
gels. There were 17 bands ranging in size from 75 kb to 1 900 kb.
X ladder (New England Biolabs): Concatemers of X DNA were also used as a
size marker. The ladder spans the size range 48 kb to 1 018 kb, each band
increasing in size by 48 kb. The marker is supplied suspended in 1% agarose.
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2.6.4 Conventional agarose gel electrophoresis
Agarose concentrations of0.8 to 3.5% in lx TAE, 0.5 pg/ml of ethidium bromide
were used for conventional, horizontal agarose gel electrophoresis to separate DNA
fragments. The electrophoresis of small DNA fragments was usually run at 80 to
120 V, gDNA samples which were used for Southern blots were separated more
slowly, at 20 to 50 V, usually overnight. Gels were viewed on a UV
transilluminator and photographed with a Polaroid MP4 Land Camera using Polaroid
667 coatless instant film.
2.6.5 Preparative agarose gel electrophoresis
Probes for hybridisation to Hybond lsT filters were labelled either as whole plasmids
or the DNA insert was cut from the plasmid vector using restriction endonucleases.
DNA fragments which were to be used as hybridisation probes were separated in
LMP agarose at 20 to 60 V, the band ofDNA was cut out ofthe gel, diluted with
about 2 volumes of dH20 and melted at 65°C.
2.6.6 Pulsed field Gel Electrophoresis (PFGE)
Pulsed field gel electrophoresis was conducted using the CHEF (contour clamped
homogenous electric field) DR-II apparatus (BioRad). The 1 % agarose gels were
made in 0.5x TBE and run at 200 V for 20 to 24 hours at 12-15°C using pulse times
between 1 to 120 seconds. The gels were run without ethidium bromide since this
slows DNA migration through the gel and changes the pulse conditions needed for
separation (Southern 1987). The gels were stained in 500 ml of 0.5x TBE,
lOOpg/ml ethidium bromide for 30 minutes before viewing.
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2.6.7 Polyacrylamide gel electrophoresis (PAGE)
Polyacrylamide gel electrophoresis was used to visualise or purify small DNA
fragments such as oligonucleotides, to separate fragments which were very close
together in size and for sequencing reactions. The 30% acrylamide stock was made
up by adding 500 ml dH20 to the pre-made 190g acrylamide and lOg bis-acrylamide
mixture (supplied by Merck). The gel mixture was polymerised using 1.25 gl/ml
each of 25% ammonium persulphate and TEMED (N,N,N'N'-
tetramethylethylenediamine).
PCR products were separated in non-denaturing 10 % acrylamide, lx TBE using
1mm spacers and combs. Gels were run at 80 mA for 3 to 4 hours. A denaturing
polyacrylamide gel containing 8 M urea was used to purify the 60 base primer,
RARE1, used in the RARE analysis. The primer was run out in 15% acrylamide
using 3 mm spacers at 20 to 40 mA for 5 hours. The gel was not stained, the
shadow of the primer created by the DNA absorbency was viewed under UV light
(240 nM) using an intensifying screen. To purify the DNA the band was cut out of
the acrylamide gel and treated as described in section 2.13.1.
Sequencing reaction products were run out at 70 W in a 6% acrylamide, 8 M urea
gel in lx TBE for up to 5 hours depending on the size ofDNA fragments to be
resolved. The sequencing reactions, in a formamide loading buffer (see section
2.10), were denatured at 95°C and then placed on ice, 3 pi of each reaction were
loaded into a well. Initially, after the gel had been run it was 'fixed' in 10 % acetic
acid, 10 % methanol to remove urea. This step was found to be unnecessary and
was omitted in later experiments. The gel was placed on 3MM chromatography
paper and dried using a gel dryer attached a vacuum pump. Once dry the gel was
exposed overnight, at room temperature, to X-ray film (Curix RPI, Agfa).
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2.7 Southern Blotting
DNA which had been separated in an agarose gel was transferred onto Hybond N+
membrane by Southern blotting. Following electrophoresis the gel was
photographed under UV light and then soaked in 0.4 M NaOH for 30 minutes. To
ensure efficient transfer of large (>20 kb) DNA fragments from pulsed field gels the
gels were exposed to UV light for 90 seconds.
A standard capillary blot was constructed using 3MM chromatography paper as
wicks placed into a reservoir of 0.4 M NaOH The agarose gel was blotted overnight
or for 24 hours for pulsed field gels. When the blot was dismantled, the membrane
was removed from the blot apparatus, rinsed in 0.4 M NaOH, neutralised in 100
mM sodium phosphate, and allowed to dry at room temperature.
2.7.1 Transfer of DNA from bacterial colonies to Hybond N* membranes
Single colonies were picked from an LB agar plate and streaked onto a gridded
Hybond N+ membrane on a fresh agar plate. A second agar plate, marked with the
same grid was then streaked with the same sample. This was used as a master plate
to store a copy of each colony growing directly on the agar surface. The two plates
were incubated at 37°C for 6-16 hours.
To lyse the cells and fix the DNA, the Hybond N+ membrane was placed (colony
side up) on 3MM paper, soaked in 10% SDS, for 3 minutes. The membrane was
transferred to paper soaked in 0.5 M NaOH, 1.5M NaCl for 5 minutes and then a 5
minute soak on 1.5 M NaCl, 0.5 M TrisHCl (pH 7.4) was used to neutralise the
membrane. Finally the membrane was rinsed by placing it on 2x SSC (0.3 M NaCl,
0.03 M trisodium citrate, pH 7.0) for 5 minutes. The filter was then allowed to dry
at room temperature.
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To remove debris from large colonies of cells, the Hybond N+ filters were prewashed
for 30 minutes at 50 °C in 5x SSC, 0.5% SDS, 1 mM EDTA (pH 8.0). The soaked
membrane was then wiped with a tissue to remove the cell debris and transferred
immediately to the prehybridisation buffer.
2.8 Hybridisation of radiolabeled probes to Hybond N+ filters
2.8.1 Radiolabelling DNA probes
About 25 to 50 ng of probe DNA was labelled with [a-32P] dCTP and Klenow DNA
polymerasel by random priming from hexadeoxyribonucleotides. For these labelling
reactions a kit supplied by Boehringer Mannheim was used according to the method
described by Feinberg and Vogelstein (1983, 1984). The DNA to be labelled was
denatured by boiling and immediately added to the labelling reaction. The reaction
was incubated at room temperature for 20 minutes and then at 37°C for a further 20
to 40 minutes. The labelling reaction was stopped by the addition of 100 pi of
'Stop'(20mMNaCl, 20mMTrisHCl, 2 mM EDTA, 0.25% SDS). The probe
was denatured by boiling and immediately used to hybridise to a Hybond INT filter.
Frequently the probe being labelled contained LMP agarose. It was found that it
was not necessary to remove this prior to hybridisation.
2.8 .2 Checking incorporation of radio-isotope
The percentage of radioactive label which was incorporated into the DNA probe was
estimated by precipitation in TCA (trichloroacetic acid) using a method adapted from
Sambrook (1989). 10 pi of a 1:100 dilution of the labelling reaction was applied to
a nitrocellulose filter to use as an unprecipitated control. A second 10 pi aliquot was
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precipitated with 10 pg tRNA, 1 ml 10% TCA. This was passed through a
nitrocellulose filter using vacuum suction and rinsed with 2 - 3 ml of 10% TCA.
Both filters were placed scintillation fluid and counted using a scintillation counter.
The level of incorporation of the label in the precipitated sample was calculated as a
percentage of the unprecipitated sample. This was usually >65%. If a reaction was
found to have incorporated < 50% of the radiolabel it was not used and the probe
was relabelled.
2.8.3 Hybridisation of radiolabeled DNA
Hybond N* filters with bound DNA were prehybridised in a rotating oven (Hybaid) at
65°C for at least an hour in 0.5M NaCl, 1% SDS, 100 mM sodium phosphate.
Hybridisation of the denatured radiolabeled probe to the filters was conducted at
65°C overnight in 10 ml of the hybridisation buffer with the addition of 200 pg/ml
denatured sonicated herring testes DNA. Non-specific binding of radioactivity to the
filter was removed by washing the filters 3 or 4 times for 30 minutes at 65°C in 1%
SDS, 20 mM sodium phosphate.
2.8.4 Autoradiography
Filters were wrapped in cling film to prevent them from drying out and were then
exposed against X-ray film in cassettes with intensifying screens at -70°C overnight
or for longer if required. The films were developed in an automatic X-ray film
processor.
2 .8 .5 Removal ofHybridisation signal from Hybond N+ filters
Radioactive label was removed from the Hybond N' filters in boiling 0.5% SDS.
The filters were placed in the SDS and left to cool to room temperature. They were
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then rinsed well in 100 mM sodium phosphate and allowed to dry at room
temperature.
2.9 Exonucleaselll unidirectional deletion clones
A series of unidirectional deletion clones were produced using exonucleaselll as
described in Henikoff (1984) and Hoheisel (1986). These were used in the
sequencing project described in Chapter 3. This method is based on two useful
features of exonucleaselll: it progressively digests DNA at a uniform rate and it
cannot initiate digestion at DNA ends with 4 base 3' protrusions. About 50 pg of
plasmid DNA was digested with 600 units Kpnl, it was recovered by precipitation
with sodium acetate and ethanol and then digested with 600 units ofEcoRI. The
restriction digests were undertaken separately to ensure that digestion was complete.
The DNA was purified by phenol/chloroform extraction, precipitated in 0.1 volume
3M sodium acetate, 2 volumes ethanol and then resuspended in dH20 to a final
concentration of 0.8 pg/pl.
Exonucleaselll digestion was carried out in 75 mM TrisHCl pH 8.0, 3.3 mM MgCl2
using 16 units enzyme/pg DNA. This was calibrated to digest the plasmid DNA at a
rate of about 200 bases per minute. The 3 pi aliquots were removed at 2 minute
intervals, diluted in an equal volume ofwater and the reaction was stopped by heat
inactivation at 70 °C for 10 minutes. The aliquots were then treated with 18 units
SI nuclease in 15 pi SI buffer (16 mM NaC2H302 pH 4.6, 400 mM NaCl, 1.6 mM
ZnSC>4, 8% (v/v) glycerol) to trim single-stranded tails from the DNA fragments.
The reaction was stopped by adding 5 pi SI 'stop buffer' (800 mM TrisHCl pH 8.0,
20 mM EDTA pH 8.0, 80mMMgCl2).
The samples were run out in 0.7% LMP agarose (see diagram 3.3) and the bands
were cut out from the agarose gel and diluted in 3 volumes of dH20. The molten
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agarose/DNA sample was treated with 3 units Klenow DNA polymerasel in 60 mM
NaCl, 10 mM TrisHCl pH 8.0, 10 mM MgCl2 and 50 pM dNTP's. A 20 pi aliquot
of the Klenow treated DNA was ligated overnight as described in section 2.12. The
ligated products were used to transfect competent cells (see section 2.3), plated out
on LB agar plates, and incubated at incubated at 37°C overnight.
2.10 Double stranded DNA Sequencing
Double stranded DNA sequencing was conducted using a chain-termination method
with [a-35S] dATP and T7 polymerase. About 2 to 4 pg of the plasmid DNA was
denatured in 0.4 M NaOH, 0.4 mM EDTA (pH 8.0), precipitated in 0.1 volume 3M
sodium acetate, 2 volumes ethanol and then resuspended in 6 pi dH20. The
annealing reactions were incubated at 65°C for 2 minutes in 40 mM TrisHCl (pH
7.5), 20 mM MgCl2 and 50 mM NaCl with 2 pmoles of primer in a volume of 10 pi
and allowed to cool to room temperature.
To this annealing reaction 1 pi 0.1M DTT, 2 pi 'Labelling mix' (7.5 mM each dCTP,
dGTP and dATP) 0.5pl (0.5 pCi) [a-35S]dATP and 8 units T7 polymerase were
added. The extension reaction was allowed to continue at room temperature for 2 to
5 minutes. 3 .5 pi of this extension mix was added to 2.5pl of each Termination mix
(80 pM each dATP, dCTP, dTTP and dGTP, 8pM each ddATP, ddCTP, ddGTP
or ddTTP as appropriate) which had been preheated to 37°C. After incubation for 5
minutes the reaction was stopped by adding 4pl of 'STOP' buffer (95% deionized
formamide, 10 mM EDTA (pH 8.0), 0.025% bromophenol blue, 0.025% xylene
cyanol) which was used as a loading buffer.
For regions which had been shown to contain secondary structure which interfered
with the sequencing reactions or the resolution of the reaction products, 7-deaza
dGTP was used. The labelling mix was made by substituting dGTP with 7-deaza
67
dGTP at the same concentration of 7.5 mM. Termination mixes A, C and T
contained 80 pM 7-deaza dGTP instead ofnormal dGTP while the G termination mix
contained 160 pM 7-deaza dGTP. The concentrations ofthe other components in
the sequencing reactions were the same as before.
2.10.1 Oligonucleotide sequencing primers
The majority ofPCR and sequencing oligonucleotide primers were synthesised on the
Pharmacia 'Gene Assembler'. The oligonucleotide primers were cleared from the
support cassette by an overnight incubation at 55°C in ammonia. Initially the
primers were purified by passing the crude mixture down a Sephadex column, this
removed the ammonia and small molecular weight material and eluted the primer in
dH20. Later primers were extracted from the ammonia by drying in a centrifuge
evaporator, the resultant pellet was simply resuspended in 500 pi dH20. The
concentration of the primer was calculated by measuring the optical density of the
solution at 260 nm.
A number ofprimers, usually 18 bases in length, were synthesised for sequencing.
The majority of these primers were used in the large scale sequencing project
described in Chapter 3. Sequencing was also undertaken in the upstream probe
ACIXSR (described in Chapter 7), downstream in intron 4 ofPDGFA (Chapter 9)
and on the end-clones derived from the telomere YACs rescued by Vectorette PCR
(see Chapter 8 and section 2.12). The sequencing primers are listed in table 2.1.
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Primer Sequence Used for:
Universal reverse dAACAGCTATGACCATG pUC vectors








950L dAAGGAGAGGAGTGCTTG Intron 4
844REV dTCTGGCGACGAGCCTGGC Intron 4
PACIXSR2 dTGTTCCCTGCACCCAAGG ACIXSR
SP6 dGATTTAGGTGACACTATAG ACIXSR
7397 dCAGGCCCTCCCAGGTGACATT Intron 3
Table 2.1: Oligonucleotide sequencing primers
Sequencing of the plasmid pACY7 is described in Chapter 3, 'vectorette-PCR'
product sequencing from the telomere YACs is described in Chapter 8, clone
ACIXSR was sequenced during the analysis of the PI clones in Chapter 7 and intron
4 was sequenced for the RARE cleavage analysis in Chapter 9.
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2.11 Polymerase chain reaction (PCR)
The polymerase chain reaction was used extensively throughout this project. The
primers which were used along with their application are listed in table 2.2. A
standard reaction buffer of final concentration: 1.5 mM MgCL, 50 mM KC1,
lOmM TrisHCl (pH 8.3), 0.1 % gelatin was used in all reactions unless otherwise
stated in the table. PCR reactions were usually 50 pi in volume, containing 1 pmol
each dNTP, 50 pmol oligonucleotide primers, 1 unit Taq DNA polymerase and 100
to 500 ng DNA. The reactions were overlaid with mineral oil. On occasions a 'hot
start' of 5 minutes at 94°C was used to denature the DNA before adding the Taq
DNA polymerase. The reaction cycles were then started without allowing the
mixture to cool (see table 2.2). Once the PCR reaction cycles had been completed
lOpl of the reactions were run out in a agarose gel to check for the presence of PCR
products.
Bacterial colonies were screened by PCR using the primers T3 and T7. The colonies
growing on the LB agar plates were touched and transferred into the PCR mix using
a toothpick or a Gilson pipette yellow tip. The PCR reactions were denatured for 5
minutes at 98°C prior to adding the Taq DNA polymerase and commencing the
cycling reactions.
2.11.1 Random PCR amplification of DNA
Random PCR primers were used to amplify the telomere YAC DNA for the FISH
experiments (see section 2.14) using a method from Dr J. Warner. The YACs were
separated from the host cell genome by pulsed field gel electrophoresis using 30
second pulses. PFGE is described in section 2.6.6. The YAC bands were cut from
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dCGAATCGTAACCGTTCGTACGAGAATCGCT dTTGGAAGCATTTATCAG GT ATTGTCT AT
10mMMgCl2 Hotstart
95°10minutes 92°2" 60°2" 72°3" x38cycles
variable
Vectoretteend- escuft lom r YACclones.
Table2.2:Oligonucleotideprimersnreactioncondi ionusiPCRas ays.
The PCR amplification was conducted using a 10:1 molar ration of the primers TailL
dGGG GAG ACT ACG ATA CAG AGG and DegenL dGGG GAG ACT ACG ATA
CAG AGG NPuN PuNPu NPuN PuN. The sequence of TailL was selected to
minimise the formation of dimers and loops. It was checked to avoid common
repeats, restriction sites and palindromes. An 11 base degenerate 3' end is added to
primer TailL to make primer DegenL. The alternative bases were limited to purines
to minimise hydrogen bonding, reducing primer-primer binding.
The PCR samples were amplified in a standard 1.5 mM MgCl2 buffer using 2 pM and
0.2 pM primers, 2 pi DNA and 1.5 units Taq DNApolymerase in a 50 pi volume.
The DNA was denatured at 94°C for 5 minutes and then 5 precycling cycles were
used. These denatured the DNA at 94 °C for 1 minute and annealed the primers at
27°C for 2 minutes 30 seconds. The temperature was then increased slowly to 72°C
over 3 minutes and then left at 72°C for a further 2 minutes. These rather unusual
precycles are designed to bind and amplify from the degenerate primer. Following
these precycles, the DNA was denatured at 94°C for 5 minutes and then 25 cycles of
94°C for 1 minute, 53°C for 1 minute 30 seconds and 72°C for 2 minutes 30 seconds
were used. Finally the PCR products were extended at 72°C for 10 minutes. These
samples were checked in an agarose gel and then reamplified using the same reaction
components. The DNA was denatured at 94°C for 5 minutes and then 25 cycles of
94°C for 1 minute, 53°C for 1 minute and 72°C for 2 minutes were used. The PCR
products of 5 times 50 pi ofPCR product were pooled and the 250 pi were used as a
probe for FISH (see section 2.14).
2.11.2 Cloning PCR products
PCR products were cloned using either the 'PCR-script' cloning kit supplied by
Stratagene or the 'TA' cloning kit supplied by Invitrogen (described in section 2.2.1).
Both kits were used according to the instructions supplied with the product.
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2.12 End-cloning YACS by vectorette PCR
'Vectorette' end-cloning uses PCR to amplify the end fragments ofYAC DNA
clones (Riley 1990). The YAC clone is digested with a restriction enzyme and a
common linker is ligated to the DNA fragments. Terminal sequences are then
amplified using a vector specific primer and a linker specific primer. The linker, or
'vectorette cassette' which is ligated to the digested DNA contains an area of
mismatch. The linker specific primer (D-580) is the same as the lower sequence of
the cassette. It cannot therefore be used to seed the PCR reaction until its
complementary strand has been synthesised from the vector primer. This ensures
that PCR products can only be amplified from DNA molecules which have both the
vector and cassette sequences.
Total YAC DNA was isolated as described in section 2.4.8. About 2.5 pg ofDNA
was digested by incubation at 37°C for 2 to 3 hours using 12 unit/pg of Sau3AI or
Rsal. The reaction was stopped by incubation at 65°C for 10 minutes. The DNA
was then precipitated in sodium acetate/ethanol and resuspended in 10 pi of dlfyO.
The Vectorette cassette primers are shown in table 2.3. Primers Q292, Q293,
A294 and D-580 which were a kind gift from Dr J. Brown (MRC Human Genetics
Unit, Edinburgh) correspond to the primer sequences given in Riley (1990) The
primer PBR-4177 was designed for the vector sequence of the telomere YACs.
When annealed, primers Q292 and A294 give a linker cassette which is blunt ended.
Primers Q292 and Q293 give a cassette with a four base 5' overhang of the sequence
GATC. This cassette is used to clone fragments produced by Sau3AI digestion
which leaves a 3' overhang. The primers were mixed to a final concentration of 1
pM, heated to 94°C for 10 minutes and then slowly cooled to 20°C, over 20
minutes, to allow the primers to anneal.
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Primer Sequence
Q293 dCTC TCC CTT CTC GAA TCG TAA CCG TTC GTA
CGA GAA TCG CTG TCC TCT CCT TG
Q292 dGAT CCA AGG AGA GGA CGC TGT CTG TCG AAG
GTA AGG AAC GGA CGA GAG AAG GGA GAG
A294 dCTC TCC CTT CTC GAA TCG TAA CCG TTC GTA
CGA GAA TCG CTG TCC TCT CCT TGG ATC
D-580 dCGAATCGTAACCGTTCGTACGAGAATCGCT
PBR-4177 dTTGGAGCATTTATCAGGGTTATTGTCTCAT
Table 2.3: Oligonucleotide primers used for 'Vectorette PCR'.
The primers sequences for Q293, Q292, A294 and D-580, are from Riley (1990).
Primer PBR-4177 was designed specifically for the YAC cloning vector used to
construct the telomere YACs (analysed in Chapter 8).
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About 1 fig of the restricted yeast DNA was ligated to 6 pmole of the vectorette
primer cassette in 50 mM TrisHCl pH 7.5, 7 mM MgCl2, ImM DTT, 1 mM rATP,
using 2 units T4 ligase in 20 pi. The ligation reaction was incubated at 16°C
overnight, heated to 65°C for 10 minutes to inactivate the ligase and then stored on
ice prior to use. The ligated DNA fragment was amplified by PCR using the primers
D-580 and PBR-4177, as described in table 2.2 using 100 pM each dNTP and 100
pmole of each primer. A lOpl sample of the resultant PCR products was checked by
digestion with EcoRI since only genuine YAC end-clones should contain an EcoRI
site at the junction between the vector and the cloned insert. PCR products which
were shown to cut with EcoRI were cloned using the Stratagene PCR cloning kit.
2.13 RecA assisted restriction endonuclease cleavage (RARE)
2.13.1 PAGE purification of oligonucleotide primer
The 60 base primer RARE1 (5'-GCCTGCCTTCTTCAGGCTGCTTTAGCAGAATTCC
ATCCACTAGGAGCTGATTAGCAACAA-3') was used in the RecA-assisted restriction
endonuclease (RARE) cleavage experiments described below and in Chapter 9.
To purify the primer it was resolved in a denaturing polyacrylamide gel as described
above in section 2.6.7. The DNA was cut from the gel giving blocks of acrylamide
of about 300 to 400 pi, which were crumbled in an Eppendorf tube using a pipette
tip. At least two volumes (1 ml) of elution buffer (0.5 M ammonium acetate, 10
mM magnesium acetate, 1 mM EDTA pH 8.0, 1% SDS) was added and the sample
was left overnight at 37 °C on a shaking platform. The elution buffer was collected
and the acrylamide was rewashed in a further 500 pi elution buffer. The DNA
primer was precipitated with ethanol, the pellet was resuspended in dH20 and
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reprecipitated using sodium acetate and ethanol. The purified primer was
quantitated and compared to the original primer in a polyacrylamide gel.
Since the primer could not be seen under ethidium bromide staining the gel was silver
stained using a method base on that described in Budowle (1991). The
polyacrylamide gel was soaked in 10% ethanol for 5 minutes followed by 1% nitric
acid and then rinsed in dH20. The gel was soaked for 20 minutes in 0.12 M silver
nitrate, rinsed again in dH20 and then developed using 0.28 M sodium carbonate,
0.019% formaldehyde. Once the DNA had stained sufficiently the reaction was
stopped in 10% acetic acid for 2 minutes.
2.13 .2 RecA-assisted restriction endonuclease (RARE) cleavage
Preparation of agarose DNA blocks used for pulsed field gel electrophoresis was
described in section 2.4.7. These blocks, which contain about 10 pg of gDNA were
equilibrated by at least three washes of 30 to 45 minutes in 2 ml lx RARE buffer (25
mM Tris-acetate pEl 7.85, 4mMMgCl2, 0.5 mM spermidine, 0.4 mM DTT). The
reaction reagents were then added, in the following order, dH20 to make the final
volume of the reaction 200 pi after methylase addition: 24 pi 5x RARE buffer,
30pg RecA protein, 2 pi 10 mM EGTA, 20 pi 11 mM ADP, 20 pi 3 mM ATP-y-S,
360 to 1200 ng oligonucleotide primer (RARE1), the 80 pi DNA agarose block and
10 pi 2 mg/ml acetylated BSA. The reaction was incubated at 37°C for 30 minutes
to allow the RecA protein to bind the oligonucleotide primer, 600 units ofEcoRI
methylase and 10 pi of 2.4 mM SAM (S-adenosylmethionine) were added and the
reaction was incubated at 37°C for 1 hour to methylate the gDNA. The reaction
was stopped by the addition of 200 pi 2% SDS and incubation at 37°C for 20-30
minutes.
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To remove the SDS before digestion with EcoRI the agarose blocks were rinsed well
in TE and then washed at least four times in 2 ml TE for 30 to 45 minutes on a
rotating wheel at room temperature. It was essential to remove all traces of the
detergent to ensure that the subsequent restriction digests would be complete. The
blocks were then equilibrated into the restriction endonuclease buffer for EcoRI as
described in section 2.5.1. The EcoRI digest was incubated overnight at 37°C using
200 pi ofbuffer and 600 units of enzyme. The subsequent running of the pulsed
field gel, blotting and filter hybridisation were conducted as described above
(sections 2.6.6, 2.7 and 2.8).
2.14 Fluorescent in situ hybridisation
Fluorescent in situ hybridisation (FISH) was conducted using biotin labelled DNA
probes with metaphase chromosome spreads from a normal male essentially as
described in Fantes (1992).
2.14.1 Biotin labelling ofDNA probes
DNA probes were labelled with biotin by nick translation using biotin-16-dUTP.
The reaction labelled about 0.5 gg DNA in 50 mM TrisHCl pH 7.5, 10 mM MgSCE,
lOOpMDTT, 50 pg/mlBSA, 62.5 pM each dATP, dGTP, dCTP and biotin-16-
dUTP using 0.2 unit/ml DNase and 500 units/ml DNA polymerasel in a total volume
of 20 pi. The reaction was incubated at 15°C for 90 minutes and was stopped by
precipitating the DNA in 0.1 volume 3 M sodium acetate, 2 volume ethanol, lpl
0.5M EDTA using 1 pi (20 pg) glycogen as a carrier for the DNA. The pellet was
allowed to dry and then resuspended in 25 pi of TE.
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2.14.2 Hybridisation of DNA probes to metaphase chromosome spreads
Prior to hybridisation to the metaphase chromosome spreads, 5 pi of the biotin
labelled probe was precipitated with 5-12 pg Cotl DNA and 50 pg salmon sperm
DNA in 2 volumes ofethanol. The ethanol was removed from the precipitated DNA
using an evaporator centrifuge. Once the DNA pellet was completely dry it was
resuspended in lOpl hybridisation buffer (50% formamide, 2x SSC, 1% Tween 20
and 10% dextran sulphate) by incubation at 37°C for an hour. The probe was
transferred to 70°C for 5 minutes to denature the DNA and then returned 37°C to
preanneal for 15 minutes.
The metaphase chromosome spreads on microscope slides were prepared by T.
Johnstone. They were incubated in RNase (100 pg/ml in 2x SSC) for one hour at
37°C. The slides were rinsed in 2x SSC and then washed for 2 minutes each in 70%,
90% and then 100% ethanol to dehydrate the DNA, blotted and dried under vacuum
for 10 minutes. The slides were then warmed to 70°C for 5 minutes, denatured in
70% formamide, 2x SSC for 3 minutes at 70°C and then dehydrated by washes in
70%, 90% and 100% ethanol. Prior to use the slides were returned to the vacuum
dryer for a further 10 minutes.
To hybridise the probe to the metaphase chromosomes the biotin labelled DNA
suspended in hybridisation buffer was applied to the microscope slide over the
chromosome spread and sealed under a glass cover slip using vulcanising solution.
The slides were incubated for 16 to 20 hours at 37°C in a humid atmosphere. The
rubber seal around the cover slides was removed and the slides were washed four
times in 2x SSC at 45°C. The slides were then washed four times in 0. Ix SSC at
60°C and finally were transferred to 4x SSC, 0.1% Tween 20.
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2.14.3 Detecting the biotin labelled probe
Hybridised probe was detected by incubation with avidin FITC followed by
biotinylated antiavidin and an additional layer of avidin FITC. A 1:500 dilution of
avidin FITC was prepared in 4x SSC, 5% skimmed milk giving a working
concentration of 4 pg/ml. This dilution was centrifuged for 15 minutes and the
sbdes were incubated for 5 minutes at room temperature with 40 pi ofblocking
buffer (4x SSC, 5% skimmed milk). A 40pi abquot of avidin FITC in blocking
buffer from the top ofthe centrifuged sample was appbed to the chromosome spreads
which were incubated at 37°C in a box lined with paper soaked in 4x SSC, 0.1%
Tween 20 for 30 minutes. The slides were washed three times for 2 minutes in 4x
SSC, 0.1% Tween 20 at 45°C.
Biotinylated antiavidin was diluted 1:100 to a final concentration of 0.5 mg/ml in 4x
SSC, 5% skimmed milk. This dilution was centrifuged for 15 minutes and then 40pl
were applied to each slide. The slides were incubated at 37°C for 30 minutes and
then washed three times for 2 minutes in 4x SSC, 0.1% Tween 20 at 45°C. To this
a further 40 pi of diluted avidin FITC was added and again the slides were incubated
for 30 minutes at 37 °C and then washed three times for 2 minutes in 4x SSC, 0.1 %
Tween 20 at 45°C.
The slides were mounted in antifadent ('Vectormount') containing 10 pg/ml DAPI,
the cover slips were replaced, sealed with vulcanising rubber and then examined
using a Leitz fluorescent microscope and CCD camera.
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3. Chapter 3: Sequence and structural studies on PDGFA
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3.1 Introduction
The introduction to this thesis describes the PDGFA gene, compares it to the
PDGFB gene and discusses a number of unusual features. At the start of this project
the sequence of the exons of PDGFA was known (Bonthron 1988). In addition to
this, the short introns 5 and 6 had been sequenced along with the first 750 bases of
intron 4 (Bonthron 1992). However introns 1 to 3 and most of intron 4 were
unsequenced. Thus a sequencing project was undertaken to sequence 8 kb of
genomic sequence spanning from exon 1 to exon 4 ofPDGFA. This would leave
only the large (10 kb) intron 4 partially unsequenced.
This sequencing project was undertaken for a number of reasons: ofpressing
importance was the need for polymorphic markers from within the PDGFA gene for
linkage analysis. At the start of this project two polymorphic loci had been identified
in PDGFA. These were the minisatellite in intron 4 and the Styl RFLP which are
described in section 1.5. Neither of these provided useful polymorphic markers for
linkage analysis. The minisatellite was not sufficiently polymorphic to be useful and,
while the Styl RFLP looked more promising, the probe which was available for
Southern blotting proved difficult to use. The molecular basis for this RFLP was not
known although the distribution of Styl sites in the genomic sequence suggested that
the polymorphic band resulted from hybridisation to exon 4 (Bonthron 1992). It was
hoped that this sequencing project would answer these questions, provide a useful
probe or PCR to type the Styl polymorphism and discover other useful polymorphic
markers in PDGFA.
Alternative splicing of the PDGFA transcript involving exon 6 in human DNA and
the existence of a previously unknown exon from within intron 6 in rabbits have been
described. In addition, the omission of exon 2 and exon 6 has been found in
transcripts isolated from a human osteosarcoma cell line (section 1.5.3). These
known alternative splicing patterns raised the possibility that other exons which have
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not yet been identified exist within the introns of the gene. This sequencing project
was expected to cover about 8 kb of the genomic DNA sequence fully sequencing
introns 1 to 3. The large size of the introns meant the presence of an unknown exon
was possible. In the factor VIII gene, sequencing of intronic sequence has even
revealed the presence of a new gene sitting within an intron of another gene
(Levinson 1990).
3 .2 Plasmid clones from PDGFA
Four bacteriophage clones covering 45 kb and spanning PDGFA were available
(Bonthron 1988). Three of these are shown in diagram 5.1. One of these clones,
A.AC23, was used to make plasmid subclones for this sequencing project.
3.2.1 Exon 2 to exon 4: plasmid clone ACY7
The bacteriophage clone, A.AC23, was digested with restriction endonuclease Sail
and Xbal producing a 7.2 kb fragment spanning from the Xbal site in intron 1 to the
Sail site within exon 4. This fragment was subcloned into pBluescript II KS(+/-)and
the resultant colonies were screened by PCR amplification by D.T Bonthron. The
PCR screening used either the T3 or T7 primer with primer 144P. The primer 144P
lies within exon 4 and thus the PCR assay could identify the orientation of the cloned
insert. From this, the clone pACY7 was selected with its cloned DNA insert in the
direction shown in diagram 3.1.
3.2.2 Exon and intron 1: plasmid clone ACZ
The plasmid clone pACX, a subclone of ZAC23, which spans from the Sail site

































Diagram3.1:Theplas idsubclonespACY7npACZ TheclonepACZ,whichspansfr mtB pEls tei exon1toXbalsiteintrw ssubclonedfr mpACXsingBs I/HiucII digest.pACXwassubclonedfromA.A 23byD.TB nthronpri rthta tft isproject.C neACY7whi hspansfr mi ron1 exon4ofPDGFAwassubcloneddirectlyfromA.AC23u ingXb /Sailrestrictiondigest.Theprimer144w su dPCRre c ions withT3and7tochecktor entationft eclonedins rt.
project. A BspEI/HincII restriction endonuclease digest was used to remove the
promoter region and 5' end of exon 1 from this clone. On religation this produced a
plasmid, pACZ, with a 1.6 kb insert. This insert spans from a BspEI site in exon 1
to the Xbal site in intron 1, pACZ is shown in diagram 3.1.
3.2.3 A series of exonucleasein unidirectional deleted clones
A series ofunidirectional deleted clones was prepared from the two plasmid clones
pACY7 and pACZ using exonucleaseDI as described in section 2? . As diagram 3.2
shows, the plasmid clones were restricted in the polylinker region with Kpnl and
EcoRI producing a linear plasmid with overhanging ends at both the 3' Kpnl site and
the 5' EcoRI site. Since exonucleasein cannot initiate digestion at DNA ends with
four base 3' protrusions (the Kpnl site) digestion was unidirectional from the EcoRI
site.
Aliquots of the digestion reaction were removed at 2 minute time intervals. These
were optimised for a decrease in size of about 200 - 300 bp between each sample
creating a series of clones with progressively larger deletions from one end of the
plasmid insert. The panel ofplasmids were checked by separation in an agarose gel
(diagram 3.3) and then religated and transformed into DH5a cells. Using these
deleted clones for the sequencing project allowed all of the clones to be sequenced













series of deleted clones from
pACY7
Diagram 3 .2: Exonucleaselll nested deletion clones
Schematic diagram illustrating the use ofexonucleaselll to generate a series ofnested
deletion clones from the plasmid pACY7. Exonucleaselll digestion progresses only
from the EcoRI site.
86
minutes digested with Exonucleaselll
S>-
10 12 14 16 18 20 22 24 m
bp
26 28 30 32 34 36 m
Diagram 3.3: The exonucleaselll deleted subclones from pACY7
The deleted subclones are separated in 1% agarose prior to religation and
transformation. The clones show a progressive decrease in size with increasing time
points (shown in minutes).
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3.2.4 Size analysis of the deleted clones from pACY7
The size of the deletion in each clone derived from the same aliquot from the
exonucleaselll digest should, in theory, be the same. However the cloned inserts
were checked before the sequencing was started to avoid redundant sequencing
caused by large overlaps between the clone inserts. For this a small scale DNA
extraction using phenol/chloroform (see section 2.4) was prepared from a random
selection of the deletion clones. The plasmid contained two restriction sites for the
enzyme Pvul. This separated the cloned insert from the vector, producing two
bands and allowing the size of the insert to be measured directly. As an example, a
series of clones with smaller inserts cut with Pvul are shown in diagram 3 .4(a). This
photograph clearly shows the sequential decrease in insert size in the deleted clones.
However in a standard agarose gel it was difficult to adequately resolve small
differences in size (<1 kb) between the clones which contained the larger (~8 kb)
sized inserts.
The majority of the clones were digested with PvuII. This restriction enzyme has
several sites within the cloned insert, producing a complicated pattern of bands in the
undeleted original clone pACY7. Inspection of the pattern of the bands, the order
in which they decreased in size and then disappeared allowed a provisional PvuII
restriction map ofpACY7 to be drawn (diagram 3.4(c)). The second photograph in
diagram 3.4 (b) shows PvuII digests of the same clones as in the Pvul digests. The
clones which have been selected for this illustration contain relatively small inserts,
thus several of the DNA fragments which are marked on the restriction map are
already missing from these plasmids. The undeleted whole plasmid pACY7 is shown
in lane 1. Unfortunately the photograph is not well exposed and the fragments 0.2
kb, 0.4 kb and 0.5 kb are not easy to see. Several of the bands can be seen to
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Diagram 3.4: Pvul and PvuII digests to size the deleted subclones from pACY7.
Pvul digests (a) show the decrease in size of the cloned inserts. The order in which
the bands disappear in the PvuII digests (b) correspond to the restriction map shown
(c). Hie original undeleted plasmid pACY7 is shown in lane 1 of each photograph.
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Sizing the inserts in the panel of clones found that there were substantial differences
in size (>300 bp) between some clones derived from the same time point. Thus, the
relative order of size of the cloned inserts in the deleted clones derived from these
restriction digests was used to direct the order of the sequencing. Clones of all sizes
were selected and sequenced in the first round of sequencing giving an even coverage
of sequence across ACY7. This increased the likelihood of overlaps in the sequence
data from each subsequent round of sequencing. The sequencing reactions and the
running of the sequencing gels is described in Chapter 2, sections 2.6.7 and 2.10.
3 .3 ACY7 sequence data assembly
The sequence data, which was read manually from the 'autorads', was assembled
using the Seqaid and 'GCG' computer programs. The sequence data was checked
against a database ofvector sequences prior to being entered into the fragment
contigs at points of overlapping sequence. Discrepancies in the overlapping
sequence were checked against the original autorads. If they could not be resolved
from this original data those plasmids were resequenced. Where appropriate,
7-deaza dGTP was used in the reaction mixes to remove compressions and 'stops' in
the sequencing reactions (see section 2.10).
3.3.1 Completion of the seqence data
Once the majority of the sequence had been assembled, the remaining gaps were
filled by synthesising sequencing primers and sequencing using the original pACY7
clone as the DNA template. In total 7 short, 18 base, primers were synthesised:
P71209, P70501, P70708, P7EX03, P70621, P70110 and P70110B. Their
sequence is shown in table 2.1. The use of these primers filled the gaps between the
aligned sequence contigs, completing the sequence of the 8 kb pACY7. The frill
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sequence is shown in diagram 3.5, the sequencing primers which were used are
marked.
3.4 Sequence data from intron 1
The sequencing ofplasmid pACZ was started using the T7 primer from the plasmid
sequence. This generated about 250 bases of sequence from the downstream end of
the cloned insert, that is the region immediately upstream from the Xbal site in intron
1 which is marked on diagram 3.5 (position 1110). Searching the GenEmbl
databases using this sequence found the sequence for intron 1 which had already been
submitted (Takimoto 1993: Accession number S62078). This sequence for the 3'
end ofPDGFA from the GenEmbl database extended to exon 2 of the gene.
Comparison ofthis sequence to the data generated by this project revealed a region
of overlap of about 650 bp. Since the sequence data in the region of overlap was
found to be identical, sequencing ofpACZ was not pursued any further. The






































TGTCACACAAAGTTCAGCCGCGCCTCCGCCAGGTGTGCGGGCCCCGCGCCTGCCCTCGGGCCGGGGGAGC 18 9 0
GGCAGGATCCGGCCCAGACCCTGGGCGCAGAGCCCTGGCCCGTGCGCGGGGGCGCAGCCCGCGGAGGGAG 196 0
Styl







Diagram 3.5: The gDNA sequence of PDGFA from exon 1 to exon 4.
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TGGTCTAGTCATTTGGAAATTTGTACCTAATTATGGTGGTGGAGAGGCCTGAACTATTTTCGTTTCATGC 2 56 0
P70501
CAAAACCATTTTCTAACAAGGCCGATGGTTTCTGTAGTTTCTTGACCCAGGAAATCCCTGGGCTGATCCT 273 0
TATCGGGGGCGGAGGGTGGGGGGTGCGGTAGAGTTTCACTCCCACAGCACAGCTGGGCGGGGGATTTTGA 2 8 0 0
CCGGATCCCTCAGTGGATAACTCTAGGGAAAAGGATCTGGCTCTGGTTTGTGGGGGGGAATCCCTTGCCT 28 70
GAATCTCGCTGGTCCTGGATGGGTTTGGAAAAGTGGGGGGGGGGGGGCTGCTTCCTGGAGAAGGTTTCAG 2 94 0
PstI
GGCTTTGGAAGCTGCAGGGAAATGGGCCATTCACTTTCTGCTGGGACTATTCTTATTCTGGTCTTGGCGC 3 08 0
CCCGCCTCCTCCACCCCCACCCATTATCGCCTTTAGCATTGCAGCTTCGTGGGGTATGCTGATGGCATTC 315 0
CTCACCCGGGGGCTTCTAGGTCGTAGGGTCCGAACAGAAAAAAACAAGGATGCCCCTAAGCTAGTCCTGG 3 22 0
PstI
CCGGTTTCAAATTCCCTCTGCAGTCATGTCCCAGGAGCTCTCTCCTCCTGCCCCAGGGAATGCAGAGTGG 3 2 90
ATCTCAGCCCTCCTGTGTCCGTGAGAGGTTTTGGGGTCTGAATAGGATTCTCCTAGTGTCTGGGAGGCTT 33 6 0
TGTGTGTGAGAATATGGGGGTGGCATCTACCTCCTCTCTTGCCCTGGTGGGGGACCTTTTGTAACATAGG 343 0
Styl
GGGGCCTCCTTGGTCCTGTCCAGTCCCCTCCCCAGGTGTGGCTGAAAACAGAACCAGAGAAACCCACAGT 3 5 0 0
CTCTCGCCTGAGGACAGGAGAGGCACCGGCTGCTCCTCCAGCTTGTAGGGGGTGTCTTTTCTTCAACTCC 3 57 0
CGTTCTCTGTCGTAGGGAGGGTTGTAAACTGGTTGAGGTCAGTTCTCATTGGGTAAGCATCCTCCGGGTC 3 64 0
CTGGACTCCCTTTTCAATCCAGAGGTGCTTCTGGTCTGTTAGGGGCAGGGGACAGTGCAGGGGCTCATGA 3710
GGAAGGGGCTGGGTGCTGGGAGAAACCCAACGCAACGAACTTTCCCTCGGAGTCCCTTTATAACCCTTCC 378 0
AGGCTGATGTTCTTGGCATTAGGTGCCTCTAAGGCCCACGCTGTAGGAAGCAGAAAAGAGGCTTTGAGGA 3 85 0
ATCCCAGGGGTGCGCCCCAGCTATGCTGACTCCTCCTCCAGGTGGGTGGGGCTTTGTGACTGGCATTTGG 3 92 0
CTCCTCCCAGCATGCAGGCTGCGTCCCACTGTACAGTTGGGGAGACTGAGCCAGGCACCGTCTTGGCCGC 3 9 9 0
TCCTTGACTGTGGCTGGAGGAGCACGGGTAGTGGGATTCCTCACCATCCTCCCGGAGCCCAAGCGTTTCA 4 06 0
TTCGGAGGGTGTGCTGGAGTGAAGAGTGAAGGCTTTTCACCTGTGGCTTTTAGATCCAGAGGCCAGCATG 413 0







CTGTCCCTTGTCTCAAGAAATTTGCCAGCTCAGGCTTTCTGGGGGTCAATGAGCTAGCACGGCTGCCGTC 4 62 0
TTCTCTGTTTATTAAGCCAGGGCTAGAGGGTGGCGGGGCACGGGGACTGTGCTCTGTGGACGCAGACCAC 4 6 90
Diagram 3.5: The gDNA sequence of PDGFA from exon 1 to exon 4.
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ATGAGTCTCCTGCGAGCCACTTCTGGTCCTGTTATATTTCTCTGGGCCTCAGTTTCCTCGGATGTGAAGA 4760
AGTGATAGCACCCACCGCACACTCAGAAGCTAAGTCATTGGTAAAGCAGCTAATGCAAACGTGGCTATCA 48 3 0
CAAGGCATCCGAAAATGGGAGCTGGTGTTATTGAATTTTCTCCTACGAGTGGAGAACGGACCCGTTACTC 4 900
Styl




CGGAGGAAGCTGAGGTTT CTCCGGTTGGTTTGTGGATAGTCACGGATGCCTCGGTGGGCTGGGGAGAGAC 525 0
ACTTTGGGCTGCTAGTCCTGAACCCAGGAGGTGCAGAGACCCATTAGCCGTCTGGGCTGGTGACCGGGAC 532 0










GAACTCCTCCGTGTAGCCTCCACGAGAGGCCACGTGCCCTCCTGCCTCTCCTCATGCCGCTGGCCCTAGA 58 8 0
GTAGACTCATTTCAGGAATGAGTGGGGTCTGGCCCGCAGCCCAGTCTGGCGGCTTCCAGTGCCCCTCAGA 595 0
PstI

















AGGCCTCCCTCCTTCGAGGGTGTCTCCTGCCCCAGCCCGCCTGCTCCTCCTGGAGTCCTGGTCTGGGCCA 68 6 0
P70621

























CCGCTCACTGTGCCCCCGCCGTTGCAG^GGAAGCTGTCCCCGCTGTCTGCAAGACCAGGACGGTCATTTA 7 98 0
SMI Y
CGAGATTCCTCGGAGTCAGGTCGAC 8005
Diagram 3.5: The gDNA sequence of PDGFA from exon 1 to exon 4.
The full sequence of PDGFA from intron 1 to the Sail site in exon 4. Primers 2260 and 2790 were
used to amplify the GT repeat in intron 1 which is double underlined (positions 80 to 1010), it is
described in section 3.6.1. The Xbal site at 1105 marks the start of the insert in plasmid ACY7.
The seven primers which were used to complete the sequence data are underlined (P71209, P70501,
P70708, P7EX03, P70621, P70110 andP70110B). The primers 920601A and 631 in exon and
intron 3 were used to amplify the exon 3 dimorphism which was used in the linkage analysis in
Chapter 4, it is described in section 3.6.2. Primer pair 632 and 631 were used to screen the YAC
libraries for PDGFA in Chapter 6. In intron 3 the minisatellite, described in section 3.8, is shown
between positions 7400 and 7730 in bold italics. It was amplified using the primers 7355 and 7970
which are shown underlined. In addition to these, primer 7397 was used to sequence the cloned
PCR products from the minisatellite. Styl and PstI restriction sites are shown. The Styl RFLP
described by Ferns et al (1990) corresponded to a fragment from the Styl site in position 7155 to a
site 340 bp downstream from the end of this sequence, in intron 4. A PstI fragment from ACY7
was used to hybridise the Southern blots shown in diagram 3.13, this was derived from the two sites
in positions 6490 and 7730.
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3.5 Analysis of the sequence data
Diagram 3 .5 shows the genomic sequence ofPDGFA from exon 1 to the Sail site in
exon 4. A number of features in these sequence are annotated and these are
discussed below in relation to the analysis of the sequence.
3.5.1 Database searches
The Genbank, Embl, and EST (expressed sequence tag) databases were searched
for homologous sequences using the entire 8 kb of sequence. No sequences other
than those for the PDGFA genes showed significant homology to any region of the
sequence.
3.5.2 Analysis of the splice donor and acceptor sites
Since the presence of alternative splicing in human PDGFA and the existence of
another, previously unknown exon within intron 6 of the rabbit PDGFA gene have
been described (see section 1.3) an analysis of the intron/exon boundaries of this
sequence was conducted. Two different computer programs were used to analyse
the sequence. The programs, 'Netgene'(Brunak 1991) and'Grail: genes
recognition and analysis internet link' (Uberbacher 1988), both identified exons 2
and 3 of PDGFA. The exons 1 and 4 were not easily recognised by the analysis
programs because the sequence for these exons marks the beginning and end of the
data which was analysed. No other (unknown) exons were identified in this region
ofPDGFA.
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3.6 Polymorphic loci in PDGFA
3 .6.1 Intronl: an interrupted GT repeat
An interrupted GT repeat in intron 1 was found about 120 bp upstream from the
Xbal site (position 1105). It is double underlined in diagram 3.4. Comparison of
the sequence of the GT repeat generated by this project with the sequence previously
submitted to the GenEmbl database (Accession number S62078) found no difference
in the sequence or the number of repeats.
Despite this, since dinucleotide repeats are frequently polymorphic, a PCR assay
was developed using the primers 2260 and 2790 which are shown on the sequence.
The reaction and cycling conditions for this PCR assay are described in section 2.10.
PCR analysis of 20 unrelated individuals showed that this repeat is not polymorphic.
This was not entirely surprising since the comparison of the two versions of sequence
had found them to be identical. In addition, this GT repeat sequence is not perfectly
repeated and such interruptions in repeats are associated with stability. A stable
sequence would not be expected to be polymorphic.
3.6.2 Dimorphic markers in PDGFA suitable for linkage analysis
An easy method for finding polymorphic loci is to compare sequence data from
different sources. If sequence data derived from different individuals is compared it
may be possible to identify differences. Frequently these are simple variations such
as single base deletions or substitutions. Comparison of the published cDNA and
genomic sequence for PDGFA (Betsholtz 1986, Bonthron 1988, Sanchez 1991)
was conducted by D.T. Bonthron. This identified a dimorphic locus in exon 3. A
second dimorphic locus, in intron 4, was identified by sequencing cloned PCR
products encompassing the intron 4 minisatellite (Bonthron 1992). PCR assays for
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both of these dimorphisms were developed. The two markers are described below
and are shown in diagram 3.6.
3.6.2.1 The exon 3 dimorphism
The exon 3 dimorphism is a silent C to T transition which is amplified using primers
920601A and 631K (see section 2.11 for PCR conditions). As shown in diagram
3 .6, primer 920601A is a mismatched primer, the sequence mismatch creates an
ApaLI restriction endonuclease recognition site when the C nucleotide is present in
the target DNA. The dimorphic C to T transition abolishes this ApaLI site. Thus
restriction of the PCR product provides an easy assay to determine whether the C or
T base is present. Conveniently, this C to T transition creates a Bbul restriction
endonuclease recognition site which can be used to distinguish between
heterozygosity and partial digestion of the PCR product.
The amplified PCR product is 241 bp, on digestion, in the presence of an ApaLI site
(a 'C' allele) a fragment 223 bases is generated. The two alleles T' (241 bp) and 'C'
(223 bp) have frequencies of 0.74 and 0.26 respectively. These frequencies are
derived from the analysis of284 chromosomes comprising 64 unrelated British
individuals and 78 parents from the CEPH families. This gives a calculated
heterozygosity of 38.5%. Codominant inheritance was confirmed over 36 meioses in
two families before analysis of the CEPH panel of families for the linkage analysis
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3.6.2.2 The intron 4 dimorphism
The intron 4 dimorphism is also due to a C to T transition, it lies 489 bp downstream
of the intron 4 splice donor site. It abolishes a natural ApaLI site as shown in
diagram 3.6. The locus was amplified by the primers 844 and ApaL, generating a
256 bp product. Digestion of the PCR product in the presence of the ApaLI site
('+') generates fragments of 202 bases. The two alleles(T residue: 256 bp) and
'+' (C residue: 202 bp) have frequencies of 0.30 and 0.70 respectively; calculated
from the same 284 chromosomes described above. Thus the calculated
heterozygosity of this dimorphic locus is 42%.
The level of heterozygosity for each these two loci does not compare well to highly
polymorphic loci such as the minisatellite MS31 which was used in the linkage
analysis in Chapter 4 and has a heterozygosity of> 98%. However, the two
dimorphic loci are easy to analyse using PCR, restriction digests and separation in
agarose or polyacrylamide gels. Both of these dimorphic loci were used for typing
the CEPH families in the linkage analysis described in Chapter 4. The PCR
products, digested with ApaLI and separated in agarose and polyacrylamide gels for
an example family (CEPH family 102) are shown in diagram 4.2.
3.7 Analysis of pACY7 for repetitive sequences
The sequence of PDGFA from exon 1 to exon 4 (in diagram 3.5) was compared to
itself using the 'compare' program in 'GCG'. This program will mark sequences
which match thus easily identifying regions which contain repetitive sequences. The
graphical output or 'dotplot' of the analysis revealed a sequence repeat in intron 3
between the approximate positions 7500 to 7800. The 'dotplot' output, which is












Diagram 3.7: Identification of a repetitive sequence by sequence comparison
A 'dotplot' output of the comparison of the entire sequence data in diagram 3.5
against itself. This diagram shows a closer view of the sequence between base 7400
to the end of the sequence (8000). A repetitive region containing up to five repeat
motifs is identified between position 7500 and 7800, which is intron 3 of PDGFA.
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Inspection of the sequence in intron 3 revealed a region about 250 bp upstream from
exon 4 which contained a repetitive sequence. The repetitive sequence which spans
from position 7397 to- 7722 is marked on the sequence in diagram 3.5. An alignment
of the repeats in this minisatellite is shown in diagram 3 .8. There are six repeat
elements which have been named A to F. Each repeat is based on a 49 bp sequence
which is complete in repeat C. Gaps, shown by underlining, have been introduced
into the other five repeats to allow the best fit alignment of this sequence. The size
of each repeat is very variable with repeat D containing 44 bases while repeat F is
only 14 bases in length. There are a number of base mismatches between the repeats
which are shown underlined in bold in diagram 3.8. This alignment of the repeat
sequences was determined retrospectively following the sequence analysis of the
different sized alleles which is described in section 3.8.3. It reflects the sequence of
the sections which were found to be missing from the smaller sized alleles (see
below). There are no useful markers such as restriction sites which could be used to
delineate each repeat sequence and a number of other alignments of this sequence are
possible.
3 .8 Analysis of the minisatellite in intron 3
A review of the restriction endonuclease recognition sites in the sequence of this
region showed that this minisatellite repeat and exon 4 are both within the same Styl
fragment. The upstream Styl site, at position 7155, is marked in the sequence
shown in diagram 3.5. The downstream Styl site is positioned 340 bp downstream
from the Sail site in exon 4 which marks the end of the sequence data shown in
diagram 3.5. Minisatellites are commonly multiallelic. The balance of evidence
from this sequencing analysis and earlier restriction mapping and hybridisation studies
(see section 1.4) strongly suggests that this repetitive sequence accounts for the
previously described Styl RFLP (Ferns 1990).
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REPEAT AAGG_CCCCCTC TCCCC AG CA TGGCC BCCACCTGGACTAGGTTCCCCTCTGCCCCTCCA C AC GGCC CGCACCTGGACTAAGTTCCCCTCTGCCCCTGCCACCCCCAGTCTCTGGCC DCCACCTGGACTAAGTTCCCCTCT_CCCCACCCCCAG ACTGGCC ECCACCTGGACTAAGTTCCCCTC CTC CCACTGGCC FCCACCTGTCCAGT CC AG C Diagram3.8:Sequenceoftherepeatsinint onminisat llite The49bprep atsequenceintminisatelliteintron3ofPDGFAepea d5m s.Thr peatsavb nnamedAtF.T i sequencewasderiv dfrompACY7.Bolunderlinedbasesindicatsequencemismatch sb tw nthr p ats,singlel sin i atwhere gapshavebeenintroducedntothsequ ncell wlignmentofthrepeats.
3.8.1 Database searches for homologous sequences
The sequence from this minisatellite was used to search the Genbank, Embl, and
EST (expressed sequence tag) databases. As would be expected, the 40 bp repeat
matched other repeats bases on the pentamer 'CCCCT'. However the level of
homology between these sequences was not high (less than 40%). No significant
sequence matches to this minisatellite were found.
3 .8 .2 PCR analysis of the intron 3 minisatellite
A PCR assay which spanned the intron 3 minisatellite was developed using the
primers 7355 and 7970 (marked on diagram 3.5). This PCR assay was used to
analyse this minisatellite to determine whether the sequence was polymorphic. The
PCR products were cloned and sequenced to establish the repeat structure of
different sized alleles. The PCR reaction conditions and the primer sequences are
described in section 2.11 (table 2.2). It is worth noting that the conditions which
were used are unusual and included the use of 750 mM KC1, DMSO and 7-deaza
dGTP nucleotides. The region did not amplify well even under these optimised
conditions and required twice the normal amount ofPCR product to be loaded into
the agarose gel to visualise the fragments. It seems likely that the problems which
were associated with the PCR assay across this region are due to its very high G and
C content.
PCR analysis of62 unrelated individuals identified 4 different sized alleles. The PCR
products from six of these unrelated individuals separated in an agarose gel are
shown in diagram 3.9. This photograph clearly shows the four different sized PCR
















Diagram 3.9: PCR amplification of the intron 3 minisatellite
PCR products using the primer pah" 7355 and 7970 amplified from 6 unrelated
individuals showing four different sized alleles named 1 to 4. The DNA fragments
from the alleles in the heterozygous samples were cloned and sequenced as described
in section 3.8.
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PCR analysis of 62 unrelated individuals found that the frequencies of these alleles
were'l': 30.6%, '2': 59.7%, '3': 8.9% and'4': 0.8%, giving a calculated
heterozygosity of 54.2%. The reported heterozygosity of the Styl RFLP on the
basis of analysing 40 individuals was 40%. The frequency and size of each allele was
not reported. However, despite this discrepancy it seems highly probable that this
minisatellite is the basis of the Styl RFLP.
A four allele marker system with a heterozygosity of 54% such as this minisatellite
would be ideal for the linkage analysis described in Chapter 4. In preparation for
using this marker for linkage analysis and to confirm a Mendalian inheritance of these
alleles, DNA samples from a number of families were tested by PCR. The results of
these analyses revealed some inconsistencies. This is discussed fully in section 3 .9.
3 .8.3 Sequence structure of the minisatellite alleles
To analyse the repeat number and sequence ofthe different alleles amplified by the
PCR assay described above, the PCR products from both alleles from the four
heterozygous individuals shown in diagram 3.9 were sequenced. For this, the PCR
product bands were cut from the agarose gel, extracted using 'Geneclean' and
cloned into the 'PCRII' cloning vector as described in section 2.2. Two individuals,
Smal and DTB, are homozygous, these samples were not analysed further. Thus 8
alleles were selected for sequencing giving three copies of allele size '2', two copies
of allele sizes '1' and '3' but only one copy of allele size '4'. Allele 4 is the rarest
allele with a frequency of 0.8%.
The resultant colonies were screened for the presence of an appropriately sized insert
by PCR using the vector primers T3 and T7. Unfortunately the PCR product inserts
were refractory to PCR using standard conditions and the colonies were eventually
screened by filter hybridisation as described in section 2.7. This identified
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successfully cloned inserts in 7 of the 8 alleles. One allele (Sma2/1) could not be
cloned despite several attempts. It seems likely that this failure was due to technical
problems due to the poor quality and amount of the PCR products. Allele 7337/1
appears to be the same size and presumably carries the same number of repeats was
cloned successfully.
Sequencing of the cloned PCR products was conducted using the primers 7355
which was used to amplify the original PCR products, primer P70110 which was
originally used in the sequencing of ACY7 and primer 7397 which is located
immediately upstream of the minisatellite. These primers are indicated on the
sequence shown in diagram 3.5. The sequence data for the 7 alleles was compared
using the 'GCG' program Lpileup\
3.8.3.1 Allelic repeat number variation
The 7 alleles which were cloned and sequenced were found to contain combinations
of the same repeats A to F which were described in pACY7 and are shown in
diagram 3 .8. Comparison of the sequence data from these alleles to that from
pACY7 did not identify any other basic repeat sequences. The size differences
between pACY7 and the majority of the alleles was found to be due to the complete
absence of some repeats from the smaller alleles. Alleles containing 4, 5, 6 and 9
repeats were found. These results are summarised in table 3.10. As the table
shows, repeats A, C, E and F were common to all of the sequenced alleles. Repeat
B was missing from repeats 8654/3 and 7337/3. In allele 4418/4 both repeats B and
D were missing. By contrast, the largest allele 7337/1 which contained 9 repeats,
was found to include a second copy of repeat B and two additional copies of repeat
C.
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Allele Repeats present No. of repeats
pACY7 A _ B CDEF 6
4418/4 A C_EF 4
4418/2 A
_ B CDEF 6
8654/2 A
_ B CDEF 6
8654/3 A CDEF 5
7337/1 ACBCBCDEF 9
7337/3 A CDEF 5
Sma2/2 A
_ B CDEF 6
Table 3.10: Minisatellite repeat variation
A summary ofthe repeat variation found in the sequenced alleles for the intron 3
minisatellite. The original sequence shown in diagram 3.8 corresponds to sample
pACY7, it contains 6 repeats, as do alleles 4418/2 and 8654/2. Alleles 8654/3 and
7337/3 carry 5 repeats while allele 4418/4 contains only 4 repeats. Allele 7337/1,
which is larger, breaks the pattern with 9 repeats which include two copies of repeat
B and three copies of repeat C.
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3.8.3.2 Subrepeat sequence variation
In addition to the variation in allele repeat number described above, a number of
subrepeat sequence differences were found. These sequence variations are shown in
diagrams 3 .11 and 3 .12 where the sequence for each repeat in each of the sequenced
alleles is compared to the sequence from pACY7.
These diagrams show the aligned sequence from each sequenced allele for each
repeat, a dashed line ' ' indicates where the sequence was identical, a dotted line
' ' indicates that the repeat was not found in that allele. Diagram 3.11 shows the
sequence data for 7 of the 8 alleles which were sequenced, with those alleles of the
same length, such as 8654/3 and 7337/3, adjacent. Diagram 3.12 shows the larger
allele 7337/1 which was shown to contain extra copies of repeats B and C, as shown
in table 3.10.
Comparison of the same repeat (A to F) between the different alleles (1 to 4) found
that the base changes are relatively minor, single base substitutions. The clear
differences between repeats A to F such as their length, which were described in
diagram 3.8, are retained. There is not sufficient change in sequence in the repeat
sequences to describe a new repeat. Base changes in the sequence were found
largely in repeats C and D, while no sequence variation was found in repeat F.
These base variations meant that only two of the seven alleles which were sequenced
were found to have exactly the same sequence: they were alleles ACY7 and 8654/2.
A more complex pattern of repeat order and sequence variation was seen in allele
7337/1 which was the largest allele to be sequenced. As described above, this allele
contained two copies of repeat B and three copies of repeat C in the pattern 'A C B
CBCDEF'. These additional copies of repeats B and C showed a higher level of
































































Diagram 3.11: Subrepeat sequence variation in the rninisatellite alleles.
The dashed line '—' indicates that the sequence was the same, a dotted line
indicates that the allele did not contain this repeat. Each repeat sequence is





























Diagram 3.12: Sequence variation in the repeats of allele 7337/1
The sequence of the minisatelhte repeats of allele 7337/1 which had the repeat
pattern 'A C B C B C D E F' are compared to the sequence of the basic repeats from
pACY7. Note that pACY7 has the repeat structure A B C D E F. The dashed line
'—' indicates that the sequence of 7337/1 was the same as pACY7 while the symbol
indicates where a base in pACY7 is deleted from 7337/1.
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In the second copies of both repeats B and C there were some bases missing. These
deleted bases have been marked (*) in the diagram. No deleted bases were identified
in the other sequenced alleles shown in diagram 3.11. Despite this higher level of
variation in allele 7337/1 the sequence and structure of the repeats were essentially
the same as those described in pACY7. The sequence data suggests that repeats B
and C have been copied rather than the presence of a novel repeat sequence.
3.9 Analysis of the inheritance of the minisatellite alleles
Inspection of the results of the PCR analysis of the 62 unrelated individuals described
above in section 3.8.2 suggested some worrying features in the data. In a few
samples ofwhat were apparently homozygous individuals a trace smear could be seen
above the amplified PCR products when they were separated in an agarose gel. This
smear was easier to see early in the gel run before the PCR products had been fully
resolved. As the gel was run further it became much fainter suggesting the presence
ofDNA fragments ofvariable size. The appearance of this faint smear aroused
suspicion. Inspection of the data also suggested an abnormally high number of
individuals homozygous for the rarer allele '3' although this was not found to be
statistically significant.
Since it seemed likely that the faint smear which was seen in some homozygous
individuals was caused by the PCR assay failing to amplify the second, possibly
larger allele in these samples, PCR analysis was used to trace the inheritance of the
minisatellite alleles in a panel of 10 nuclear families. The DNA samples for these
families were kindly supplied by A. Gilfillan. The families which were selected all
contained two parents and sibships of three or four children.
112
3.9.1 PCR analysis.
The DNA from the members of the 10 selected families was amplified using the
primer pair 7355 and 7970 which are described above in section 3.8.2. Individuals
4418 (genotype 2/4) and 7337 (genotype 1/3) which are shown in diagram 3.8. were
used to provide size markers for the amplified products. Seven of these families
showed normal inheritance of the PDGFA intron 3 mini satellite within the limitations
imposed by the informativeness of the parental alleles. These PCR assays amplified
the same four alleles previously described. However, the PCR results from three
families were unusual. In each ofthese families one parent appeared to be
homozygous for an allele not present in the other parent. Inspection of the pattern
of inheritance ofthe minisatelhte alleles in the children in each ofthese families
revealed children who appeared not to have inherited an allele from the homozygous
parent. The other children in each sibship carried both maternal and paternal alleles.
The PCR results from two ofthese families ('WLK' and 'RVA') are shown in
diagram 3.13(a). As shown in the diagram, the parents in family WLK are samples
2974 (father) and 2975 (mother). The genotype of2974 appears to be 1/1 while
2975 has the genotype 2/2. The children, in samples 3026 and 3030, are both
heterozygous with the genotype 1/2. However children 3694 and 2978 appear to
have the genotype 2/2 with no apparent paternal contribution. A similar pattern is
seen in family 'RVA' with the parents being samples 2090 (genotype 2/3) and 2091
(genotype apparently 1/1). The children are samples 3999 (1/2), 1672 (1/3) and
6527 (2/2). Thus, in this family individual 6527 does not appear to carry a maternal
allele for the intron 3 mini sa tellite
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Diagram 3.13: Analysis of the inheritance ofthe intron 3 minisatellite alleles
The analysis of the inheritance ofthe intron 3 minisatellite alleles for two families
(WLK and RVA) by PCR (a) and Southern blot hybridisation (b). In both families
one parent and at least one child where found to carry a new larger allele (marked
'*') which failed to amplify by PCR but was clearly visible on hybridisation of a
radiolabelled probe to a Southern blot of PstI digests of gDNA.
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3.9.2 Southern blot analysis
The samples which were used for this PCR analysis came from a bank of families
which have been extensively studied. This meant that explanations for this result
such as incorrect samples, while theoretically possible, seemed unlikely. The most
likely reason for the observed data was that the PCR assay which amplified the
minisatellite had failed to amplify some alleles. A failed PCR assay, or preferential
amplification of a smaller allele, would explain both the patterns seen in the families
analysed and the smears seen in the PCR products from some individuals.
To investigate whether additional minisatellite alleles which fail to amplify by PCR
exist, DNA samples from the three families with abnormal PCR results were
analysed by filter hybridisation to Southern blots of genomic digests. For this, a
single copy probe was generated using PstI sites at positions 6490 and 7730 ofthe
sequence in diagram 3.5. This 1.23 kb probe, named ACY7-PstI, spans from exon
3 ofPDGFA to the end ofthe minisatellite repeat in intron 3. A PstI fragment was
selected because it gave a suitably sized fragment which could be easily separated
from the other fragments produced by the restriction digest ofpACY7. PstI gDNA
digests ofthe individuals in the three identified families were separated slowly in a
1.5% agarose gel which was blotted onto Hybond N+ using standard techniques as
described in Chapter 2. The resultant filter was probed with the radiolabelled probe
ACY7-PstI. The results of this hybridisation for two families are shown in diagram
3.12. The results from the third family which was analysed are fully consistent with
the results which are presented and add no further information.
The Southern blot analysis of these genomic digests clearly reveals another larger
allele, which is indicated with an asterisk. This larger allele is seen in the parents
2974 and 2091 and in the children 3694, 2978 and 6527 all ofwhom had appeared
to be homozygous in the PCR analysis described above. In each family the children
who had appeared not to have inherited an allele from the 'homozygous' parent are
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shown to carry this same larger allele. Interestingly all three families appear to carry
the same larger sized additional allele. This fragment appears to be three size 'steps'
larger than the nearest smaller allele ' 1' which contains 9 repeats. Thus this new
larger allele may contain as many as 12 repeats. Without the ability to PCR amplify
and clone this allele it is difficult to determine its sequence.
Since alleles with 4, 5, 6 and 9 repeats have been identified, it seems likely that
there will also be individuals with alleles containing 7 and 8 repeats although these
have not been identified. Given the Southern blot analyses it is possible that further
alleles containing 10 and 11 repeats also exist but have not been identified. It is
surprising that all three of these families carried the same larger sized allele rather
than different sized larger alleles. It is also surprising that this allele is considerably
bigger than allele ' 1' which was the largest allele detected by PCR. Without the
option of PCR analysis for these larger alleles they would have to be sought by
Southern blotting.
3.9.3 Heterozygosity of the minisatellite
This new larger allele, named allele '5' has been identified in at least three of the 62
unrelated individuals analysed in section 3 .8.2. This gives it a frequency of 2.4%.
Although this figure is based on PCR analysis only for the majority of the individuals
which were tested. The adjusted frequencies for the alleles ' 1' and '2' are 29.8%
and 58.1% respectively. The frequencies for alleles '3' and '4' remain the same at
8.9% and 0.8%. These figures, which can only be regarded as estimates, give a
calculated heterozygosity of 56.5% for this minisatellite in intron 3.
A marker system such as this with a heterozygosity of 56.5% which could be
amplified by PCR and analysed simply by separation in an agarose gel would be ideal
for linkage analysis. However the problems described above caused by the failure of
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the assay to amplify at least one allele mean that this loci cannot be reliably typed by
PCR. Southern blot analysis of the minisatellite would be required to ensure that
individuals were correctly typed. Processing a large number of samples by
hybridisation would be time consuming, require larger volumes of DNA and the
handling of a large amount of radioactivity. These problems mean that this marker is
not ideal for linkage and it was not used to map PDGFA in the analysis described in
Chapter 4.
3.10 Conclusion and discussion
The major objective of this sequencing project, to find polymorphic loci has been
achieved and three potentially suitable markers have been described. Of these, the
two dimorphic sites are used for the linkage analysis described in Chapter 4. The
minisatellite in intron 3 explains the molecular basis of the Styl RFLP described by
Ferns (1990). It is more informative than the two dimorphic loci however, as
described above, PCR analysis of this minisatellite is not reliable and it was not used
in the linkage analysis.
Analysis of the sequence data shown in diagram 3.5 excluded the presence of any
further exons in introns 1 to 3 ofPDGFA despite the previously described alternative
splice forms of the gene. Following this sequencing project, only some of the very
large intron 4 ofPDGFA remained unsequenced. The sequence of this intron was
extended from that published by Bonthron (1992) during the Rec-A assisted
restriction endonuclease (RARE) cleavage experiments described in Chapter 9.
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The position of the minisatellite repeat in intron 3 which ends about 215 bp upstream
from the start of exon 4 is particularly interesting since a minisatellite overlapping
exon and intron 4 has already been described (Bonthron 1992, see section 1.3).
Diagram 3.14 shows, to scale, the positions of these two minisatellite sequences
relative to exon 4. It is unusual to find two minisatellite repeats so closely flanking
an exon and the functional effects on expression of an exon wedged between two
minisatellites are open to speculation. The repetition of the exon 4 splice donor
sequence also raises further questions about the functional effect of this sequence
structure on splicing ofPDGFA. The potential effect of these repeated sequences on
the expression of the gene is not known and it would be interesting to investigate this
further.
While both these minisatellites are based on a 'CCCT' repeat, their sequence and
structure do not show a high homology suggesting that the two repeat sequences
have separate origins. At least two other pairs of minisatellite sequences separated
by only 1 to 2 kb have been described (Royle 1988). As with the two minisatellites
within PDGFA, characterisation of these minisatellite pairs showed that they
appeared to have different origins with different core sequences, heterozygosity and
in one case opposite orientations. It is not clear whether these closely linked
minisatellites have arisen systematically or by coincidence.
The sequencing of the different sized alleles of the intron 3 minisatellites in section
3 .8 included allele 7337/1 which contained extra copies of repeats B and C. Allele
Smal/1 which looks the similar size 7337/1 failed to clone. Inspection of the
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products with allele 7337/1 producing a more smeared band which is possibly slightly
larger than Smal/1. Given the sequence structure of 7337/1 and the subsequent
identification of alleles which are refractory to PCR amplification, it seems possible
that these two alleles may be different. Furthermore alleles containing 7, 8, 10 and
11 repeats have not been identified. It would be interesting to investigate further the
existence and sequence of these larger alleles. However the problems associated
with the PCR assays ofthe minisatelhte make such an analysis difficult and limit its
usefulness.
The subsequent work described in this thesis concentrates on mapping the PDGFA
gene, firstly by using the dimorphic markers described above for linkage analysis (see
Chapter 4), followed by physical mapping ofthe region. Physical mapping of the
region was approached by pulsed field restriction mapping (described in Chapter 5)
and the screening ofYAC libraries which are described in Chapter 6.
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Chapter 4: Linkage Analysis Of PDGFA
4.1 Localisation of PDGFA by genetic linkage
As described in the introduction (section 1.5.4), human PDGFA has been mapped to
chromosome 7p22.1 - pter using in situ hybridisation and a panel ofmouse-human
hybrid cell lines containing fragments of human chromosome 7. Two cytogenetic
landmarks, the translocation in patient DSE and the cell line 004 Rag 1-15, narrow
the possible locations of PDGFA to within 7p21 or to the subtelomeric tip of 7p
(shown in diagram 1.3). However further mapping required approaches which
would provide information at a much higher resolution. Thus one of the aims of this
project was to map PDGFA by linkage analysis. Placing PDGFA relative to other
markers on a genetic linkage map was of particular interest given the various disease
syndromes associated with deletions of chromosome 7p and the putative role of
PDGFA in the various pathological processes discussed in Chapter 1.
Linkage analysis (described in section 1.12) requires (i) suitable polymorphic
markers from the region of interest and (ii) DNA from suitable families. The search
for polymorphic markers within the PDGFA gene is described as part of the sequence
analysis described in Chapter 3. Other markers from chromosome 7p and the family
samples which were used are described below.
4 .2 The CEPH panel of families
The linkage analysis in this project uses the CEPH panel of families (Dausset 1990).
The family structures in the CEPH panel are selected to give the maximum possible
number of informative meioses for the number of individuals studied. Most families
consist of two sets of grandparents, two parents and, most importantly, a large
sibship of children (average size 8.3). Table 4.1 summarises the family structure and
origin of each of the 39 families which were used in this study.
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Family Source Sibship size No. grandparents No. males
2 F 7 0 2
12 F 7 3 2
17 F 8 0 7
21 F 6 0 3
23 F 6 0 2
28 F 7 0 3
35 F 8 0 3
37 F 6 0 4
45 F 5 0 3
102 V 14 0 6
104 V 10 4 3
884 A 12 4 5
1331 U 9 4 4
1332 u 10 4 5
1333 u 8 4 7
1334 u 7 4 6
1340 u 6 4 4
1341 u 8 4 2
1344 u 9 4 4
1345 u 7 4 5
1346 u 8 4 5
1347 u 9 4 6
1349 u 8 4 3
1350 u 7 4 2
1362 u 10 4 5
1375 u 7 4 3
1377 u 7 4 7
1408 u 7 4 3
1413 u 15 2 11
1416 u 8 4 4
1418 u 8 4 2
1420 u 6 4 0
1421 u 8 2 3
1423 u 8 4 4
1424 u 8 4 6
13291 u 7 4 4
13292 u 6 4 3
13293 u 7 4 5
13294 u 6 4 5
Table 4.1. The CEPH panel of families
DNA samples from this panel of families was used in the linkage analysis. Source of
families: A: Amish pedigree, F: France, U: Utah, V: Venezuela.
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The CEPH panel of families are ideal for linkage analysis. Their use also allows the
use of data from other markers in the same chromosomal region. This data is made
available on databases. The DNA samples were a kind gift from Dr. A. Wright and
K. Wakefield, MRC Human Genetics Unit, Edinburgh.
4.3 Polymorphic markers used in linkage analysis
4.3 .1 Polymorphic loci within PDGFA
Three polymorphic loci which were potentially suitable for linkage analysis were
identified in PDGFA: the two dimorphic markers in exon 3 and intron 4 and the
multiallelic minisatellite in intron 3 (described in Chapter 3). All three of these
markers can be amplified by PCR and would have been suitable for typing the CEPH
families for linkage analysis. However the intron 3 minisatellite PCR is a less reliable
assay since the largest of the alleles which have been identified is refractory to
amplification by PCR and identification of this allele requires a Southern blot of
genomic DNA. This requires far more DNA, handling radioactivity and is a much
lengthier process than PCR analysis. Since a large number of samples needed to be
analysed it was decided to use the two PCR assays which detect the two dimorphic
markers in exon 3 and intron 4 of PDGFA.
The potential disadvantage ofusing the two dimorphic markers was that both
required restriction of the PCR products with ApaLI. Thus it was possible that
failed or incomplete digestion of the PCR products could lead to the wrong
assignment of alleles for individuals. All results were assigned and checked
independently by both myself and D.T Bonthron. Any dubious or conflicting results
were reanalysed. In addition, the C to T transition in the exon 3 dimorphism which
destroys the artificial ApaLI site also creates a Bbul restriction site. This could be
used to check results although this was seldom found to be necessary.
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Thus the two dimorphic markers in exon 3 and intron 4 ofPDGFA were used to type
the CEPH family samples. Initially the parents ofeach family were typed. Families
in which at least one parent was heterozygous for a marker were analysed folly for
that marker. The PCR conditions which were used are described in Chapter 2,
sections 2.11 and table 2.2. Following amplification, the PCR products were
digested with ApaLI (or its isoschizomer Alw44I). The exon 3 PCR products were
run out on a 10% polyacrylamide gel, the intron 4 PCR products were separated on
a 3.5% agarose gel. The restricted and separated PCR products for an example
family (CEPH family 102) for each marker are shown in diagram 4.2.
4.3.2 Markers along chromosome 7p
The linkage analysis was conducted using the combined haplotype data for PDGFA
(see below) along with data for the markers MS31 (D7S21), CRI-S202 (D7S108),
CRJ-S127 (D7S89) and CRI-S193 (D7S103). The data for these markers was
obtained from the CEPH database (version 6.0). These markers were the most distal
loci used in the first chromosome 7p linkage map shown in diagram 1.5 (Mishra
1992) which was the most recently available linkage map for chromosome 7p at the
start of this study. Table 4.3 lists the heterozygosity of each of these markers. The
marker, D7S10, which lies between D7S89 and D7S103, was omitted from the
analysis. Using marker D7S103 instead ofD7S10 extended the analysis towards the
centromere, covering a larger area and including a marker mapped to 7p21. If
PDGFA had appeared to map to the region around D7SI0, this marker would have
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Diagram 4.2: Hie PDGFA dimorphic markers used in the linkage analysis
PCR analysis of the PDGFA dimorphisms illustrated using DNA samples from CEPH
family 102. Individuals 1 and 2 are the mother and father while samples 3 to 16 are
the fourteen siblings. The exon 3 PCR products (a) are amplified using the primer
pair 90601A/631. The intron 4 PCR products (b) use primers ApaLI and 844. All
the PCR products have been digested with ApaLI.
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Locus Probe / PCR assay Heterozygosity
PDGFA exon 3 PCR 0.38
IVS 4 PCR 0.42






Table 4.3: The markers used in the linkage analysis.
The chromosome 7p markers whch were used in the linkage analysis combined the
PDGFA markers (described in Chapter 3) with five other loci from the region. Most
of these markers were ideal for linkage analysis with heterozygosities greater than
50%. The PDGFA haplotye heterozygosity was derived from the CEPH family data.
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A more recently described marker, D7S531, was not used in the Mishra linkage
map. However the more recent linkage maps which are shown in diagram 1.5 do
include D7S531 (Grzeschik 1994, Gyapay 1994). As discussed in section 1.12,
these linkage maps place D7S531 distal to D7S21 or cannot place the two markers
relative to each other. However, the data on which some of these maps are based
includes very few families or is data which has not been checked. Following
publication of these linkage maps, the two-point linkage and Cri-Map linkage
analysis in this study was repeated using D7S53J.
4.4 PDGFA haplotype frequencies
The two dimorphic sites in PDGFA are separated by only about 420 bp (see diagram
3.14), however they lie either side of the two minisatellites in introns 3 and 4,
described in Chapter 3. Minisatellites have been shown to be 'hot-spots' for
recombination, thus there is a possibility that recombination events may occur
between the two markers in PDGFA. Bearing this in mind, each locus was typed
independently for each individual in the CEPH families. Inspection of the data, both
by hand and using pairwise linkage analysis using the MLINK program, showed that
there were no recombinants between the two markers in PDGFA in the individuals
studied in this analysis. Thus, the data for the two markers were combined into one
haplotype for each individual. As table 4.3 shows, the calculated combined
heterozygosity of the two PDGFA markers was 0.73 which provides a highly
informative marker system, ideal for linkage analysis. All the linkage analysis
presented in this report was performed using the combined haplotype data.
A chi-squared analysis was applied to the haplotype data. Table 4.4 shows the
observed frequency ofeach haplotype and the calculated expected frequencies for
each of these haplotypes (calculated from the allele frequencies given in Chapter 3).
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Haplotype Observed no. Expected no. x2 P
+C 51 41 2.44 ns
+T 110 117 0.42 ns
-C 4 18 10.89 <0.005
-T 61 50 2.42 ns
Total 226 226 n/a n/a
Table 4.4. PDGFA Haplotype frequencies.
The two dimorphic markers span the two minisatellites in intron 3 and intron 4 of
PDGFA. Despite this, the two loci, which are only 420 bp apart, are in linkage
disequilibrium for the haplotype '-C' which is observed with a much lower than
expected frequency. The expected frequencies were calculated from the allele
frequencies: '-' = 0.3, ' + ' = 0.7 and C = 0.26, T = 0.74.
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A striking difference can be seen for the -C haplotype which was found in only 4
chromosomes in contrast to an expected 18 chromosomes (x2=10.89, 1 df, p =
0.001). The other three haplotypes were found at the expected frequencies and the
observed heterozygosity was 72%, which is close to the expected 73%. The finding
of linkage disequilibrium also suggests that these two loci do not span a
recombination 'hot-spot'. However it is important to remember that only a relatively
small number of meioses are being studied in this analysis.
4.5 Two point linkage analysis.
Data for the loci D7S21, D7SI08, D7S89, D7S103 and D7S531 was combined
with the data for PDGFA to produce an appropriately formatted file using the
Genbase program (version 1.1). Following this, two point linkage analysis was
carried out using the MLINK program from the LINKAGE package, version 5.2 for
ultrix (Lathrop 1984) using equal recombination fractions for males and females.
Table 4.5 shows the pairwise lod scores for linkage between PDGFA (haplotype
data) and the previously described markers on chromosome 7p.
A maximum pairwise lod score of 39.49 (9 = 0.14) was obtained between PDGFA
and MS31 (D7S21), D7S21 was the most telomerically placed marker on the 7p
map published by Mishra (1992, see diagram 1.5) and is a highly informative marker
(heterozygosity > 98%). D7S531 shows a peak lod of4.11 at 0 = 0.264, these
maximum two-point lod scores indicate that the genetic distance between PDGFA
and D7S531 (28.3 cM) is much larger than between PDGFA and D7S21 (14.0 cM).
The third marker from chromosome 7p which shows significant linkage to PDGFA in
these two point analyses is D7S89 with a lod score of 9.86 at 9 = 0.15. The other
markers are less informative; D7S103 reaches a just significant lod score of 3 .96 at 9
= 0.21; D7S108, which is a much less informative marker with a heterozygosity of
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4.6 Multipoint linkage analysis
A multipoint analysis using the haplotype data and the three chromosome 7p markers
D7S21, D7S108 and D7S89 was undertaken using the LINKMAP program from the
LINKAGE package (Lathrop 1984). The results are shown in diagram 4.6. For
these calculations, the distances between adjacent markers were set equal to the
maximum 0 derived from two-point intermarker analyses on the same data set. Map
distances were calculated using Kosambi's mapping function.
This multipoint analysis assigns PDGFA a sex averaged location 14 cM telomeric to
MS31 (D7S21) with a maximum lod score of 41.53 at 0 = 0.13. The next highest
lod score peak is seen beyond D7S89 moving towards the centromere in the position
0 = 0.32. This peak is 9 lod scores lower than the highest peak, giving odds for a
telomeric location for PDGFA against this location of 1 : 109. Thus PDGFA is
assigned a telomeric location on chromosome 7p, extending the previously available
linkage maps.
The marker D7S531 was not included in this multipoint analysis since the data
available cannot place this marker in an unambiguous position on the chromosome 7p
map. Unambiguous placing of each marker other than the test locus (in this case
PDGFA) is required prior to running the LINKMAP program. However a
multipoint linkage analysis was conducted using just D7S21 and D7S531 as fixed loci
with PDGFA as the test locus. This multipoint linkage analysis clearly placed
PDGFA on the opposite side ofD7S21 from D7S531, with odds of 1:109 against a
location for PDGFA closer to D7S531. This is consistent with the results ofthe




















Diagram4.6:Multipointlinkageanalysis MultipointlinkageanalysisofPDGFAag instthelociD7S21,7S108dD 89us gtheLINKMAPprogram
4.7 Cri-Map analysis.
Since LINKMAP is not designed for the analysis of large amounts of data across
large distances, an alternative computer program Cri-Map (version 2.4), was also
used. Diagram 4.7 shows the sex specific and sex averaged chromosome 7p genetic
linkage maps derived from using the Cri-Map program and the chromosome 7p loci
PDGFA, D7S21, D7S108, D7S89, D7S103 and D7S531. Map distances were
calculated using Kosambi's mapping function.
The Cri-Map sex-averaged analysis places PDGFA 16 cM telomeric to D7S21
although a large difference of6.5 cM can be seen between the male and female maps.
This distal position for PDGFA is favoured against inversion ofPDGFA and D7S21
by odds of 1: 1016.
This analysis could not place D7S531 relative to the other loci used in this map. The
most likely position for D7S531 is between D7S21 and D7S89. The odds against a
location for D7S531 distal to D7S21 are 1:1000. The D753J locus was of particular
interest since it is used in other linkage maps of chromosome 7p (see diagram 1.5)
and was potentially distal to D7S21. This would have meant that D7S531 would
have been the closest marker to PDGFA, however this Cri-Map analysis suggests
that D7S531 is proximal to D7S21 when compared to PDGFA. This confirms the
results from the pairwise and multipoint analyses, presented above, which both
suggested that PDGFA is further from D7S531 than from D7S21.
The Cri-Map analysis places PDGFA as the most distal marker on chromosome 7p.
No other marker has been placed closer to PDGFA than D7S21 and no flanking


































Diagram 4.7: Cri-Map analysis of chromosome 7p.
Cri-Map analysis of the chromosome 7p loci PDGFA, D7S21, D7SJ08, D7S89,
D7S103 and D7S531. PDGFA is placed at the telomeric end of the chromosome 7
map, 16 cM from D7S21. There is large difference of 6.5 cM between the male and
female maps. D7S531 is located proximal to D7S21 although it could not be placed
relative to D7SJ08 and D7S89.
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4.8 Eurogem Consortium.
The haplotype data for PDGFA was submitted to the Eurogem consortium
collaboration and was incorporated into their data. The Cri-Map program was used
to build whole chromosome maps for each chromosome in the human genome using
the collated data generated using the CEPH panel offamilies. The chromosome 7
linkage map was compiled by F. Badbanchi in Marburg, Germany (Badbanchi 1994).
As can be seen in diagram 4.8, this map uses a different set ofmarkers across
chromosome 7p to those used in the analysis described above. Unfortunately these
two maps have no markers in common.
Like the earlier analysis, the Eurogem linkage map places PDGFA as the most distal
marker on the chromosome 7p linkage map. In the sex-averaged map from this
analysis, PDGFA is placed 10.0 cM telomeric to the nearest proximal marker which
is D7S596. The difference between the male and female linkage maps, of3.8cMis
less marked than the earlier analysis in diagram 4.7.
The locus D7S531 was initially used in the analysis for this Eurogem linkage map.
However it was not included in the final published map because it could not be placed
in an unambiguous position on the linkage map, that is with odds of 1:1000 or
greater. D7S531 was mapped to the region between D7S462 and D7S513 which is
clearly proximal to PDGFA and its nearest linked marker, D7S596.
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4.9 FISH analysis of a cytogenetic breakpoint in chromosome 7p22.
A somatic cell hybrid panel had been used previously to map PDGFA to chromosome
7p21-pter as described in section 1.3 (Bonthron 1992). The most distal known
cytogenetic landmark on chromosome 7p is the breakpoint ofthe X;7 translocation:
46,XX,t(X;7)(q21;p22) in the GM 1696 cell line (Vortkamp 1991). Following the
results of the linkage analysis above, this cell line was analysed by fluorescent in situ
hybridisation with PDGFA and MS31 (D7S21). This was done by N. van Roy and
Dr F Speleman (Department ofMedical Genetics, University Hospital, Gent,
Belgium). Two PDGFA clones, pAC23/4 and pAC41/12 which span exon and
intron 4 and from intron 4 to intron 6 respectively, were used. The clones are more
fully described in Bonthron (1992). For D7S21 the plasmid pMS31 which contains a
Sau3AI genomic fragment cloned into the BamHI site ofpUC13 was used. The
pMS31 plasmid was kindly provided by Professor A. Jeffreys (Department of
Genetics, University ofLeicester).
These experiments showed that both MS31 (D7S21) and PDGFA are located on the
extreme distal fragment of chromosome 7 which is translocated to the derivative X
chromosome (not shown). Unfortunately the signals obtained with MS31 were
somewhat weak, with background signals generally observed elsewhere (>20
metaphases examined). However, the MS31 signal was consistently present in most
metaphases on the tip ofthe normal 7p as well as on the derivative X chromosome.
Therefore, both PDGFA and D7S21 he distal to the GM 1696 7p22 translocation
breakpoint and the results of this FISH experiment do not provide any further
information about the relative positions ofPDGFA and D7S21.
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4.10 Conclusion and discussion
The linkage analyses conducted for this project and for the Eurogem collaboration
assign PDGFA to a location beyond the previous telomeric limit of the 7p linkage
map. This distal location for both PDGFA and D7S21 is confirmed by the FISH
analysis of the GM 1696 cell line. There is no known marker flanking PDGFA and
no telomere STS or probe for the chromosome 7p telomere is available at present.
D7S531 was included in the analysis because some linkage maps have placed it distal
to D7S21, as the most telomeric marker on chromosome 7p. The ambiguities which
arise in the mapping ofD7S531 in these linkage maps may be due to the very low
number of families in the CEPH panel which have been typed. The D7S531 locus
maps to the proximal, or centromeric side of the nearest marker to PDGFA in both
of the analyses presented in this report. Thus, D7S531 lies proximal to D7S21 in
the first analysis and proximal to D7S596 in the Eurogem analysis. The relative
order ofD7S21 and D7S596 is not known.
The linkage maps, especially the Eurogem map, show an increase in the distance
between PDGFA and its nearest proximal marker in comparison to the distances
between other markers on the map. This may reflect a larger physical distance
between the two loci but is seems more likely that this increase reflects the increase in
recombination which is seen in telomeric regions.
The increase in recombination frequencies towards the chromosome telomeres is
generally greater in males than females. Thus the male genetic map is frequently
longer towards the telomere than the female map. These differences are in contrast
to most areas of the genome where female recombination is usually greater than male.
The distance between, for example, D7S21 and PDGFA also shows a large
difference between the male and female maps: 19.5 cM to 13 cM respectively. A
similar pattern is seen between PDGFA and D7S596 in the Eurogem analysis. The
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observation that the male map is longer than the female map in this region also
suggests that PDGFA is in a subtelomeric location on chromosome 7p.
There is no marker available for chromosome 7p which is known to be telomeric to
PDGFA, so the distance between PDGFA and the telomere cannot be measured on
the basis of this linkage analysis. The physical distance between PDGFA and D7S21
is also difficult to estimate from this linkage data. The rough conversion of 1 cM = 1
Mb (section 1.10.3) would suggest that PDGFA lies 12.5 - 16 Mb away from D7S21.
This seems unlikely given the available information about this region of chromosome
7p. The cell line GM 1696 which was used for the FISH analysis in section 4.9 was
used in a physical mapping study of chromosome 7 (Vortkamp 1991). This study
found that only 2 probes out of 148 mapped to the region distal to the breakpoint in
this cell line while the FISH experiments reported above showed that both PDGFA
and D7S21 map to this small distal region. Assuming a random distribution of the
probes, and estimating the size of chromosome 7p to be 60 Mb, the size of this
region of the chromosome could be less than 1 Mb. However, this estimate
assumes that these probes were distributed randomly which may not be the case. An
alternative source of information for estimating the size of this region of chromosome
7p comes from the CEPH/NIH collaborative study linkage map (Mishra 1992). This
map was estimated to cover >97% of the physical map of chromosome 7 between the
7q telomere and D7S21, suggesting that the distance from PDGFA to the telomere
may well be less than 2 Mb.
As described in section 1.10, some forms of craniosynostosis have been mapped to
chromosome 7p. At the start of this study the more distally identified region for
craniosynostosis in the panel of patients with chromosome 7 deletions was 7p21-p22.
This overlapped with the assigned location for PDGFA. Molecular studies had been
conducted using DNA from a subset of patients with non-familial deletions. However
these did not include PDGFA. These studies found that all of the patients studied
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were heterozygous for MS31 (D7S21). As this linkage analysis shows, PDGFA
maps distal to D7S21 and thus is excluded as a candidate gene for craniosynostosis in
these patients.
The linkage analysis of Saethre-Chotzen craniosynostosis syndrome (see diagram 1.4)
included the locus D7S5J2. The regions identified as candidates for Saethre-
Chotzen syndromes all lay proximal to this locus. The Eurogem linkage analysis
presented in this report (diagram 4.8) includes D7S513 which is mapped some
distance proximal to PDGFA. Thus, PDGFA clearly lies at some distance from
even the most distal region linked to craniosynostosis and therefore is excluded as a
candidate gene. Recently the homeobox gene MOX2 has been mapped to 7p22.1-
p21.3 making it a more likely candidate for the Saethre-Chotzen craniosynostosis
syndrome (Grigoriou 1995).
To obtain further information about the location ofPDGFA, physical mapping of the
region by pulsed field restriction mapping (described in Chapter 5) and screening of
libraries for YAC clones (Chapter 6) was undertaken. A major aim ofthe physical
mapping project was to physically link PDGFA to other loci such as D7S21 and to
landmarks such the telomere through the development of a clone contig. In addition,
markers distal to PDGFA were required. Ideally such markers would include the
chromosome 7p telomere and thus would allow the distance between the telomere
and PDGFA to be measured. For this, telomeric YAC clones which were
candidates for chromosome 7p were analysed in Chapter 8.
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Chapter 5: Pulsed Field Restriction Mapping
5.1 PFGE restriction map ofthe PDGFA locus
To develop a physical map of the region two approaches were used: a long-range
restriction map was constructed using pulsed-field gel electrophoresis (described
below) and YAC and PI clone libraries were screened for large clones spanning the
region (Chapter 6). The methods and principles behind pulsed-field restriction
mapping are described in the introduction (section 1.13.1). Since the sequence of
DNA in clones may be rearranged during the cloning process it is important to
compare contigs to the genomic DNA sequence from which they derive. This is
usually done by comparing long range restriction maps derived from both cloned
DNA and genomic DNA. With this in mind a pulsed-field restriction map of
PDGFA was undertaken at the same time as the screening ofthe YAC clone libraries
The linkage analysis described in Chapter 4 mapped PDGFA as the most telomeric
marker on chromosome 7p. The most closely linked proximal locus was D7S21
(MS31). The linkage maps show a large sex averaged genetic distance of 16 cM
between these two loci. However, as discussed in section 4.10, the increase in
recombination in subtelomeric regions means that the physical distance between these
two loci may be considerably less than that implied by the genetic distance. It is
impossible to accurately estimate the physical distance between PDGFA and D7S21
and the two loci may even be very close together. The possibility that the two loci
are very close was investigated by pulsed-field restriction analysis since if two
markers are close they may be found to map to the same restriction fragment.
5.2 Probes used in the PFGE restriction mapping
Prior to the start ofthis project PDGFA had been cloned in bacteriophage clones
which spanned about 45 kb (Bonthron 1988). These clones were used to identify
suitable single copy probes from PDGFA which could be used for the restriction
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mapping. Four potentially suitable probes from PDGFA were identified (see
diagram 5.1), two ofthese: ACY7 and ACIXSR were selected, they are described
below. The third probe which was used for the pulsed-field mapping was MS31
(D7S21), a highly polymorphic minisatellite probe which was found to be the closest
linked locus to PDGFA in the linkage analysis.
5.2.1 Probe ACY7
Plasmid clone ACY7 spans 8 kb from the Xbal site in intron 1 to the Sail site in exon
4. It was subcloned from AAC23 (see diagram 3.1) and is more fully described in
Chapter 3, where its full sequence is presented. The insert was isolated from its
plasmid vector by an Xbal/Sall digest and the probe was hybridised to genomic DNA
digests on a Southern blot which confirmed that the insert is a suitable, single copy
probe. Since ACY7 spans 8 kb ofthe gene including three exons, it was the first
probe to be used in the PFGE analyses.
5.2.2 A downstream probe: AC41HR
As shown in diagram 5.1, AC41HR spans 1.7 kb in exon 7 ofPDGFA. It was
isolated using a HincII/EcoRI digest ofAAC41. Like ACY7 it was hybridised to
genomic DNA restriction digests in Southern blots to confirm that it did not contain
repetitive sequences. However AC41HR is only about 10 kb downstream from
ACY7. The initial mapping data (described below) showed that AC41HR lies well
within the boundaries of the restriction map produced with ACY7. Thus, AC41HR
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5.2.3 An upstream probe: ACLXSR
A probe which lay upstream from PDGFA was sought following the results from the
restriction mapping using ACY7. A number ofdifferent fragments from a subclone
of AAC10 were tested by hybridisation to gDNA Southern blots before a single copy
probe was found. Repetitive DNA was found using probes from the region between
the first EcoRI site and the second Xbal site which are about 0.8 kb and 10.7 kb
respectively from the 3' end of A.AC 10 (see diagram 5.1). This eliminated over 10
kb of the upstream region ofPDGFA. However two potentially useful probes were
identified, they were ACIXNR and ACIXSR both ofwhich are shown in diagram
5.1.
The probe ACIXNR spans from an EcoRI site to the NotI site upstream of PDGFA.
The position of this NotI site was found to be critical in the development of the
pulsed-field restriction map of the region (discussed below). Thus a probe further
upstream from this site was preferred in an attempt to extend the restriction map as
far as possible given the available clones. The second probe, ACIXSR, is a 1.6 kb
Sall/EcoRI fragment from about 20 kb upstream from PDGFA. It is also about
12 kb upstream from ACIXNR and therefore was selected to be used in the PFGE
mapping.
All three of the probes from PDGFA: ACY7, AC41HR and ACIXSR were used to
screen the YAC and PI libraries (described in Chapters 6 and 7).
5.2.4 The minisatellite MS31 (D7S21)
The third probe which was used for the PFGE restriction mapping was MS31. It
identifies the highly polymorphic minisatellite at D7S21 which has previously been
mapped to chromosome 7p22-pter (Royle 1988). The probe is a 3 kb
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Sau3AI genomic fragment cloned into the BamHI site ofpUC13. The pMS31
plasmid was kindly provided by Professor A. Jeffreys (Department of Genetics,
University ofLeicester).
MS31 (D7S21) was included as one ofthe markers in the linkage analysis which
placed PDGFA as the most distal marker on chromosome 7p. MS31 was found to
be the nearest proximal marker, separated from PDGFA by 16 cM. As discussed in
Chapter 4 and above (section 5.1) it is difficult to estimate the physical distance
between PDGFA and MS31. However, given the increase in recombination which
is seen in subtelomeric regions, it seems unlikely that the two loci are as far apart as
the large genetic distance suggests. Thus, to investigate the possibility that two loci
may be close together, the probe MS31 was used to probe the pulsed-field Southern
blots.
It is possible to measure the maximum distance between two markers if they are
shown to hybridise to the same band from gDNA digests on Southern blots. For
this, several different enzyme digests should be shown to produce a common band
with both probes to eliminate the possibility that the two probes identify two different
DNA fragments which are comigrating. The apparent size of fragments in PFGE
may be inaccurate, for example overloading gel lanes can cause DNA fragments to
migrate at apparently larger sizes. Thus, the size ofbands from different probes
should only be compared when each probe has been hybridised to the same Southern
blot.
5.3 The pulsed-field electrophoresis gels
Throughout the restriction mapping study, DNA was prepared from a single normal
male to avoid problems in interpreting the data arising from polymorphisms. DNA
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from lymphocytes was prepared in agarose blocks from fresh blood samples.
Standard methods were used for the preparation of agarose blocks containing high
molecular weight DNA, preparation of yeast chromosome DNA as size markers,
restriction digests, alkaline blotting and the subsequent hybridisation ofHybond N '
filters (described in Chapter 2). Fresh blood samples were used because cultured
cells have been shown to methylate genes whose functions are superfluous for
growth in a tissue culture flask. As a consequence, up to half all CpG sites will be
methylated in cells grown in vitro (Antequera 1990).
Smaller fragments reorientate faster when the direction of the electrical field is
changed, as a consequence they spend a larger proportion ofeach pulse interval
migrating through the gel. The size of the fragments resolved is directly related to
the length of the pulse times. The pulse times were altered to allow different DNA
fragment sizes to be resolved. The pulse times which were used to run each gel are
included in the title of each diagram. Otherwise, all of the pulsed field gels were run
at 12 to 15°C using a 1% agarose gel in 0.5x TBE, at 200 V for 24 hours. To
ensure that the sizes ofbands could be directly compared, the same pulsed-field gel
was probed with all three probes ACY7, MS31 and ACIXSR. 'Autorads' of the
Southern blots, hybridised with each of these probes are shown in diagrams 5.5 to
5.12.
5 .4 Restriction enzymes used in PFGE
The restriction endonuclease enzymes used in this pulsed field work are listed in table
5.2. These restriction enzymes, which generate large DNA fragments, often
recognise eight base cleavage sites and/or contain at least one CpG in their
recognition sites. Most of these rare cutting restriction enzymes cannot cleave
methylated CpG sites. As the table shows, the enzymes were selected to cover a
range of average sized fragments.
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Restriction Enzyme Recognition site Appx. size (kb) of
average fragment




BspDI (Clal) ATCGAT 100




Table 5.2: Restriction enzymes used for PFGE restriction mapping
These restriction enzymes, or their isoschizomers (shown in brackets) were used for
the pulsed-field restriction mapping. Their recognition sites and the approximate
average sizes ofgDNA following digestion are listed (From Birren and Lai 1993)
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A negative control, without restriction enzyme, was run with each different buffer
every time that buffer was used to ensure that no nuclease activity was present. This
is essential since even low levels ofnuclease activity may degrade DNA sufficiently to
interfere with the PFGE mapping. It is often impossible to distinguish low levels
DNA degradation from restriction digests. Where appropriate double digests, using
two different enzymes simultaneously, were used to position restriction sites more
accurately.
Prior to commencing the restriction digests for the pulsed-field gels, a control
titration using increasing amounts ofthe restriction enzyme EcoRI was used
conducted. This was used to measure the amount of enzyme which would be
required to fully digest the DNA samples. It is shown in diagram 5.3, full digestion
is seen using between 80 and 160 units ofEcoRI. For subsequent digestions, 100 to
140 units of enzyme were used.
5.5 The physical distance between MS31 and PDGFA
The patterns ofhybridisation using the PDGFA probes, ACY7 and ACIXSR, were
compared to the band sizes from MS31. The results are shown in diagrams 5.5 to
5.10, they are summarised in table 5.4 which is a guide to the following photographs
The nine restriction enzymes which are fisted in table 5.2 were all found to generate
different sized fragments when hybridised with MS31 on comparison to hybrisisation
with ACY7 or ACIXSR.
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Units
0 20 40 80 160 320
Diagram 5.3: Partial EcoRI digests.
EcoRI digests using 0 to 320 units were used to titrate the amount of restriction
enzyme needed to fully digest the genomic DNA. Full digestion is seen between 80
and 160 units of enzyme.
151
The restriction digests using the enzymes Nrul, Sail and BspDI all showed clearly
different band sizes when comparing ACY7 and MS31 (see table 5.4 for diagram
numbers). By contrast, the band sizes hybridised by these two probes with other
enzymes initially looked similar in size. Size differences between the fragments
hybridised by ACY7 and MS31 could be seen if the two autorads from each digest
were superimposed. Doing this confirmed that the fragments hybridised in the Sfil
digests (diagram 5.5) and the SacII digests (diagram 5.5) were different sizes,
however this difference was not convincing for other enzymes. For example, the
Xhol digests in diagram 5.5. The Xhol digests were repeated and are shown in
diagram 5.10, where a clear size difference between the hybridised fragments can be
seen.
The pulse times in the gel in diagram 5.10 were changed to optimise the resolution of
smaller DNA fragments. In the gel in diagram 5.5 the pulse times separate fragments
sized from 48 kb to 533 kb, the gel in diagram 5.10 does not resolve fragments
larger than 242 kb. Pulsed -field gels have been shown to provide optimal
separation of DNA fragments in the central area of the gel with areas of compression
both at the top in the region of limiting mobility and at the bottom of the gel. It
seems likely that the apparent similarity in size between the fragments hybridised by
ACY7 and MS31 in the Xhol digests in diagram 5.5 was due to this compression
effect. Changing the pulse times of the gel run has confirmed that these fragments
are not the same size.
Comparing the hybridisation patterns of ACY7 and MS31 shows a similar effect for
NotI (diagrams 5.6 and 5.9), BstZI (diagrams 5.7 and 5.9) and Mlul (diagrams 5.6
and 5.10).
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Enzyme Diagram Comparing ACY7 and MS31
NotI 5.6 Not well resolved
5.9 Clear size difference
Nrul 5.6 Clear size difference
BspDI 5.7 Clear size difference
BstZl 5.7 Not well resolved
5.9 Clear size difference
Sail 5.9 Clear size difference
Xhol 5.5 Not well resolved
5.10 Size difference when autorads superimposed
Mlul 5.6 Not well resolved.
5.10 Size difference when autorads superimposed
Sfil 5.5 Size difference when autorads superimposed
SacII 5.5 Size difference when autorads superimposed
Enzyme Diagram Comparing ACIXSR and MS31
NotI 5.9 Clear size difference
Nrul 5.9 MS31 band just below LM, not well resolved
BspDI 5.7 Clear size difference
BstZI 5.7 Not well resolved
5.9 Size difference when autorads superimposed.
Sail 5.9 Clear size difference
Xhol 5.5 Not well resolved
5.8, 5.10 Clear size difference
Mlul 5.8, 5.10 Clear size difference
Sfil 5.8 Clear size difference
SacII 5.5 Size difference when autorads superimposed
5.8 Clear size difference
Table 5.4: Measuring the physical distance between PDGFA and D7S21 (MS31).
No common sized fragments were found on comparing the hybridisation patterns
between MS31 and ACY7 or ACIXSR, thus the physical distance between the two loci
cannot be estimated. , „
If the PDGFA gene is sited within a CpG island then the average fragment sizes from
using ACY7 would be very small. The cluster of restriction sites at the 5' end ofthe
gene would make it impossible to identify physical linkage to any upstream site. At
this time during the project, the orientation ofPDGFA on chromosome 7p and thus
the side on which MS31 lay was not known. For this reason, the hybridisation
patterns seen using probes ACIXSR and MS31 were compared. The probe
ACIXSR lies about 20 kb upstream from PDGFA, and would be far more likely to
identify common restriction fragments ifMS31 lay on this side ofPDGFA.
Obviously ifMS31 lay downstream ofPDGFA a downstream probe would
potentially have been more useful. The probe AC41HR was available and mapped
to downstream ofPDGFA. However the development of a long range restriction
map around PDGFA, which is discussed below, found that AC41HR lies within the
majority ofrestriction fragments identified by ACY7 and thus using AC41HR would
not supply any further information. The orientation ofPDGFA on chromosome was
subsequently determined by Rec-A assisted restriction endonuclease (RARE)
cleavage experiments (discussed in Chapter 10).
Comparison of the hybridisation patterns produced by the probes ACIXSR and
MS31 did not identify any common sized fragments. As for ACY7, some of the
digests (BstZI, Xhol and SacII) were repeated with changed pulse times to confirm
that the hybridised bands were of different sizes. In the BstZI digest shown in
diagram 5.9 ACIXSR hybridises very faintly to a small, 20 kb band. When the two
autorads are superimposed to compare the hybridisation patterns ofMS31 and
ACIXSR the bands identified by the two probes are found to be different sizes. The
diagrams which show each of these experiments are summarised in table 5.4.
Since no common restriction fragments were hybridised, the distance between
















(c) AC1XSR ^ MS31
Diagram 5.5: Pulsed field restriction analysis: experiment 1
(a) Pulsed field analysis using the restriction enzymes Sail, Xhol, SacII and Sfil,
probed with (b) ACY7, (c) ACIXSR and (d) MS31. The gDNA samples were


















Diagram 5.6: Pulsed field restriction analysis: experiment 2
(a) Pulsed field analysis using the restriction enzymes Mlul, Nrul and NotI, probed



























(c) MS31 (d) ACIXSR
Diagram 5.7: Pulsed field restriction analysis: experiment 3
(a) Pulsed field analysis using the restriction enzymes BstZI (EagI) and BspDI (Clal),
probed with (b) ACY7, (c) MS31and(d) ACDCSR. The gDNA samples were






(b) MS31 (c) ACIXSR
Diagram 5.8: Pulsed field restriction analysis: experiment 4
(a) Pulsed field analysis using 5 second time pulses with the restriction enzymes Mlul,
Xliol, Sfil and SacII, probed with (b) MS31 and (c) ACIXSR.
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(c) MS31 (d) ACIXSR
Diagram 5.9: Pulsed field restriction analysis: experiment 5
(a) Pulsed field analysis using 5 second time pulses with the restriction enzymes NotI,
Nrul, BstZI and Sail, probed with (b) ACY7, (c) MS31 and (d) ACIXSR.
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(c) MS31 (d) ACIXSR
Diagram 5.10: Pulsed field restriction analysis: experiment 6
(a) Pulsed field analysis using the restriction enzymes Mlul, and Xliol, probed with
(b) ACY7, (c) MS31and(d) ACIXSR. The gDNA samples were separated using .
10 second pulses.
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5.6 A long-range restriction map for PDGFA
Single and double restriction digests were used to construct a long range restriction
map around the PDGFA locus. The results from hybridising the Southern blots of
the pulsed-field gels with ACY7 and ACIXSR are shown in diagrams 5.5 to 5.12, in
diagrams 5.13 and 5.14 Southern blots from conventional electrophoresis agarose
gels are shown, the restriction map derived from these results is shown in diagram
5.16.
5.6.1 NotI restriction sites
The NotI site which lies about 7 kb upstream from the 5' end of ACY7 proved to be
critical in the development of this restriction map. This NotI site had been mapped
prior to that start of this project (Bonthron 1988) and it is shown in the restriction
map in diagram 5.1. A NotI digest probed with ACY7 is shown in diagram 5.11,
the probe hybridises to a 145 kb sized fragment. A single band is hybridised
indicating that this site cuts fully, this was found to be extremely useful in the
analysis of the other restriction enzymes and this NotI site is assigned position 0 on
the restriction map. Probing the NotI restriction digests with ACIXSR gave a 150kb
band, thus three NotI restriction sites can be placed on the restriction map in
diagram 5.16, they are in positions -150, 0 and +145.
5.6.2 Nrul restriction sites
Probing an Nrul digest with ACY7 identified a DNA fragment of around 600 kb
(diagram 5.6). Probing with ACIXSR in diagram 5.9 found that the probe hybridises
to the large limiting mobility band which marks the limits of resolution under the
pulse times used in this gel. Therefore the Nrul fragment must be larger than 194 kb
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and it is possible that both probes hybridise to the same fragment. A double digest
using Nrul and NotI is shown in diagram 5.11. For both probes ACY7 and
ACIXSR, the bands hybridised in the double digest are the same size as those in the
NotI only digest. Thus the restriction sites for Nrul he outside the NotI sites, and
cannot be placed on the restriction map in diagram 5.16.
5.6.3 Mlul restriction sites
A single Mlul digest produced a 100 kb fragment when probed with ACY7 (diagram
5.10). A double digest ofMlul with NotI is shown in diagram 5.12, hybridisation
with ACY7 produced an interesting pattern. The Mlul band remains the same size in
the double digest indicating that two Mlul sites he within the NotI sites. However
closer inspection ofthe Mlul single digest in diagram 5.12 shows that there is a
second, larger band of about 200 kb. Hybridisation to this band is much fainter
suggesting that it arises from a partial digest which may arise as a result of
incomplete methylation of a restriction site. This band disappears in the MluI/NotI
double digest. These results suggest that three Mlul sites can be mapped from
hybridisation with ACY7, the first hes close to the NotI at position 0, with the other
two sites being at + 100 and + 170 in the restriction map in diagram 5.16.
The alternative explanation for the two fragments seen in the Mlul single digest is
there is an Mlul restriction site within ACY7. If this were the case, the double
digest with NotI would not produce a band corresponding to the NotI single digest.
It would produce two fragments: one the same size as one ofthe Mlul fragments,
the second corresponding to the distance between the NotI site and the Mlul site in
ACY7.
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Probing Mlul and MluI/NotI digests with ACIXSR confirmed the first hypothesis
proposed above. An Mlul site within ACY7 would mean that one ofthe two bands
hybridised by ACY7 should also be seen, at the same size, when probed with
ACIXSR, no such band was seen. The single Mlul digest hybridised with ACIXSR
produced a fragment sized over 436 kb, within the region of limiting mobility in the
gel in diagram 5.12. The MluI/NotI digest produced the same pattern as the NotI
digest confirming that this Mlul site is beyond the upstream NotI site and cannot be
marked on the restriction map in diagram 5.16.
5.6.4 Xhol restriction sites
In contrast to the very large distances covered using enzymes such as Nrul and Mlul,
Xhol produced small DNA fragments. Diagram 5.10 shows an Xhol digest probed
with ACY7, the smallest fragment is considerably smaller than the smallest band in
the X ladder marker which is 48 kb in size. The sizes of the Xhol digests were
investigated further in a standard agarose gel, using double digests of Xhol with
Hindlll and EcoRI (see diagram 5.13). There is a Hindlll site within ACY7, about
12 kb downstream from the NotI site in position 0 on the restriction map in diagram
5.13 (shown in diagram 5.1). On hybridisation with ACY7, the Hindlll/Xhol
double digest produced bands of 4.5 and 7 kb, giving two possible locations for the
Xhol site on each side ofACY7.
The sequence of the promoter region ofPDGFA was known to contain an Xhol site
(D.T Bonthron, pers comm.). This known site placed the upstream Xhol site in
position +5 on the restriction map in diagram 5.16, thus the downstream site
corresponds to position +16.5. These positions for the Xhol sites were confirmed
by the XhoI/EcoRI digest shown in diagram 5.2 which produced just one band of
10.5 kb in size.
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The upstream Xhol fragments, hybridised by ACIXSR are shown in diagram 5.10.
Two bands sized about 20 and 50 kb can be seen. These have been marked on the
restriction map in diagram 5.16 in positions -20 and -50.
5.6.5 Sfil restriction sites
The restriction enzyme Sfil also produced very small fragments, in diagram 5.5
ACY7 hybridises to a band smaller than the 48 kb size marker. Thus the restriction
sites for this enzyme were mapped using conventional electrophoresis. A single Sfil
digest is shown in diagram 5.14 where two bands sized 10 kb and about 15 kb are
hybridised. The two bands are of equal intensity, implying that there is an Sfil site
which cuts within the ACY7 probe. The presence of an Sfil restriction site within
ACY7 (in position 4427) was confirmed by inspection of the sequence.
The Sfil/NotI double digest in diagram 5.5 also produced two bands, sized about
8kb and 10.5 kb. Since the NotI site in position 0 cuts fully, one of these bands
must correspond to the Notl-Sfil fragment while the other is an Sfil-Sfil fragment.
This would mean that the 8 kb band is a Notl-Sfil fragment, placing Sfil sites in
positions + 8 (within ACY7) and +18.5 on the restriction map. The third site which
accounts for the two fragments seen in the single Sfil digest must lie upstream from
the NotI site. An Sfil site at -7 would give rise to the two fragments of 15 kb and
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Diagram 5.11: Pulsed field restriction analysis: experiment 7
(a) Pulsed field analysis using the restriction enzymes NotI, Nrul and BspDI, probed












Diagram 5.12: Pulsed field restriction analysis: experiment 8
(a) Pulsed field analysis using the restriction enzymes NotI, Mlul and SacII, probed
with (b) ACY7 and (c) ACIXSR. The gDNA samples were separated using 20
second pulses.
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Diagram 5.13: Restriction sites for Xhol on hybridisation with ACY7.
Conventional gel electrophoresis analysis placed sites for Xhol 4.5 kb downstream
and 7 kb upstream from the Hindlll site in ACY7 (discussed in section 5.6.4). The
4.5 kb band in the Hindlll/Xhol digest was very faint and is not shown in this
diagram. The HindllJv'Sall double digests produced the same pattern as Hindlll
alone, however the 15.6 kb band is fainter in the double digest suggesting that the
Sail site which marks the 3' end ofACY7 does cut to a very small extent, however
Sail was not included in the restriction map in diagram 5.16. A gDNA sample from
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Diagram 5.14: Restriction sites for Sfil on hybridisation with ACY7.
Conventional gel electrophoresis produced two fragments for Sfil of about 10 kb and
15 kb. The Sfil/NotI double digest placed these sites in postions + 8 and + 18.5 in
the restriction map in diagram 5.16. These positions were confirmed by the
Sfil/Xhol and Sfil/Xbal digests which are shown. The known restriction sites for
Xbal are shown in diagram 5.1. A gDNA sample from the same individual used for
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Diagram 5.15: Localisation of the restriction sites for BstZI
Conventional gel electrophoresis was used to analyse the position of restriction sites
for the enzyme BstZI. Genomic DNA from the same individual as used in the pulsed
field gel was used. The blot was hybridised with the probe ACY7
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5.6.6 SacII restriction sites
The SacII single digest in diagram 5.12 shows two bands of 50 kb and 130 kb when
hybridised with ACY7, this pattern remains the same in the SacII/NotI double digest.
This suggests that the SacII sites lie within, or very close to, the NotI sites. The
two bands hybridised with ACY7 in the single SacII digest must to be due to a partial
digest. The alternative explanation for two bands, that a SacII restriction site exists
within ACY7, cannot be correct because the SacII sites do not span the NotI site
7kb upstream from ACY7 and no SacII sites were identified in the sequence of
ACY7. Thus, SacII sites have been marked on the restriction map in diagram 5.16
in positions 0, +50 and +130. Probing the same blot in diagram 5.12 with ACIXSR
produced a 50 kb fragment in the single SacII digest. This pattern does not change
in the SacII/NotI digest, thus a SacII site lies at position -50 in the restriction map.
5.6.7 BspDI restriction sites
Very large DNA fragments of > 776 kb were produced on probing BspDI digests
with both ACY7 and ACIXSR (shown in diagram 5.11). Hybridisation to double
digests with BspDI and NotI identified the same fragment sizes as the NotI single
digest, thus the nearest BspDI sites lie outwith the NotI sites and cannot be marked
on the restriction map in diagram 5.16.
5.6.8 BstZI restriction sites
Like the enzymes Xhol and Sfil, BstZI was found to give very small DNA fragments
in single digests (see diagram 5.7). In diagram 5.9, ACY7 hybridises to a 38 kb
fragment, thus the restriction sites for BstZI were mapped using conventional
electrophoresis (see diagram 5.15). A BstZI/HindlH double digest gave fragments
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of 14 kb and 21 kb. Since the position of the Hindlll site is known this gives two
possible locations for the two BstZI sites, those are positions -5 and +30 or +2 and
+37. In the BstZI/NotI double digest, ACY7 hybridises to a band which is clearly
smaller than that in the BstZI single digests. Since the NotI site is known to be in
position 0 and to cut completely, the two locations for the BstZI sites must be -5 and
+ 30, these are marked on the restriction map in diagram 5.16. ACIXSR hybridises
to a 38 kb band in the single BstZI digest (see diagram 5.9) locating an upstream
restriction site to position - 45.
5.7 The long range restriction map
The restriction map produced by these experiments is shown in diagram 5.16, it
shows a cluster of restriction sites around the exons of PDGFA. Sites are present
for all the restriction enzymes which were studied, with the exception ofNrul and
BspDI. The enzymes Xhol, Sfil and BstZI all have several restriction sites within
the area spanned by the exons of PDGFA. For other enzymes such as NotI, Mlul
and SacII the sizes of fragments hybridising to ACY7 are also relatively small, the
majority being less than 100 kb. This pattern clearly demonstrates a CpG island
(Bird 1986). The apparent extent of this CpG island on the basis of the restriction
mapping is marked in the diagram. This cluster of restriction sites for rare cutting
enzymes is most marked around position 0 on the restriction map which corresponds
to the promoter region for PDGFA. The identification of a CpG island around the
start of the gene is not surprising. This cluster ofrestriction sites covers about 25 kb
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A dramatic increase in fragment size for enzymes such as Mlul and Sfil is seen on
hybridisation with ACIXSR. This second probe lies about 20 kb upstream from
exon 1 of PDGFA. As the restriction map shows, this is upstream from the CpG
island. Thus, this probe would be expected to identify much larger fragments.
5.8 Extension of the restriction map
Extending the long range restriction map as far as possible is obviously of great
interest if the map is to be useful for a long range physical mapping project. The
downstream probe AC41HR which maps to exon 7 of PDGFA has been described
above (see diagram 5 .1). This probe is from the extreme 3' end of the cloned region
around the gene and is therefore potentially useful for extending the restriction map.
However, as described above, the majority of the enzymes which were used for the
restriction map have been mapped to sites beyond AC41HR and this probe would
provide very little further information.
Extension of the restriction map described above was not possible given the
resources which were available at this time during the project. The probes ACIXSR
and AC41HR mark the limits of the cloned region around PDGFA thus extending the
restriction map in this direction requires new clones to be identified. Towards this
aim, YAC and PI clone libraries were screened (described in Chapters 6 and 7). It
was hoped that this library screening would extend the cloned region and provide
further probes. Restriction sites for the enzymes BspDI and Nrul have not been
found within the mapped region. The large fragments produced by these enzymes
could be useful for extending the restriction map if more distant probes were
identified.
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5.9 Discussion and conclusion
The physical distance between PDGFA and its nearest proximal marker MS31
(D7S21) cannot be measured in this pulsed-field mapping project given the probes
which are available. Thus the distance between PDGFA and MS31 remains difficult
to estimate. As discussed, above it is likely that the distance between the two loci is
not as large as the linkage data suggests. Unfortunately this PFGE analysis cannot
confirm or refute this hypothesis.
The presence ofa CpG island at the 5' end ofPDGFA is not surprising since
sequence data had already shown that the region had a high CG content (Bonthron
1988). CpG islands are described in section 1.13, they are defined on the basis of
the CpG content of the sequence of a region. Thus the presence of such a CpG
island around PDGFA in this project is inferred from the cluster of restriction sites
for rare-cutting enzymes. CpG islands have been described at the 5' end ofmost
genes which, like PDGFA, are widely expressed. They are less commonly
associated with genes that have a restricted, tissue specific pattern of expression.
The size of CpG islands appears to be similar regardless of the size of the associated
gene. Consequently a wide variation in the area covered by CpG island has been
described, with some genes the CpG island is found to be tightly restricted to the 5'
promoter region while other genes such as the a-globin gene have been found to
have CpG islands which span their entire length (Bird 1987b). As discussed above,
this CpG island across PDGFA spans most of the gene. No functional significance
has been determined for this variation in the extent of the CpG islands.
The major aim of this project is to map PDGFA within the region of 7p22, thus the
possibility of other loci which could be physically mapped to PDGFA should be
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considered. Unfortunately there are few other probes available for the telomeric
region of chromosome 7p and most of the loci which were used in the linkage
analysis in Chapter 4 were based on PCR assays for which there are no probes
available. The second set ofmarkers which were analysed in the Eurogem linkage
analysis placed the marker D7S596 as the nearest proximal marker to PDGFA.
Unfortunately the linkage analyses do not place the relative order of MS31 and
D7S596 in the same linkage map, thus there is no information available about the
distance between MS31 and D7S596. Also, there are no probes available for
D7S596 and the possibility of establishing physical linkage between this locus and
PDGFA has not been pursued. Thus, at present there are no candidates other than
MS31 which could be used to establish the distance between PDGFA and proximal
loci.
The linkage analysis presented in Chapter 4 suggests that PDGFA may have a
subtelomeric location. Thus a second goal for this physical mapping project is to
physically link the gene to the telomere of 7p. Attempts have been made, both in
this project and by others, to try to isolate a suitable single copy probe using
candidate chromosome 7p telomere YACs (see Chapter 8). Isolating single copy
probes from the telomeric regions of chromosomes is complicated by the presence of
a high number of repeated sequences which may be present on several chromosome
telomeres and unfortunately there are no telomere probes available at present. The
extension of the restriction mapping project towards the telomere ofPDGFA cannot
be undertaken until suitable probes are available.
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Chapter 6: Analysis of the human YAC libraries.
6.1 Introduction
To allow the construction of a clone contig, human YAC clone libraries were
screened for clones spanning the PDGFA gene. Traditionally, the screening of
libraries has been undertaken using filter hybridisation of radiolabeled probes to
gridded filters. The gridded filters have the individual clones laid out on nylon
filters. When a potentially positive clone is detected, the original YAC clone can
immediately be identified from its position on the grid. More recently most libraries
have been constructed as a series of pooled samples which contain many clones.
These pools can be analysed by PCR screening the master or primary pools. For
those pools which screen positive, that is that they contain a clone carrying the target
DNA, the secondary pools and subsequently the tertiary pools are screened. Each
round of testing screens progressively fewer YACS until the original clone can be
identified (Green 1990). In this project both filter hybridisation and PCR analysis
were used to screen the YAC libraries for the PDGFA gene.
A number of YAC libraries are now available. Both total human genomic DNA
libraries and chromosome 7 specific libraries were screened. The libraries which
were screened for this project are described in section 1.14.
6.2 PCR analysis of the YAC libraries
Three PCR assays from the PDGFA gene were used to screen by PCR, these
identified loci in exon/intron 3 (primers 631/632), intron 4 (primers ApaL/844) and
intron 5 (430/731). The primer sequences and conditions used for each PCR assay
are described in Chapter 2 (table 2.2). The location of each STS along the PDGFA
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The intron 4 primer pair, ApaL/844, identify a dimorphic site which is described in
Chapter 3 (see diagram 3.6) and was used in the linkage analysis in Chapter 4. The
other two primer pairs amplify sites which are not polymorphic. The primer pair,
631/632, uses the downstream primer, 631, which was used to amplify the
dimorphic site in exon 3 for the linkage analysis. However the upstream primer used
to amplify the dimorphic site, 920601A, contains a mismatched base in its sequence
(discussed in section 3.6). It has been substituted with the primer 632 which lies
downstream ofthe variant base. This provided a more 'robust' PCR assay. The
intron 6 primer pair (430/731) are larger oligonucleotides of 30 bases, this STS was
developed specifically for the YAC library screening.
Table 6.2 summarises the YAC libraries which were screened, their source and the
PCR assays which were used. The majority ofthe resolved PCR products were
blotted onto Hybond N" membrane and then probed with the radiolabelled PCR
product. This was done to ensure that there was no PCR product in the reaction.
A poor amplification ofthe target DNA may not have been visible by eye but would
have been detected by this approach. Where the PCR products were blotted and
probed this is noted in table 6.2.
The Washington total genomic library and both the chromosome 7 libraries (see
section 1.14) are not made widely available. All three sets ofthe PCR primers
shown in diagram 6.1 were sent to E. Green (NIH, Bethesda, USA) and to S.
Scherer in L-C Tsui's laboratory in Toronto, Canada. They both kindly screened
their chromosome 7 specific libraries using the primer pairs noted in table 6.2. In
addition, E. Green also screened the ICI total genomic DNA library, the
Washington total genomic DNA library and the telomere YAC library from H.
Riethman. The telomere YAC library from H. Riethman is discussed further in
Chapter 8: Telomere YACs.
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Library Source Primer pair ? probed Comments
ICI K.Dry ApaL/844 yes no positives
631/632 yes no positives
430/731 no no positives
Factor VHI no positive control
see diagram 6.5
J.Warner 430/731 yes - pool 28
positive
2° pool screened - no
positives (diagram 6.6)
E. Green ApaL/844 not available screened by E. Green
631/632 not available - no positives
430/731 not available
CEPH M. Jones ApaL/844 no no positives
631/632 yes no positives
see diagram 6.7




Washington E. Green ApaL/844 not available screened by E.Green
total genomic no positives
631/632 not available no positives
430/731 not available no positives
Washington E. Green ApaL/844 not available no positives
chromosome 7 631/632 not available no positives
430/731 not available no positives
Toronto L-C Tsui 430/731 not available screened by S.Scherer
chromosome 7
Table 6.2: PCR analysis of the YAC libraries
A summary ofthe PCR screening of the human total genomic and chromosome 7
specific YAC clone libraries. Whenever possible the agarose electrophoresis
separated PCR products were Southern blotted and probed using radiolabelled PCR
product from a gDNA PCR control, this is indicated in column 4.
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6.2.1 A Positive Control: A PCR assay for the Factor VIE Gene
To ensure that the aliquots of the YAC library primary pools and the general method
PCR screening were reliable, a PCR for a different gene and chromosomal location
was used as a positive control. Thus, the library was screened using a PCR assay
which identified an STS from intron 19 ofthe Factor VTH gene (Graham 1990).
This assay was selected since it was known that the Factor VTH gene was represented
in the library (pers. comm. J. Warner). The PCR primers and the reaction conditions
were kindly supplied by L. Strain (Human Genetics Unit, Edinburgh University) and
are described in table 2.2. It is acknowledged that this control would not identify
failures to find positive YACs which were due to problems specific to the PDGFA
PCR assays.
6.3 Filter hybridisation analysis of the YAC libraries
A PCR reaction may fail if it is particularly sensitive to the presence of agarose or to
the low levels of target DNA which are present for each individual YAC in the
primary pools. An alternative approach which avoids these problems is to screen the
YAC libraries by filter hybridisation using membranes which have been gridded with
an array of individual YACs. The ICI library, which is described in section 1.14.1,
was kindly supplied as a set of 40 gridded filters by R. Elaswarapu (HGMP Resource
Centre, London).
Two single copy probes from PDGFA were used to probe the ICI YAC library
filters. These two probes, ACY7 and AC41HR, are shown in diagram 6.1 and they
are described in section 5.2. Subsequent to this a third probe, ACIXSR, which
maps to a region about 20 kb upstream from PDGFA was developed (see section
5.2). Since this probe is also single copy it would potentially have been useful in the
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screening ofthe YAC libraries. Using this probe to screen the library would have
extended the area around the gene for which screening had been undertaken.
However the results from using this probe to screen the ICRF PI library, which are
described in Chapter 7, led to the decision not to use this probe to screen the ICI
YAC library.
6.4 Results of the YAC library screening
6.4.1 The positive control: the Factor VIII gene
The Factor Vm gene PCR assay was used to screen the ICI YAC library using the
primary pools from K. Dry. The results of screening the ICI YAC library are shown
in diagram 6.3. In addition to the 0 control (marked '0') and the genomic DNA
positive control (marked a yeast gDNA sample was included (marked 'Y') to
ensure that the PCR primers do not amplify the yeast DNA background. Three
strong (pools 8, 21 and 24) and three fainter (pools 5, 15 and 26) PCR products
were seen in the primary pools. This number ofpotential positives corresponds to
the expected number for this library which is estimated to have a 3 to 4 times
coverage of the genome. Since this screen was used simply as a positive control to
check the integrity ofthe samples and the screening procedure, the secondary pools
for these potential positives were not screened.
This positive control was not used on the second set of samples of the ICI YAC
library from J. Warner or the CEPH 'megaYAC' library since there was a limited
amount of each sample available. The results of this positive control suggest that the
YAC library primary pools and the PCR screening method are reliable.
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0 + + Y 1 2 3 4 5 6 7 8 9 10 11 12 13 M
+ Y 14 15 16 17 18 19 20 21 22 23 24 25 26 27 M
0 + + Y 28 29 30 31 32 33 34 35 36 37 38 39 40 M
Diagram 6.3: Analysis of the 1CI YAC library for Factor VIII.
The 1CI YAC library primary pools screened with the PCR assay for intron 19 of the
Factor VIII gene. Strong positive PCR products are seen in pools 8, 22 and 24,
fainter PCR products are seen in pools 5, 15 and 36.
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6.4.2 Screening for PDGFA
The total genomic and chromosome 7 YAC libraries listed in table 6.2 were screened
extensively using three different PCR assays. In addition, the ICI YAC library was
screened by filter hybridisation using two single copy probes from PDGFA. Despite
this exhaustive screening project, no positive clones for PDGFA were identified.
An example of the negative results from both the ICI YAC library is shown in
diagram 6.4. The PCR products were blotted and probed, identifying one
apparently positive pool, number 28. However screening ofthe secondary pools for
pool 28 did not identify any positive clones suggesting that this weak positive signal
was due to contamination of the first PCR reaction.
6.5 Conclusion and discussion
The failure to find any positive clones for PDGFA from the YAC libraries despite an
exhaustive search is interesting. Since it is possible that any individual library may
not contain clones spanning PDGFA, five different libraries have been screened.
The absence ofpositive clones from all of these YAC libraries suggests that this
region is genuinely not represented in these libraries and that clones have not been
accidentally missed.
However the lack ofpositive clones could be due to a failure to find clones from
PDGFA which are present in the libraries, so a number of steps have been taken to
avoid sources of error. It is theoretically possible that the aliquots of the primary
pools for a library from an individual source contained faults which led to a positive
clone being missed. To eliminate this possibility, three different sources of the ICI
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Errors arising from using the PCR approach to screening the libraries have been
countered by screening by hybridisation of radiolabeled probes to gridded filters. In
addition, three different PCR assays for PDGFA were used. The positive control
PCR assay for the Factor VIII gene, used with the ICI library, has demonstrated
that other PCR assays are effective. Also, since agarose in the samples may chelate
magnesium, inhibiting the PCR reaction, the PCR screening was repeated using
MgCl2 concentrations increased to 2.5 mM. The possibility that the PCR reactions
had failed to amplify sufficient product to be seen in the agarose gels was investigated
by blotting and probing the PCR 'products'.
Finally, the possibility of operator errors leading to the failure to find positive clones
has been countered by the independent screening undertaken by the two other
laboratories in Toronto and Washington.
It is possible that the failure to find clones may be due to chance. However, the
likelihood of any locus being present in a YAC clone library with a genome coverage
of 3 to 4 times is about 95 %. For this project three total genomic libraries were
screened for PDGFA, giving a combined probability of> 99 % for finding a clone
spanning the gene. In addition, two chromosome 7 specific libraries were screened.
The screening of several genomic and chromosome 7 specific YAC libraries lowers
the likelihood that the failure to find any clones was due to chance.
It is possible that the PDGFA gene is not represented in these YAC libraries because
it is unclonable in YACs. The use of the eukaryotic yeast as host for the YAC
cloning system was expected to overcome the problems associated with cloning some
regions in E.Coli. For many regions of the human genome the YAC system is a
great improvement, however the cloning of some sequences into YACs leads to
structural instability of the recombinant clones. This instability may cause
breakdown of the YAC clone producing several YAC bands ofdifferent sizes or the
cloned DNA insert may be found to be rearranged without a change in the clone size.
If the clone is particularly unstable then it may be completely deleted and thus lost
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from the library. Very little information has been published about DNA regions
which are unclonable or unstable in YACs. A review on this topic which depended
largely on personal communication reports rather than published data concluded that
highly repetitive regions of the human genome such as rDNA and alphoid satellites
were the major causes of instability in YAC clones (Vilageliu 1992). The Y
chromosome repeat sequences have also been shown to be unstable in YAC clones
(Neil 1990). From the data which is described above it is not possible to determine
whether YAC clones spanning PDGFA are not represented as a consequence of clone
instability.
The search for clones spanning PDGFA in an attempt to build a physical map ofthe
region was continued using two separate approaches. Firstly, since the region may
well be unstable in YACs, an alternative vector system was sought. For this the
ICRF PI clone library was screened, the screening ofthis library is described in
Chapter 7. An alternative possibility, given the results of the linkage analysis
described in Chapter 4, is that the PDGFA gene lies very close to the telomere.
Such regions are difficult to clone in the standard YAC vectors but are clonable using
a telomere YAC vector system. Thus a telomere YAC library was sought and
analysed, this is described in Chapter 8.
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7. Chapter 7: Analysis of the ICRF human gDNA PI library.
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7.1 The PI cloning vector
This project aimed to generate a physical map of the PDGFA locus, instrumental to
this was the construction of a contig of clones from the region. Since PI clones
carry much smaller DNA inserts than YACs they are not the system of choice for a
mapping project such as this. However, following the screening of the YAC clone
libraries (described in Chapter 6) which did not find any YAC clones which spanned
PDGFA, an alternative cloning vector system was sought.
The PI cloning system, which is described in section 1.13.5, can clone inserts up to
95 kb in size which is considerably larger than the insert size possible in cosmid
clones (up to 40 kb). The PI cloning vector system has been shown to be useful for
cloning regions which are unstable in YACs and where cosmid walks have failed
(Halford 1993). During the construction of the S. pombe whole-genome mapping
project, the PI cloning vector was found to be more successful than cosmids in
spanning rDNA repeat regions (Hoheisel 1993, Francis 1994). It is possible that
instability of the YAC clones, perhaps caused by repetitive regions of sequence, is
the reason why no YAC clones of PDGFA have been identified. More importantly,
the P1 cloning system has been used to make a human total genomic DNA clone
library which is available to the scientific community for screening (Francis 1994).
These factors made the PI cloning system an obvious choice for a second round of
library screening in an attempt to find clones spanning PDGFA.
7.2 Probes used to screen the ICRF PI clone library
Three different single copies from PDGFA were used to screen the library. The
probes ACY7, AC41HR and AC1XSR are described in Chapter 5, see diagram 5.2.
Both ACY7 and ACIXSR were used extensively in the pulsed-field restriction
mapping experiments. The probes, ACY7 and AC41HR, were also used to screen
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the ICI YAC library, as described in Chapter 6. A genomic DNA probe for the
yeast asparaginase gene, ASP1 (Sinclair 1994) was included in the hybridisations to
hybridise to the yeast background to allow the position in the grid of any positive
colonies to be identified. This probe, which was supplied by D.T. Bonthron, was
labelled with [a-35S] dCTP to give a weaker signal than the [a-35P] dCTP labelled
human gDNA probes.
The ICRF PI clone library was sent as a gift by F. Francis (ICRF, London). The
library is supplied as two sets of two duplicates filters. In each case, all four filters
ofthe PI clone library were screened with each probe. The duplication of the filters
gave some degree of internal control which was used to asses whether potentially
positive colonies were genuine. The pattern of the background grid suggested that
the filters are gridded in 6 blocks whose position is varied but whose internal order
remains the same. Thus, although the clones were not gridded in the same order on
the two duplicate filters, the order of the clones within each segment ofthe grid was
the same. Thus any positive clones within the same segment would have the same
spatial orientation to each other on the separate filters. This is discussed further in
section 7.4, below.
The level ofbackground DNA hybridised by the yeast ASP1 gDNA probe was found
to be very variable. The grid shown in diagram 7.1 is an extremely good example,
other filters were found to have much more patchy background. Thus, a major




Diagram 7.1: Filter hybridisation of the PI library using PDGFA probe ACY7
Screening the ICRF PI library by filter hybridisation using the PDGFA probe ACY7.
The background filter grid is hybridised using a[a-35S] dCTP labelled yeast ASP1
gene probe. No positive colonies are identified.
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7.3 Results of the P1 library filter hybridisations
Screening the library with the probes ACY7 and AC41HR did not detect any positive
colonies. An example filter (100.5.4) probed with ACY7 and the ASP1 probe is
shown in diagram 7.1. There were no positive colonies identified in this
hybridisation.
The third probe which was used to screen the PI library filters was ACIXSR which,
like ACY7, was used in the pulsed-field mapping in Chapter 5. Using ACIXSR,
five potential positives clones were identified, these are shown in diagram 7.2. The
two filters 100.5.48 and 100.5.4 are duplicate filters of the same set of clones. The
two positive colonies which were identified in each of these two filters showed the
same orientation to each other although they were not in the same position on each
filter. As discussed above, this suggested that the same two clones had been
identified. The third potentially positive colony on filter 110.5.36 was not matched
by a similar positive on the duplicate filter. However the appearance ofthis colony
and comparison to the level ofbackground hybridisation suggested that it was a
positive clone.
7.3.1 Identification of the positive clones
The potential positive clones were identified by their filter and grid numbers and were
requested from ICRF, they are listed in table 7.3. As expected, the positive clones
identified in filters 100-5-4 and 100-5-48 were found to be duplicates ofthe same PI








Diagram 7.2: Potential positive clones identified by hybridisation with ACDCSR
Five potential positive clones on three different filters were identified by screening the
ICRF PI library using the probe ACXISR. The positive clones on the duplicate
filters 100.5.48 and 100.5.4 look like a matching pair of clones.
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More surprisingly, the clones J1174 and M0356, which had been identified in
duplicate and seemed to be promising as potential positive clones, had also been
identified and requested by two other groups. Neither group were using probes
specifically from chromosome 7p. It was surprising that these clones had been
identified and requested by other groups who were not working on the same
chromosomal region since the probe which had been used, ACIXSR, has been
shown to be single copy in the pulsed field experiments in Chapter 5.. The
subsequent analysis of these PI clones made this observation less surprising.
7.4 Analysis of the PI clones
The clones were supplied by ICRF as agar stabs, on receipt they were streaked out
onto LB/kanamycin agar plates. From these plates 16 to 18 single colonies were
selected and transferred to Hybond N1" filters and to fresh agar plates as described in
section 2.7. The colonies were screened by filter hybridisation using the probe
ACIXSR and the results of this experiment are shown in diagram 7.4. ACIXSR
hybridised to several of the clones from M0356 and J1174, although the signals were
surprisingly weak, requiring an overnight exposure to the X-ray film. Less
surprisingly, no positive clones were identified from clone L101, the clone which had
been identified only on one filter.
7.4.1 Fluorescent in situ hybridisation.
DNA was extracted from a large scale culture (induced with IPTG) of a positive
clone from both J1174 and M0356. The DNA was LiCl/PEG purified and then
biotin labelled for use in fluorescent in situ hybridisation (see section 2.14). The
biotin labelled probes were hybridised to metaphase chromosome spreads of a normal
male which were prepared by T. Johnson.
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Filter Number Clone position Clone identified
100-5-4 cnIIX Y= 12 ICRF P700M0356
X= 112 X II K> O ICRF P700J1174
100-5-48 X = 64 oII>* ICRF P700M0356
oTi¬llX 00II>- ICRF P700J1174
110-5-36 X = 43 Y = 63 ICRF P700L101
Table 7.3: The positive clones requested from ICRF.
The five positive clones shown in diagram 7.2 were identified by their grid numbers
and requested from ICRF. As expected, the two pairs from filters 100.5.48 and
100.5.4 identified the same two clones, thus three clones were returned for analysis.
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Diagram 7.4: Screening single colonies from the PI clones.
Single colonies from the agar stabs returned by ICRF were screened by filter
hybridisation using ACIXSR. Clones A1-D3 are from clone J1174, E3 - F5 are
from clone M0356 and clones G5 - G7 are from L101. Several positives are seen
for clones J1174 and M0356,, there are no positive colonies from LI 01.
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The FISH hybridisation results showed that both probes hybridised strongly to a
region near the centromeres of several pairs of chromosomes (see diagram 7.5).
Analysis ofthe metaphase spreads was conducted by J. Fantes (MRC Human
Genetics Unit, Edinburgh). Clone J1174 appears to hybridise to chromosomes 1,
2, 15 and 16. The signal on the centromere of chromosome 2 is especially strong.
The second clone, M0356, hybridises to the centromeres of chromosomes 1, 5 and
19. Thus the pattern ofhybridisation is clearly different for the two probes,
suggesting that they contain different sequences. No hybridisation to chromosome
7p could be detected for either clone despite considerable elfort.
7.4.2 Restriction digests ofPI clones.
Although no hybridisation to chromosome 7p could be detected for either of the two
PI clones it remained theoretically possible that the clones contained single copy
sequence from the PDGFA region. The strong hybridisation to the centromeric
regions of the other chromosomes could swamp the signal from hybridisation to 7p.
With this in mind the PI clones were analysed further by restriction digests.
Restriction digests were performed using the enzymes NotI, Sail, Sfil, EcoRI,
Spel, BglH, Xbal and Hindlll. These digests suggested that the total size of J1174
is around 30 kb, while M0356 seems to be about 20 kb. The PI vector is about
16 kb in size, which means that the clones carry inserts of 14 kb and 4 kb
respectively.
Hybridisation of the ACIXSR probe to Southern blots of the EcoRI digests of the PI
clones was particularly interesting. The probe hybridised to four bands in the digest
of J1174 and to three bands from clone M0356. Since ACIXSR is derived from an







Diagram 7.5: Fluorescent in situ hybridisation analysis of the PI clones
(a) PI clone J1174 hybridised to a normal, male metaphase chromosome spread.
The probe hybridises to the centromeric region of chromosome 1, 2, 15 and 16.
(b) M0356 hybridises to the centromeres of chromosomes 1, 5 and 19.
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In the Spel and Bglll digests the probe ACIXSR hybridised to bands which
corresponded to the expected sizes ofbands derived from the vector arms. A very
low level ofhybridisation of the probe to the vector sequence may have been
expected since the probe was found to faintly hybridise to the background grid from
the filters during the library screening. In addition ACIXSR shows a low level of
hybridisation to the DNA ofthe ladders of size markers. However, hybridisation to
the PI vector arms by ACIXSR does not explain the failure of the PI clones to
hybridise to 7p22 in the FISH experiments. These clones were identified in duplicate
on the gridded library filters because they showed a much higher level of
hybridisation than the background grid. The apparent size of the clones and the
unusual hybridisation pattern from the restriction digest strongly suggested that the
PI clones do not come from the region upstream ofPDGFA.
7.4.3 PCR Screening ofthe PI clones.
The results described above suggest that the PI clones M0356 and J1174 do not
correspond to the sequence of the upstream region of PDGFA, to confirm this a
PCR assay was developed. For this, ACIXSR was partially sequenced using the
vector primer Sp6. From this sequence a second primer was synthesised
(PACIXSR2) which was used to 'walk' further into the clone. The sequence data is
shown hi diagram 7.6. This sequence was sufficient to allow two PCR primers to be
made: ACIXSR91 and ACIXSR260 to amplify a 189 bp fragment. The PCR














Diagram 7.6: Sequence data from the ACIXSR probe
Sequence data generated from the 3' end ofACDCSR using the sequencing primer
Sp6 (from the vector sequence, not shown) and primer PACIXSR2 (broken
underline). The PCR primers ACDCSR91 (upstream ) and ACDCSR20
(downstream), shown in bold and underlined, were synthesised from this sequence
and used to develop a PCR assay.
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This PCR assay was used to analyse DNA extracted from 'minipreps' of all of the PI
clone colonies which were hybridised by ACIXSR (see diagram 7.4). As shown in
diagram 7.7, PCR products of the expected size (189 bp) were seen only with human
gDNA and control plasmids pACCATIX and pACIXHN. These two plasmid are
derived from the same bacteriophage clone as ACIXSR. No PCR products can be
seen with the two PI clones DNA samples (diagram 7.8). The failure of the PCR on
the PI clones implies that the sequence identified by the primers is not present in the
clone.
7.5 Conclusion and discussion.
The PI cloning system has been shown in previous mapping projects to be more
successful than cosmids in spanning some regions such as rDNA repeat sequences
(Francis 1994). In the attempts to map the Di George syndrome region on
chromosome 22q, PI clones were identified from a region which had been found to
be unstable in YAC clones (Halford 1993). Unfortunately the PI clones have not
been found to be useful for mapping PDGFA.
The PI clones which were identified from the library have been fully analysed. The
results of the FISH experiments, the restriction digests and the PCR assay all
indicate that these clones do not correspond to the 5' region of the PDGFA gene.
For the purpose of developing a physical map ofthe PDGFA locus these PI clones
were not useful and thus were not analysed any further.
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Diagram 7.7: PCR analysis of the PI clones.
The primer pah" ACIXSR91/ACIXSR260 were used to analyse the positive PI clones
identified by the filter hybridisation shown in diagram 7.4. The expected 189 bp
PCR product is seen only in the positive controls of human gDNA and the plasmid
clones pACCATIX and pACIXHN. No PCR products are seen for either of the P1
clones which were analysed (J 1174 and M0356).
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This result was surprising since the two clones J1174 and M0356 were identified in
duplicate using the two sets of filters. Hybridisation ofACIXSR to the clones was
confirmed on receipt of the agar stabs. This suggests that the probe ACIXSR which
was used to identify these clone does cross-hybridise specifically with some sequence
in the clones although the molecular basis of this cross hybridisation is not known.
The pattern ofhybridisation to the chromosome centromeres in the FISH experiments
was unexpected since the clones were identified using the single copy probe ACIXSR
(see Chapter 5). The chromosome centromeres are known to contain highly
repetitive DNA, suggesting that the PI clones, J1174 and M0356, contain
sequences similar to the centromeric repeats. However neither of the two different
patterns ofhybridisation shown by these clones corresponds to a known distribution
of centromeric repeat sequences. It is tempting to speculate as to whether the
upstream region ofthe PDGFA locus may contain similarly repetitive DNA
sequences. The presence of such sequences upstream from PDGFA would help to
explain the failure to identify YAC clones spanning the gene. However in the
absence of any data for the region surrounding the PDGFA gene such suggestions
can only be highly speculative.
The presence of a repeat motif in the PI clones might also explain why these clones
had been identified and requested by two other research groups, neither ofwhom
were working on chromosome 7p. It is also possible that these clones had been
identified by other groups by coincidence or that more that one clone was present in
the DNA at these grid co-ordinates. It may be that the clones contain several
repeated sequences or they may contain a centromere repeat sequence which has not
been described. It would be interesting to explain the FISH pattern which has been
observed, however this avenue of inquiry was not relevant to the aims of this project
and thus was not pursued.
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Chapter 8: Telomere YACs
8.1 Chromosome telomere YAC clones
The linkage analysis described in Chapter 4 has shown PDGFA to have a distal
location on chromosome 7p. At present no marker distal to PDGFA has been
described and there is no telomere probe available for chromosome 7p. Rough
estimates ofthe distance between PDGFA and the chromosome telomere suggested
that the gene may be less than 1 Mb from the chromosome end (discussed in section
4.10). The subtelomeric regions of chromosomes have been found to be
underrepresented in YAC clone libraries (Cohen 1993) and this may explain the
failure to find positive YAC clones during the screening ofthe YAC libraries
described in Chapter 6.
The candidate chromosome 7 telomere YAC clones were screened for the presence
ofthe PDGFA gene: ifPDGFA mapped very close to the telomere the gene itself
may have been contained within the YAC clones. The clones were also analysed in
an attempt to identify a polymorphic marker which could be used to complete the
chromosome 7p linkage map and a single copy DNA probe which could be used to
extend the pulsed field restriction map and to screen the YAC library
8.2 Telomere YAC vectors
Cloning chromosome telomeres in YACs uses a modified YAC vector with a single
yeast telomere. The telomere YAC vector, pTYACl, which has been used to
develop a telomere YAC library is described in section 1.13.4. This approach is
possible because the essential elements required for telomere function are conserved
between yeast and humans, allowing the yeast cell to recognise the human DNA as a
functional telomere. Whilst the cloning ofhuman telomere-associated DNA using
the telomere YAC vector cloning system is conceptually simple, it is difficult to
isolate clones which contain single copy DNA from specific individual telomeres.
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The DNA adjacent to the telomere consists of long tracts ofrepetitive sequence
which can be present at several different telomere loci (Brown 1990a). The extent
ofthis repetitive telomere associated DNA varies between telomeres. In addition
specific individual telomeres show polymorphic variation between individuals (Brown
1990a, Wilkie 1991). However, the development oftelomere YAC libraries
(Riethman 1989) means that the human chromosome telomeres are now rapidly being
cloned and mapped.
8.3 The human telomere YAC Library
A library ofpotential human telomere YAC clones in the size range 50 -250 kb has
been developed. Transformants were screened with the human telomere repeat
(TTAGKjG)n to identify potential telomere clones (Riethman 1989). Four YAC
recombinant clones from this library which have been identified by FISH and PCR as
candidates for the telomere of chromosome 7p were sent as a kind gift by H.
Riethman.. The details of these YACs are listed in table 8.1. Note that y2185
contains two YACs, y2185e is a subclone ofthe larger YAC in y2185. The largest
ofthese candidate chromosome 7p telomere YACs is 260 kb making these clones
relatively small in comparison to conventional YACs. As table 8.1 shows, none of









y2178 170 kb 2,7,(5,8-10,13-22)
7p22, 5q53, 3q29, lpl5, 8p23,
lp36, lq32-41, Yql2, 16q24,
19pl3.3, 6q27, 4q28
y2185 255, 145 kb 7(2)
7p22, 7cen, 7q32-34, lip 15,
lOcen, 16pl3.3, 16q24, 5q35,
19pl3.3, 2Op 12, 20ql3.3, lp36,
lq41, lq44, 9p24, 9q34,. 4q28,
Yql2
y2185e 260 kb 7(2) as for clone y2185
y2200 60 kb 3,7,9 7p22, 3q29 (weak signals)
Table 8.1: Candidate telomere YACs for 7p.
The candidate telomere YACs for the chromosome 7p telomere, y2178, y2185,
y2185e and y2200 were a kind gift ffomH. Rietlrman. YAC clone y2185e is a
subclone of clone y2185 containing only the larger ofthe two YACs.
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8.4 Analysis ofthe telomere YAC clones for PDGFA
8.4.1 PCR analysis of the telomere YACs
A crude DNA extract ofthe YAC along with the genomic DNA ofthe yeast host was
prepared from each clone (see section 2.4.3). This crude preparation was purified by
extraction with phenol and chloroform and reprecipitated in ethanoL
The tYAC clones were analysed with three different PCR assays using the primer
pairs ApaL/844 from exon 3, 430/731 from intron 6 and 2260/2790 from intron 1 of
PDGFA. The PCR assays using primers ApaL/844 and 430/731 are described in the
YAC library screening in Chapter 6 (see diagram 6.1). Primers 2260/2790 span the
GC repeat in intron 1 ofPDGFA which is described in Chapter 3 (section 3.6.1).
The reaction and cycling conditions for all the PCR assays are listed in table 2.2.
None ofthe three PCR assays which were used to screen the candidate telomere
YACs gave a PCR product for any of the four YAC clones which were analysed. As
an example, the PCR reactions from the 430/731 primer pair PCR are shown in
diagram 8.2. This PCR assay included three different gDNA positive controls
(marked '+') all ofwhich gave the expected 331 bp product. No PCR product can
be seen in any ofthe tYAC DNA samples. These three PCR assays span the length
ofPDGFA and these results strongly suggest that these YAC clones do not contain
the gene.
8.4.2 Analysis of the telomere YACs by filter hybridisation
It is possible that the absence ofPCR products from the crude yeast gDNA extracts
described above was due to PCR failure, thus the clones were also screened by filter






















Diagram 8.2: PCR analysis of the telomere YAC clones for PDGFA
PCR analysis using the primer pair 430 and 731 with yeast gDNA from the telomere
YAC clones y2178, y2185, y2185e and y2200. The expected 330 bp PCR product
is seen in the three human gDNA control samples but not with any ofthe tYACs.
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were prepared as described in section 2.4.7. The yeast chromosomes were separated
by pulsed field gel electrophoresis in a 1% agarose gel at 15°C for 22 hours at 200
volts using 30 second pulses. The pulsed-field gel was blotted onto Hybond N"
membrane and then hybridised with radiolabeled probes.
The filter was hybridised with the probe ACY7 which spans intron 1 to exon 4 of
PDGFA. This probe was also used in the pulsed field restriction mapping (see
diagram 5.2). Following this, the blot was stripped and reprobed using MS31. The
MS31 probe identifies the nearest proximal locus to PDGFA in the linkage analysis
described in Chapter 4. The probe was kindly supplied by A. Jeffreys and is
described in section 4.9. The telomere YACs were screened for MS31 since it was
theoretically possible that MS31 may be present in the absence ofPDGFA. Such a
situation could arise if the data from the linkage analysis is incorrect or if the
telomere YAC is rearranged and does not represent the DNA sequence at the 7p
telomere despite being derived from that region. Finally, the blot was stripped and
probed with radiolabeled Cotl DNA. Cotl DNA will hybridise to human repeat
DNA sequences and confirm that the YAC clones contain human DNA.
Neither of the probes ACY7 or MS31 hybridised to any of the four telomere YACs
indicating that neither locus was present in the clones. Diagram 8.3 shows a pulsed-
field gel and the results of probing the blot with ACY7 and Cotl. The Cotl DNA
hybridised to all four tYACs confirming the presence ofhuman repeat sequences in
all of the clones. Hybridisation of the Cotl DNA to the filter was conducted last,
after the same filter had been probed with both ACY7 and MS31. Since the DNA
could have failed to transfer onto the membrane during the Southern blotting, or
could have been removed when the blots were stripped, this also confirmed the
presence of the tYAC DNA on the Hybond N! membrane.
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8.5 Screening the whole telomere YAC library
While the whole telomere YAC library is not made widely available, it has been
screened by PCR for the presence ofPDGFA. The three PCR assays 631/631,
ApaL/844 and 430/731 were used by E Green (NIH, Bethesda, USA) to screen this
library at the same time as he screened the other YAC libraries described in Chapter
6. No positive clones were identified although this is not surprising given that the
most likely clones, the candidates for the 7p telomere, have been analysed more
fully as described above.
8.6 Further analysis of the telomere YACs
The results described above clearly show that PDGFA is not present in the telomere
YAC clones which are candidates for the 7p telomere. This is not entirely surprising
since the largest of these clones is 260 kb, the gene would have to be very close to
the telomere to be cloned in these YACs. Further analysis of the telomere YACs
was conducted since a single copy probe or a polymorphic marker derived from the
telomere would be very useful in extending the genetic linkage map and to continue
to attempt to build a physical map ofthe region.
A single copy probe would be useful to extend the pulsed-field restriction maps of the
region arid, ifPDGFA and the telomere are in close proximity, the two loci may
map to the same restriction fragment. Such a probe would also be useful for
screening the YAC and PI libraries. While such clones would not be expected to
contain PDGFA since the libraries have already been screened for the gene, YAC
clones from the subtelomeric region would be extremely useful for developing a
physical map ofthe region.
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A polymorphic locus for the region would allow the linkage map of chromosome 7p
to be completed by providing a telomere marker. Such a marker would allow an
estimation ofthe distance between PDGFA and the telomere although the genetic
distance may not correspond to the physical distance since the telomeric regions of
chromosomes are known to have high recombination rates.
8.6.1 Fluorescent in situ hybridisation
To confirm that these telomere YAC clones do hybridise to the chromosome 7p
telomere, fluorescent in situ hybridisation experiments were conducted. For these a
substantial amount ofthe YAC DNA (about 1 fig) was required. To isolate the
YAC bands from the genomic DNA ofthe yeast host cell, the whole chromosomes
were separated by pulsed field electrophoresis. The bands corresponding to the
YACs were cut from the agarose gel and the DNA was extracted using the
'Geneclean' method. Fragments of random DNA sequence were amplified from the
purified YAC DNA by PCR. This PCR reaction was conducted using a method and
oligonucleotide primers from J. Warner, it is described in section 2.11.1. The PCR
products obtained were ofrandom size producing a smear ofDNA sized 220 bp to
1 kb when separated in an agarose gel. About 1 fig ofthis randomly sized DNA was
biotin labelled and used for fluorescent in situ hybridisation to metaphase
chromosome spreads from a normal male.
The biotin labelled DNA fragments from each of the telomere YACs was found to
hybridise to large number ofboth interstitial and telomeric loci. Amongst this,
hybridisation to chromosome 7p telomere was confirmed for all four of the candidate
telomere YACs. As an example, diagram 8.4 shows the PCR products from y2185
(a), and y2185e (b). The probe hybridises to the chromosome 7p telomere (marked






Diagram 8.4: Fluorescent in situ hybridisation using y2185 and y2185e
FISH analysis using biotin labeled, randomly amplified DNA from (a) tYAC y2185
and (b) tYAC y2185e. Hybridisation to chromosome 7p (marked with the arrows)
can be seen, as well as hybridisation to a large number of other sites including other
telomere loci. Hie chromosome identification and analysis was done by J. Fantes
(MRC Human Genetics Unit, Edinurgh).
215
This pattern ofhybridisation ofthe YAC DNA to many different loci across the
genome was expected given the repetitive nature oftelomeric DNA sequences. It is
consistent with the possibility that these YAC clones are derived from the 7p
telomere.
8.6.2 Screening for CA repeats in the YAC clones
CA dinucleotide repeats are frequently the source ofhighly polymorphic loci. The
randomly amplified DNA from the YAC clones was screened for the presence of
such repeats using a (GT)i5 oligonucleotide primer. The random PCR products
which were generated for the FISH experiments (described above in section 8.6.1)
were separated in an agarose gel to check their average size. This agarose gel was
blotted using Hybond N1" and then probed using a (GT)is oligonucleotide primer.
Hybridisation to the YAC DNA was very weak which suggests that there are few CA
repeat sequences in the YAC clones. Thus efforts were directed towards isolating
end sequence from the YACs rather than searching for a polymorphic CA repeat.
8.7 Isolation of endclones from YACs
The isolation and analysis ofYAC clones is restricted by the large size and low copy
number ofthe vector. A number ofmethods based on the use ofPCR have been
developed to isolate and characterise the clones. Several ofthese methods, such as
Alu-Alu PCR and Alu-vector PCR depend on the presence ofAlu sequences within
the DNA insert at a suitable distance from each other or from the vector/insert
boundary to allow amplification by PCR. Other approaches such as plasmid rescue
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and vectorette PCR depend on the presence of specific restriction sites within a
suitable distance from the vector/insert boundary.
For the analysis of the candidate telomere YACs none of these methods are ideal
since they are all based on the assumption that the sequence of the cloned DNA and
the distribution of features such as Alu repeats and restriction sites is random. This
is not generally the situation in the telomeric regions of chromosomes. However,
since the insert end of the telomere YAC clones will be furthest away from the true
telomere repeats and closer to landmarks of interest on chromosome 7p such as
PDGFA, it was decided to attempt to clone the ends of the telomere YACs. Unlike
conventional YACs, each telomere YAC contains only one arm and only one insert
end can be cloned for each.
Two approaches, those of plasmid rescue and vectorette PCR were attempted. Of
these approaches the plasmid rescue attempts were not successful and are not
described, the end-cloning using vectorette PCR is described below.
8.7.1 Vectorette PCR end cloning
Vectorette end-cloning uses PCR to amplify the end fragment of the human DNA
insert in the YAC clones (Riley 1990). The YAC clone is digested with a restriction
enzyme and a common linker is ligated to the DNA fragments. Terminal sequences
are then amplified using a vector specific primer and a linker specific primer. The
linker, or vectorette cassette which is ligated to the digest DNA contains an area of
mismatch. The linker specific primer matches the lower sequence of the cassette. It
cannot therefore be used to seed the PCR reaction until its complementary strand has
been synthesised from the vector primer. This ensures that PCR products can only
be amplified from DNA molecules which have both the vector and cassette
sequences.
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Total yeast DNA, including the telomere YAC, was digested with the enzymes
Sau3AI leaving the DNA fragment with a GATC overhang or with Rsal leaving a
blunt ended fragment. The digested DNA was purified and then ligated with the
vectorette cassette, with a GATC overhang or blunt ended as appropriate. The
primer sequences and PCR conditions are described in section 2.12. The resultant
PCR products were checked by digestion with EcoRI since only genuine YAC end-
clones should contain an EcoRI site at the junction between the vector and the cloned
insert. PCR products which were shown to cut with EcoRI were cloned into the
vector PCR-Script using the Stratagene PCR cloning kit. The resultant bacterial
colonies were screened directly using the primer pair T3 and T7 as described in
section 2.11.
This approach generated end-clones for all four of the telomere YACs. The PCR
products for y2178 (1C) were amplified from the Sau3Al digests, while the Rsal
digests led to PCR amplified products from y2185 (6B), y2185e (7A) and y2200
(8C). As shown in diagram 8.5, the PCR product from y2185e (7A) does not cut
with EcoRI. It cannot bridge the vector/insert junction and thus was not analysed
further. Further attempts to generate a subclone from y2185e were not successful.
PCR products were also obtained from Sau3Al digests ofy2185 and y2200. The
fragments produced from these samples appeared to be smaller than those shown in
diagram 8.5, thus they were not investigated. Unfortunately, the PCR products
produced for all three ofthe successfully cloned YACs are very small, containing
only about 70 bp of the human insert DNA. This is not surprising since the method
has only been successful using the frequently cutting restriction enzymes. Other,
less frequently cutting, restriction enzymes such as BamHI, Bglll and Bell were also
used to digest the yeast/YAC DNA in attempts to endclone the YACs. None of
these digests produced PCR fragments.
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1C:y2178 6B : y2185 7A : y2185e 8C : y2200
bp
Diagram 8.5: The vectorette PCR products digested with EcoRI
Tlie vectorette PCR products amplified from YACs y2178, 2185, 2185e and 2200.
The samples are undigested in the first lane of each pair and digested with EcoRi in
the second lane of each pah. Samples 1C (y21780), 6B (y2185) and 8C (y2185e)
all cut with EcoRI confirming that they are derived from the vector/insert boundary.
Sample 7A (y2185e) does not cut with EcoRI and was not analysed any further.
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The PCR products 1C, 6B and 8C were sequenced using the primers T3 and T7.
The end clone sequences are shown in diagram 8.6. Sequencing these cloned PCR
products confirmed that they are derived from the vector/insert boundary of the YAC
clones. However, as expected from the size ofthe PCR products, the length of the
inserts which have been subcloned are very short. This made the development of
PCR assays difficult.
8.7.2 Development ofPCR assays for the YAC endclones
The sequence derived from the vectorette end-cloning ofthe telomere YACs was
used to scan the GenEmbl databases: no sequences with significant homology were
identified. However, searching the GDB database found primer sequences for PCR
'STSs' for the end sequence from two ofthe YAC clones: y2178 and y2185. These
had been submitted by H. Riethman at the same time as the end-clones presented
above were being sequenced for this project. One ofthese primers, sv-1-2178F
matches the sequence in end clone 1.2 (see diagram 8.6) which was also derived from
y2178.
The primers for these two PCR assays were made and tested on the YAC clones.
Primer pair sv-l-2178F and sv-l-2178R are derived fromy2178 while sv-l-2185F
and sv-1-2185R are from y2185. The sequence for the primers and the conditions
used for the PCR reactions are described in table 2.2.
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Diagram 8.6: Sequence from the Vectorette endclones of the tYACs
Endclones from the tYACs y2178, y2185 and y2200. The size of each of these
clones is very small containing only about 65 to 90 bp of the YAC insert DNA(in
bold). The YAC vector primer sequences PBR-4177 and the vectorette primer
sequence D-580 are marked.
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PCR analysis showed that both PCR assays, using primer pairs sv-2178F/R and sv-1-
2185F/R, amplified products from all four tYAC clones. These PCR assays were
used to analyse a panel of chromosome hybrid cells containing fragments ofhuman
chromosomes 7 and 2. The PCR products generated using primer pair sv-1-
2178F/R are shown in diagram 8.7. The amplified PCR product is seen with all four
tYACs and with gDNA. Hamster and mouse gDNA controls do not amplify
confirming that the products seen from the cell hybrid lines are derived from human
DNA. All three samples from chromosome 2 and the majority of the panel of
chromosome 7 hybrids amplify with this PCR assay. One sample, corresponding to
7 cent-qter, has not amplified. This is thought to be a false negative, there was no
sample left in the eppendorf tube which was rinsed with 5 pi of dH20 to attempt this
PCR reaction. The regions of chromosomes 2 and 7 contained within each hybrid
sample are indicated on the diagram. Samples containing only chromosome 2 or 7q
clearly amplify confirming that this PCR assay is not unique for the 7p telomere.
Thus these PCR assays do not identify unique sites. This means that the endclones
of these telomere YACs do not contain unique or single copy DNA. Further efforts
to isolate single copy sequence which could be used as a 7p telomere STS or probe
will require cloning methods which search the whole cloned insert rather than just its
end.
8.8 Discussion and conclusion
Screening both the individual candidate telomere YACs for chromosome 7p and the
whole telomere YAC library (Riethman 1989) has found that this library does not
contain clones spanning PDGFA. The absence ofPDGFA in the candidate
chromosome 7p telomere YACs is not surprising since the largest of these was 260
kb. The RARE cleavage experiments presented in Chapter 9 measure the distance




Diagram 8.7: PCR analysis of somatic cell hybrids using primers sv-l-2178F/R
PCR analysis ofgDNA, the tYACs and somatic hybrid cell lines containing
fragments from human chromosomes 2 and 7. Mouse and hamster gDNA did not
amplify confirming that the PCR product is specific to human DNA. The 98 bp PCR
product is seen in cell lines which contain DNA from chromosomes 2 and 7q only,
thus this PCR assay does not identify a single copy sequence from chromosome 7p
and is not a true 'STS'. The absence of a PCR product in sample 7cen -qter is
thought to be a false negative arising from a failed PCR reaction (see section 8.7.2).
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FISH analysis of random DNA amplified from these candidate 7p telomere YAC
clones has confirmed that the clones do hybridise to the telomere of chromosome 7p.
However, as shown in diagram 8.4, these clones also hybridise to a number of other
chromosomes telomeres as well as to other interstitial loci. This is not surprising
since it is known that the repetitive DNA in the subtelomeric region can be present at
several different telomeric loci.
End-cloning the DNA inserts by Vectorette PCR yielded very small fragments. H.
Riethman has had more success using plasmid rescue to clone the ends of these
YACs and has developed PCR assays for two of the clones. Unfortunately these
PCRs do not identify unique sites on chromosome 7p and are therefore not useful
STSs. While the end of these telomere YAC clones are not unique sequences it is
possible that the clones do contain 7p unique sequence within their length.
Further analysis of these clones has not been undertaken since they are also being
analysed by H. Riethman. The cloning of other chromosome telomeres using this
telomere YAC library have been reported recently (Riethman 1994) and it seems
likely that a similar report for chromosome 7p is simply a matter of time. In addition
a second large group (Helms 1993) have also indicated that they have candidate
clones for 7p. However neither of these two groups has reported any substantial
data for the chromosome 7p telomere. The availability of unique DNA sequence in
the form of an STS or a probe would be very valuable to continue the attempts to
map PDGFA. Of most value would be a polymorphic marker for the 7p telomere
which could be used to complete the linkage map.
The main aim of this project was to map PDGFA rather than the chromosome 7p
telomere. Given the time constraints that are inevitable during any project, along
with the knowledge that at least two large groups are attempting to clone the 7p
telomere it was decided not to pursue this avenue of inquiry. Other approaches
towards mapping PDGFA were sought. Given that the direct mapping
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approaches ofgenetic mapping by linkage and physical mapping through building
clone contigs had been exhausted a less direct approach was required. For this the
technique of RecA restriction endonuclease (RARE) cleavage mapping was used to
measure the distance between PDGFA and the chromosome 7p telomere. This
approach had been used to measure distances near to the chromosome 4p telomere
during the hunt for the Huntington's chorea gene. The use of the RARE cleavage
mapping technique is described in the next chapter.
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9. Chapter 9: RecA-assisted restriction endonuclease (RARE) cleavage.
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9.1 Introduction
The preceding chapters in this thesis describe the screening ofYAC, PI and
telomere YAC libraries in an attempt to find clones spanning PDGFA. Without
clones from the region it is not possible to develop clone contigs to build a physical
map ofthe region. Given the absence of such clones, an alternative approach is
required.
The most obvious approach is to determine the physical distance between the
PDGFA gene and other landmarks on chromosome 7p. Attempts have already been
made, in the pulsed field mapping project in Chapter 5, to measure the physical
distance between PDGFA and the linked marker MS31 (D7S21). None of the other
loci used in the linkage mapping are suitable candidates to be physically mapped to
PDGFA. However, the evidence from the linkage analysis described in Chapter 4
suggests that PDGFA is in a sub-telomeric location on chromosome 7p. No markers
have been mapped distal to PDGFA, thus the telomere itself is the most obvious
landmark to which PDGFA could be mapped.
As discussed in section 4.10, the distance between PDGFA and the telomere was not
easy to determine from the linkage data. However estimates had suggested that the
distance was likely to be between 1 Mb to 5 Mb, with the possibility that it was less
than 1 Mb. Given that the distance from the gene to the telomere could be relatively
small, the technique ofRecA-assisted restriction endonuclease (RARE) cleavage was
used. The technique and its application to the mapping ofPDGFA is described
below.
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9.2 RecA assisted restriction endonuclease (RARE) cleavage
RecA assisted restriction endonuclease (RARE) cleavage is used to perform
sequence-specific cleavage of genomic DNA. It was described by Ferrin (1991,
1993) who used RecA protein to bind a large (60 base) primer to a known EcoRI
restriction site. RecA binds the primer to the homologous sequence in duplex DNA
creating a triple helix, this protects the restriction site from methylation which can
then be used to block all other EcoRI sites on the chromosome. Subsequent
removal of the primer and restriction with EcoRI should generate a fragment ofDNA
from the telomere to the targeted restriction site which can be identified by PFGE and
Southern blotting. This procedure is illustrated in diagram 9.1. Using the original
protocol, attempts to cleave fragments greater than a few hundred kilobases were
unsuccessful (Ferrin 1991). However, a modification to this protocol which raises
the reaction pH from 7.5 to 7.85 was found to reduce non-specific cleavage and this
modified protocol has been used to generate fragments as large as 1.7 Mb (Ferrin
1993, 1994).
9.3 Application ofthe RARE cleavage technique
To apply the RARE technique to mapping the distance between PDGFA and the
chromosome 7p telomere there were a number of requirements. Firstly a suitable
EcoRI site was required along with the sequence ofthe flanking DNA to allow a
large 60 base primer to be designed. An EcoRI site in intron 4 was selected, the
sequencing ofthis region is described below in section 9.4.
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Diagram 9.1: RecA-assisted restriction endonuclease (RARE) cleavage
Schematic illustration of RecA-assisted restriction endonuclease (RARE) cleavage,
adapted from Ferrin (1993) to show the application of the technique to identifying
telomere fragments.
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Since the orientation of the PDGFA gene on chromosome 7p was not known, it was
important to have two probes flanking the selected EcoRI site. It was not known
which probe would identify the telomere fragment. This requirement for two single
copy probes on either side of the selected EcoRI site restricted the choice of
restriction sites. The EcoRI site in intron 4 is flanked by the probes ACY7 and
AC41HR which are shown in diagram 5.1. Since both of these probes had been
used before they were known to be suitable single copy DNA sequences.
Obviously this technique is based on the use of PFGE techniques which are described
in Chapter 2, pulsed field mapping had already been used to develop a long range
restriction map around PDGFA, this is described in Chapter 5.
9.4 A suitable EcoRI site in intron 4 ofPDGFA
As mentioned above, the EcoRI restriction site in intron 4 ofPDGFA was selected
(see diagram 5.1). It lies 1.1 kb downstream from exon 4, beyond the minisatellite
which flanks exon and intron 4 and is shown in diagram 5 .1. Sequence data was
available for the first 750 bp of intron 4, this sequence was used to synthesise the
first of the two primers (P844rev and P950) which were used to extend the sequence
downstream to beyond the EcoRI site (shown in diagram 9.2).
A 60 base primer (RARE 1) which contained the EcoRI site at its centre was
synthesised, its sequence is marked on diagram 9.2. The primer was purified to
remove debris and incompletely synthesised primers by separation in a



























Diagram 9.2: Sequence data from intron 4
This 1.26 kb of sequence spans from the Sail site in exon 4 (boxed) to beyond the
EcoRI site in position 1100 (marked in bold). It was extended from the available
sequence using primers P844rev and P950. The minisatellite in intron 4 is shown
underlined in italics, between positions 98 and 580. The ApaL site at position 620
(in bold) marks the intron 4 dimorphism which was used in the linkage analysis in
Chapter 4. The 60 base oligonucleotide (RARE1) which spans the EcoRI site and
was used in the RARE cleavage experiments is indicated (double underlined).
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9.5 The RARE experiments
In preparation for the RARE experiments, a control experiment was conducted to
measure the amount of methylase required to methylate the DNA samples. The
methylation step is critical in this procedure and it is often difficult to achieve
adequate methylation of the entire DNA sample. The genomic DNA samples were
methylated using 0 to 800 units of EcoRI methylase by incubation at 37°C for 1 hour.
The samples were then equilibrated in the appropriate buffer and digested with 100
units of EcoRI using the standard conditions described in section 2.5 .1. The samples
were separated in a pulsed field gel using 10 second pulses and are shown in diagram
9.3. As this gel shows, maximal methylation is seen with 600 units of methylase,
thus in the subsequent experiments 600 units ofEcoRI methylase were used.
The methods used for the RARE cleavage are described in Chapter 2, section 2.13.
In the early experiments three samples with 360, 680 and 1200 ng of oligonucleotide
primer were used since the primer concentration had been found to be critical (Ferrin
1993), however the modified pH of the buffer (Ferrin 1994) seems to have removed
this problem. In the experiments conducted for this project, the primer
concentration was not found to be a critical factor and only one concentration of
primer (680 ng) was used in the later experiments.
In each experiment a number ofcontrol reactions were run. These included a 0
control from which EcoRI methylase and EcoRI were omitted, a methylation control
from which RecA protein and the oligonucleotide primer had been omitted and an
EcoRI digest control from which the RecA protein, oligonucleotide primer and the
EcoRI methylase had been omitted. These are shown on the experiments illustrated
in diagrams 9.4 to 9.6. The challenging nature of this technique meant that these
controls were found to be essential. The appearance of the control samples in the
resolved pulsed field gel were a good indicator as to whether the reactions had been
satisfactory before the gel was blotted and probed. Of critical importance were the
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Units
Diagram 9.3: EcoRI methylation of genomic DNA
EcoRI digests ofgDNA samples which had been methylated with 0 to 800 units of
EcoRI methylase. Maximal methylation is seen with 600 units ofmethylase, thus
600 units were used in the subsequent RARE cleavage experiments.
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methylation and the EcoRI digestion. Washing and equilibration of the agarose
samples in the appropriate buffers had to be rigorous to ensure that the EcoRI
digestion of the DNA sample would be complete.
9.6 Results ofthe RARE cleavage experiments
Selecting appropriate conditions for the pulsed field gel separation ofthe RARE
treated samples was not straight forward. The expected size ofthe PDGFA/
telomere fragment was not known. In addition, the orientation of the gene on
chromosome 7 was not known, thus it was not possible to predict which of the two
probes, ACY7 and AC41HR, would hybridise to that fragment. To overcome this
problem the gels were run with two sets of samples, after blotting the membrane was
cut in two and the two halves were probed separately with the two selected flanking
probes ACY7 and AC41HR.
Diagram 9.4 shows a pulsed-field gel which was produced using ramped pulses of 15
to 60 seconds, it has been divided and hybridised with both probes. This diagram
shows two bands sized about 630 to 679 kb in the left half of the gel which has been
probed with AC41HR. The right hand of the gel which has been probed with
ACY7, does not show any bands. No bands are hybridised in the control sample
lanes. The two fragments hybridised in this gel are close to the limiting mobility




Diagram 9.4: RARE cleavage experiment 1
(a) The RARE samples were separated using pulse times of 15 to 60 seconds, (b)
Probing the left half of the gel with AC41HR identified two fragments of 630 and
679 kb (marked In the right half of the gel, probed with ACY7, no bands are
identified. The autorad was exposed to the hybridised blot for 21 days.
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The experiment was repeated using ramped pulse times of 45 to 120 seconds to
optimise the separation of fragments in the 500 kb to 1 Mb size range. This second
experiment, probed with both ACY7 and AC41HR is shown in diagram 9.5. As this
diagram shows, AC41HR hybridises two bands sized about. 630 kb and 679 kb in
both hybridisations. Following this hybridisation, the blots were stripped and
reprobed with the alternative probe to the previous hybridisation. On hybridisation
to the right hand side of the blot AC41HR identified the same two bands. These
fragments are not hybridised in the control sample lanes or with the probe ACY7.
Thus these experiments indicate that the PDGFA gene is about 650 kb from the
chromosome 7p telomere and that the gene is positioned on the chromosome with its
5' end centromeric and its 3' end telomeric.
9.7 Polymorphic length variation in the sub-telomeric region
As shown in diagrams 9.4 and 9.5 the probe AC41HR hybridises to two bands. All
ofthese gDNA samples are derived from the same individual (a normal male). This
pattern ofhybridisation suggests that the sub-telomeric region of chromosome 7p
shows variation in its length. A polymorphic length variation has been described for
several other chromosomes telomeres (discussed below in section 9.8) and it would
not be surprising to find a similar length variation in the chromosome 7p telomere.
To determine whether the chromosome 7p telomere does show a polymorphic
variation in length, fresh blood samples were collected from a further four unrelated
individuals and used to make gDNA agarose blocks (as described in Chapter 2).
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ACY7 AC41IIII
Diagram 9.5: RARE cleavage experiment 2
(a) PFGE separation ofRARE samples using ramped pulse times of 45 to 120
seconds, (b) hybridised with ACY7 (left side) and AC41HR (right side). ACIXSR
hybridises bands of 630 kb and 679 kb, autorad exposed to blot for 21 days.
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The RARE experiments were repeated using these additional samples. For these
experiments, only one primer concentration of 360 ng ofRARE1 was used. The
filters from the gels were probed with AC41HR only. The hybridised blot was
exposed to a phosphoimager cassette for 28 days and then scanned to produce the
image shown in diagram 9.6.
The results ofthis RARE cleavage experiment suggest than individuals SI, LL and
JW all carry two different sized telomere fragments. The lower band is also present
in individual LS, unfortunately the quality of the image makes it difficult to
determine whether LS has a second, large band. No bands can be seen for
individual DC. This absence ofbands for individual DC seems likely to be due to
imaging process since the sample in the agarose gel looks adequately methylated.
Thus the telomere region of chromosome 7p may show length variation similar to
that described for other chromosome telomeres. With the data available it is not
possible to confirm this or to estimate the number and size of different lengths or the
level ofheterozygosity. The difficulty in resolving small size differences between
such large fragments (650 kb) makes it difficult to determine whether the bands
hybridised in this experiment are the same size. Clearly further experimental data
would be required to resolve these questions, this is discussed further below in
section 9.8.
238




































O 00 HH hJ > 2S o"g "9
Q J ^ J £ 6
W° *3, ° oO ^ o O
IS o
Diagram 9.6: RARE experiment 3
(a) PFGE separation using ramped pulses of 45 to 120 seconds ofgDNA samples
from 5 unrelated individuals, (b) hybridised with AC41HR. The results are discussed
in section 9.7. The phosphoimager cassette was exposed to the blot for 28 days.
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9.8 Discussion
These RARE experiments identify discrete DNA fragments in the genomic DNA
samples when probed with AC41HR, placing PDGFA about 650 kb from the
chromosome 7p telomere. Thus PDGFA is located less than 1 Mb from the
telomere, confirming the estimations ofthis distance which were discussed in
Chapter 4 (section 4.10) following the results ofthe linkage analysis.. The
implications of a location so close to the chromosome telomere for a growth factor
gene such as PDGFA are discussed in the conclusion to this thesis in Chapter 10.
The PDGFA/telomere fragment is hybridised by the downstream probe AC41HR,
thus the gene is positioned with its 5' end centromeric and its 3' end telomeric. This
means that the coding region of the gene separates its control sequences from the
telomere of the chromosome. Thus telomeric deletions of chromosome 7 would not
be expected to delete the promoter region ofthe gene without also removing the
coding region ofthe gene. This is in contrast to the orientation of the a-globin gene
which has been shown to be very close to the telomere on chromosome 16p (Wilkie
1990a). However it is not known what effect telomeric deletions of chromosome 7p
have on the expression ofPDGFA.
This orientation ofPDGFA means the 5' end of the gene lies closest to the
proximally linked locus MS31 (D7S21). Thus, only the upstream probe ACIXSR
could have been useful in the attempts to measure the physical distance between
PDGFA and MS31 in the pulsed field restriction mapping experiments described in
Chapter 5. Given the failure to establish physical linkage between PDGFA and
MS31 in the pulsed-field gel experiments in Chapter 5, it would be interesting to use
the RARE cleavage technique to measure the distance between these two loci.
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The final experiments (shown in diagram 9.6) hybridised different sized
PDGFA/telomere fragments in at least three different individuals. This size variation
may be due to the subtelomeric repeat sequences. These he proximal to the simple
tandem repeats and are highly variable in length and degree of repetitiveness. These
sub-telomeric repeat sequences may be present on several different chromosomes but
entirely absent from others (Brown 1990a, deLange 1990, IJdo 1992). These
regions show variation in length and in the type of repeats which are present at the
chromosome telomere between different individuals, making the subtelomeric region
highly polymorphic.
Polymorphic length variation has been described for several of the chromosome
telomeres which have been cloned and characterised including 7q (Efing 1993,
Dietz-Band 1990), 2q and 8p (Macina 1994). The most striking example is that of
chromosome 16p where the a-globin gene has been has been shown to be 170 , 350
or 430 kb from the chromosome 16p telomere (Wilkie 1991). The two most
common alleles, the 170 kb and 350 kb sizes have been found to contain different
repeats with no sequence homology between the two. Thus the two chromosome
16p telomeres carried by one individual may be completely different and may be more
similar to the telomeres of other chromosomes. The results of the experiments
presented above show that a similar length variation is present on chromosome 7p, it
would be interesting to investigate this further.
It important to acknowledge that these experiments do not provide direct evidence
that the hybridised DNA fragments do correspond to a true telomere fragment.
However the results presented above have been shown to be consistent both within
the same individual and between unrelated individuals. No bands were seen with the
probe ACY7 or in any ofthe control sample lanes, thus the DNA fragments which
are hybridised are specific to the probe AC41HR, require the presence ofthe RecA
bound oligonucleotide primer and methylation ofthe DNA. All of these factors
strongly suggest that the hybridised band does correspond to a PDGFA/telomere
DNA fragment.
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Alternative explanations for the observed pattern ofhybridisation can be theorised.
One possible alternative explanation would be a duplication of the sequence around
the protected EcoRI site. If the sequence duplication was located about 650 kb
downstream from PDGFA and positioned in the opposite orientation to the sequence
within the gene then this pattern ofhybridisation would be seen. However, such an
explanation seems unlikely given the additional evidence for a telomeric location for
PDGFA provided by other experiments such as the linkage analysis described in
Chapter 4.
In the absence of a unique telomere probe for chromosome 7p, there is no easy way
to confirm whether this hybridised fragment does correspond to the telomere. The
telomere probe TelBamll does hybridise to the chromosome 7p telomere, however
it is not unique and also hybridises to several other chromosome telomeres (Brown
1990a). Such a probe would be expected to hybridise to the 650 kb band seen in the
experiments presented above, however it would be expected to hybridise to many
other telomere fragments as well. This would be expected to produce a high level of
background.
The autorads which are shown above were exposed to the hybridised filters for at
least 21 nights at - 70 °C. The signals are relatively weak and an increase in the level
ofbackground above that which is seen in these exposures was expected to obliterate
the specific signals which can be seen. Thus these filters were not hybridised with
non-specific telomere probes. Since at least two large research groups are
attempting to clone the chromosome 7p telomere it seems likely that single copy
probes from the region will soon be available (see section 8.8). When a unique
probe for the chromosome 7p telomere does become available it would be interesting
to reprobe these RARE experiments to confirm that the hybridised fragments are true
telomere fragments.
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Chapter 10: Conclusion and discussion.
10.1 A telomeric location for PDGFA
The introduction to this thesis proposed two possible locations for PDGFA,
confining the gene to two relatively small cytogenetic regions: (i) between the
breakpoint in 0044 Rag 1-15 and the proximal breakpoint in DSE or (ii) between the
distal breakpoint in DSE and the chromosome 7p telomere. These two possible
locations for the gene are illustrated in diagram 1.3. The mapping ofPDGFA to
about 650 kb from the chromosome 7p telomere means that the deletion in patient
DSE cannot be a true terminal deletion and that the second of the two possible
locations for the gene has been found to be correct. A telomeric location for a gene,
especially a growth factor such as PDGFA is interesting. Thus, the major features
of the telomeric regions of chromosomes, the consequences for physical mapping
and the implications of such a location on the expression and function ofPDGFA are
discussed below.
10.2 The telomere sequence and structure
Human chromosomes end with tandem repeats of the sequence (TTAGGG)n. The
sequence of these tandem repeats are well conserved through evolution with the G
rich strand corresponding to the 3' end of the chromosome. These repeats at the
telomere end overcome the problems with replication of the far end of the DNA
strand. DNA polymerases require an RNA primer and synthesise DNA in the 5' to
3' direction. Thus a short length ofDNA equivalent to the size of the RNA primer
is lost from the chromosome end during replication. The use of the specialised DNA
polymerase, telomerase, which carries a (TTAGGG)n RNA template allows this
sequence to be replaced. These (TTAGGG)n repeats alone appear to be sufficient
for telomere function. Individuals with terminal deletions of chromosome 16p have
been described in whom the broken chromosome had been 'healed' by the direct
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addition of the (TTAGGG)n repeats to the breakpoint site (Wilkie 1990, Flint 1994).
These 'healed' chromosomes function normally.
The telomere ends appear to give stability to the chromosome: double strand breaks
in the chromosome or loss of all telomere repeats cause the chromosomes to become
unstable. As a consequence of this, a large number of chromosome breakage-
reunion events are seen which lead to the develooment of chromosome
rearrangements and ultimately cell death. The progressive loss of telomere repeats
in somatic cell lines is thought to be related to the cellular ageing process, this is
discussed further in section 10.5.
Proximal to the simple tandem repeats described above is a more complex region of
repetitive DNA sequences. These subtelomeric repeats which are highly variable in
length and degree of repetitiveness are described in section 9.8. The RARE
experiments which are described in Chapter 9 show that the telomeric region of
chromosome 7 shows length variation similar to that described for other chromosome
telomeres. The role of this sub-telomeric repeat region is not clear, it may simply
act as a buffer between the telomere and essential DNA sequences protecting them
against telomere loss. These sequences may be involved in processes such as
chromosome pairing in meiosis. However, it is also possible that these sequences
have no direct role and have arisen as a consequence of recombination or
translocations between non-homologous chromosome telomeres (reviewed in Kipling
1995).
10.2.1 Minisatellite sequences in subtelomeric regions
The sub-telomeric regions of chromosomes have been shown to contain a large
number ofminisatellite repeat elements (Royle 1988, Hing 1993) the reason for this
clustering of sequences is not known. It is possible that this clustering of
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minisatellite sequences may explain the increase in recombination which has been
described in the telomeric regions ofthe chromosomes. However it is also possible
that these minisatellite sequences have arisen as a consequence ofthat increase in
recombination.
It is interesting to have found two minisatellite sequences within the PDGFA gene.
As described in section 3.10, these two repeat elements are separated by only 1 kb,
however their sequence and structure indicate that they are not related. Interestingly
the two other pairs of closely physically linked minisatellite sequences which are
described in Chapter 3 were also found in subtelomeric regions. It is not clear
whether or not these closely linked minisatellites have arisen by coincidence.
10.3 Development ofmaps oftelomeric regions
10.3.1 Linkage analysis
The linkage data which is shown in Chapter 4 gave unexpectedly large values for the
genetic distances between PDGFA and the nearest proximal loci. The finding that
the PDGFA gene is very close to the chromosome telomere made this result less
surprising. An increase in recombination has been observed in the telomeric regions
of other chromosomes (for example Burmeister 1991, Helms 1992). This increase
in recombination towards the telomere, which is greater in male meioses then female,
is thought to be due to 'hot-spots' ofhigh recombination frequency rather than a
generalised increase. For example, comparing the genetic and physical maps for the
long arm of chromosome 21 found that one region (21q22.3) which accounted for
40% ofthe length of the genetic map corresponded to only 10 % ofthe cytogenetic
length ofthe chromosome, indicating a small region of dramatically increased
recombination (reviewed in Kipling 1995).
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10.3.2 Long range restriction maps
Generation of a single copy telomere probe for chromosome 7p would allow the
extension of the pulsed field restriction map described in Chapter 5. Extending the
restriction map to the telomere should be possible given that the region is relatively
small Such information may help to identify CpG islands and indicate whether there
are any other genes distal to PDGFA. However similar restriction mapping in the
pseudoautosomal region ofthe X and Y chromosomes found a large number of rare
cutter restriction sites in the terminal region of the chromosome. These sites were
particularly common in the last 200 kb of the chromosome (Petit 1988). If a large
number of sites are also present in the telomere region of chromosome 7p further
probes may be required. This cluster of restriction sites described in the telomere of
the pseudoautosomal region were spread randomly and did not appear to identify
CpG islands. It is possible that this pattern ofrestriction sites is related to the
function of the telomere.
10.3.3 YAC clone contig maps
The comparison ofthe linkage, YAC and NotI restriction maps for chromosome 21
identified a number of discrepancies most importantly the order of some loci were
different (Chumakov 1992, Ichikawa 1993). Comparison ofthe YAC clone contigs
to the NotI restriction map identified the majority of the discrepancies:while the
linkage and NotI restriction maps were in much closer agreement. In particular,
discrepancies were identified around the telomeric regions of chromosome 21 which
seems to be relatively unstable in clones (Tanzi 1988). Cloning the region around
PDGFA will depend on the identification of telomeric clones. The evidence from
other chromosomes suggests that this region will be problematic and that alternative
approaches to YAC cloning would be advised, this is discussed further below.
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10.4 Representation of loci in YAC clone libraries
The subtelomeric regions of chromosomes are known to be underrepresented in YAC
libraries. The majority of the YAC clone libraries are made from partial EcoRI
digests of the target DNA which is cloned into an EcoRI site in the YAC vector.
Since only some EcoRI sites will be cut, the chance of cloning a individual fragment
will reduce as it gets nearer to the telomere and there are fewer distal EcoRI sites.
Obviously the requirement for flanking restriction sites means that standard YAC
cloning vector systems cannot clone the true telomere end of the chromosome.
Alternatively, the region surrounding PDGFA may be unstable or unclonable in
YACs. As discussed in section 6.5, regions which contain repetitive DNA
sequences are thought to be particularly unstable in YAC clones. Since the sub¬
telomeric regions of chromosomes are known to contain long tract of repeats this
may explain the failure to identify YAC clones spanning the gene.
With the data available it is not possible to determine whether the PDGFA region was
not identified in the YAC clone libraries through chance, a systematic selection
against the region as a result of the way in which the libraries are constructed or
because the region is unclonable in YACs. IfPDGFA was not in the libraries which
were screened due to a combination of decreased likelihood and chance, screening of
further YAC libraries may eventually identify clones spanning PDGFA. However,
the screening of the YAC libraries has been exhaustive and it seems reasonable to
conclude that future attempts to clone the region around PDGFA should use
alternative approaches.
10.4.1 Development of chromosome telomere clones
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The telomeres of chromosomes are cloned using a modified or 'half-YAC' vector and
a telomere YAC library is described in Chapter 8. The development of telomere
YAC s quickly allowed the cloning ofthe 7q telomere (Riethman 1993) and the
pseudoautosomal X/Y telomere (Brown 1990b). The cloning of these chromosome
telomeres proved to be particularly easy because they carry largely unique DNA
sequences. The cloning of other chromosome telomeres is complicated by the
presence ofthe sub-telomeric repeats. These make it very difficult to identify unique
sequence and mean that the telomere YAC clones need to be relatively large to
overlap with conventionally cloned DNA. Despite these problems, to date a large
number ofhuman chromosome telomeres have been cloned and characterised. These
include lq (Negorev 1994), 2q (Macina 1994), 4p (Youngman 1992, Bates 1990),
4q (Weber 1990), 7q (Riethman 1993), 9q (Guerrini 1990) 16p (Wilkie 1991), 21q
(Reston 1995) and the psuedoautosomal telomere (Brown 1990b).
Following the results of the linkage analysis and the screening of the standard YAC
clone libraries, candidate chromosome 7p telomere YAC clones were screened for
PDGFA (see Chapter 8). The largest of these YACs was 260 kb while the distance
between PDGFA and the telomere of chromosome 7p subsequently shown to be
about 650 kb, thus it is not surprising that these telomere clones did not include
PDGFA. Analysis of the telomere YACs was then concentrated on identifying single
copy DNA which could be used as a telomere probe. This analysis was frustrated by
the difficulty in isolating single copy DNA sequence, a consequence ofthe sequence
structure ofthe subtelomeric regions. The problems associated with identifying
unique sequence from the telomere YAC clones are explained well in Negorev
(1994). However, since several groups are working on this problem, it seems likely
that the 7p telomere will eventually be cloned.
10.5 The implications of a telomere location for PDGFA
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10.5.1 Chromosome telomeres in malignancy
Expression ofPDGF is frequently seen in mesenchymal tumours, and this may result
in important autocrine stimulation of tumour growth. However, the molecular
mechanisms underlying aberrant growth factor synthesis by tumours are largely
unknown. One phenomenon which accompanies tumour cell proliferation is
reduction in length ofthe terminal telomere repeat. Loss of all telomere repeats
results in instability of the chromosome ends and chromosome breakage-reunion
events (Hastie 1989). This may explain the increased number of chromosome
rearrangements seen in malignant cells. Such subtelomeric rearrangements can have
dramatic effects on expression ofnearby genes; for example truncation ofthe 16p
telomere can silence expression from the nearby a-globin cluster (Wilkie 1990b).
Characterisation ofthese 16p deletions has shown that expression of the a-globin
gene was silenced even when the gene itselfwas intact. It has been speculated that
the deletion affected control sequences related to the gene.
Because ofthese phenomena, a sub-telomeric location for PDGFA is of great
interest. The orientation ofthe PDGFA with its 5' or promoter region centromeric
would mean that telomere deletions would not be expected to delete just the control
sequences of the gene.
10.5.2 Telomere length and ageing
The length of the telomere repeat sequences has been shown to be greater in sperm
than in somatic tissues such as fibroblasts or lymphocytes suggesting that somatic
tissue cells lose their telomere DNA sequences. This loss oftelomere sequences is
progressive and has been shown to be related to donor age (Hastie 1990). In
culture, the telomere length of fibroblasts decreases with each cell passage by up to
50 bp per generation and up to 2 kb are lost before cell death. In the last few
250
doublings of senescent fibroblasts in culture dramatic increase in the number of
chromosome-chromosome fusions is seen (reviewed in Greider 1990, Harley 1991,
1991). It has been suggested that this progressive shortening of the chromosome
telomeres is related to the phenomenon of cellular ageing or senescence. However,
it is important to note that while telomere loss is implicated in the process of cellular
senescence of the cell this does not explain its significance to the ageing of the
organism. The progressive loss of telomere repeats may have interesting
consequences for the expression of sub-telomeric gene such as PDGFA which is
involved in the control of cell growth.
10.5.3 Ring Chromosome 7 and PDGFA
X subtelomeric location for PDGFA makes the abnormalities seen in ring
chromosome 7 interesting. As discussed in section 1.9, the two constant findings
amongst patients carrying a ring chromosome 7 were growth retardation and skin
lesions which may predispose to malignancy.
It has been suggested that the clinical manifestation of ring chromosome syndromes
may not be related to loss of DNA sequence. In one study of three patients with ring
chromosome syndrome, telomere repeats were identified at the fusion site by in situ
hybridisation, no deletions ofDNA could be detected (Pezzelo 1993). High
resolution cytogenetic analysis of a fourth patient with ring chromosome syndrome
also failed to identify any deletion ofDNA (Sawyer 1993). Thus it has been
proposed that the clinical problems may be caused by instability of the ring
chromosome during somatic cell growth leading to chromosome rearrangements and
aneuploidy in some cells in the somatic tissues. However the clinical symptoms of
the described patients with ring chromosome 7 include specific abnormalities in
addition to the general symptoms associated with ring chromosome such as growth
retardation. These specific abnormalities, which are described in section 1.10.4,
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included skin lesions bearing some similarity to the patch mutant mouse (see section
1.7.1). In one patient, a boy who died at 20 months, gross abnormalities in
development of the brain were described. PDGFA is known to be expressed by
neurones and is thought to be involved in the development of the brain. It seems
likely that these patients with ring chromosome 7 may have deletions of PDGFA. It
would be interesting to conduct molecular studies to establish whether the gene has
been deleted.
10.6 Future work
This mapping project has used the standard approaches of linkage analysis, long
range restriction mapping and screening YAC libraries in addition to the technique of
RARE cleavage. To develop fiirther information about the region surrounding
PDGFA, a major goal must be to clone the chromosome telomere itself, as
described in Chapter 8, several large research groups are working towards this. The
development of a single copy probe and a polymorphic marker would allow the
completion of the linkage and pulsed field restriction maps.
In the absence of clones for the chromosome 7p telomere, an interesting alternative
approach to extending the pulsed field mapping of the telomere of a chromosome
would be to use a telomere probe which is not unique. Such a probe could be used
to probe restriction digests ofDNA from a human-hamster hybrid cell line which
contains chromosome 7p as its only human contribution. This approach has been
used by Burmeister (1991) who used a non-unique subtelomeric fragment from the
chromosome 21q telomere to complete their PFGE restriction map. The probe
TelBaml 1 which has been mapped to the 7p telomere in addition to several other
chromosomes (Brown 1990a) or an end-clone from the candidate telomere YACs
described in Chapter 8 could be suitable candidates for probes. Such an approach
would depend on a suitable somatic hybrid cell line being available for culture. As
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discussed in Chapter 5, the methylation pattern ofDNA derived from cultured cells
would be altered. Thus the restriction map analysis ofPDGFA would have to be
repeated to using the DNA from the cultured cell lines. While the distance of 650 kb
between the chromosome telomere and PDGFA is relatively small, if a large number
of sites are present this approach may fail to link the two loci.
Ultimately the completion of a mapping study ofthis region depends on the
development of a clone contig which spans from the chromosome telomere, across
PDGFA to proximal loci such as MS31 (D7S21). The PDGFA gene itselfhas
already been found to be easily clonable in the bacteriophage vector (Bonthron 1988)
and it may be that the region could be mapped using bacteriophage and cosmid
vectors. Using cosmid 'walking' to map the region would be laborious and slow
given the small size of the cloned inserts in these vectors (<50 kb). However, the
inevitable future development ofYAC clone contigs for the rest of chromosome 7p
may mean that such an approach would only be required to bridge a small gap.
Unfortunately the majority of chromosome 7p has not yet been mapped in YAC clone
contigs (see diagram 1.10) and this approach could not be undertaken at present.
The large size of inserts which can be carried in YAC clones along with the ease of
cloning some regions which have been found to be difficult to clone in E.Coli based
systems has meant that YACs have become very widely used as the system of choice
for long range mapping projects. However regions such as the PDGFA gene which
seem to be unclonable in the YAC vector will require alternative approaches. A
number of alternative cloning systems to YACs are currently being developed
including BACs (bacterial artificial chromosome) and MACs (mammalian artificial
chromosomes). It may be that these systems, especially MACs which would be
maintained in mammalian cell lines, will be found to allow the cloning ofDNA
sequences which cannot be maintained in yeast cells. Unfortunately alternative
vector cloning systems such as these are still under development and no libraries of
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Appendix I Suppliers of chemicals and enzymes
(i) Suppliers of chemicals
Acetic acid A & J Beveridge, Edinburgh, Lothian, UK.
Acetylated BSA New England Biolabs, Hitchin, Hertfordshire, UK.
Acrylamide Merle Ltd, Lutterworth, Leices, UK.
ADP Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
Agarose GibcoBRL, Life Technologies Ltd, Renfrewshire,UK.
Ammonium acetate Sigma, Poole, Dorset, UK.
Ammonium persulphate GibcoBRL, Life Technologies Ltd, Renfrewshire,UK.
Ampicillin NBL, Cramlington, Northumberland, UK.
ATP-y-S Sigma, Poole, Dorset, UK.
Avidin FITC Vector, Peterborourgh, UK.
Antiavidin Vector (as above).
Bacto-agar Difco, EastMolesey, Surrey, UK.
Bacto-tryptone Difco (as above).
Bacto-yeast extract Difco (as above).
Bio-16-dUTP Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
Bromophenol blue Sigma, Poole, Dorset, UK.
Calcium chloride MerkLtd, Lutterworth, Leices, UK.
Chloramphenicol NBL, Cramlington, Northumberland, UK.
Chloroform A & J Beveridge, Edinburgh, Lothian, UK.
CotI DNA Gibco-BRL, Life Technologies Ltd, Renfrewshire,UK.
DAPI Sigma, Poole, Dorset, UK.
Dextran sulphate Pharmacia, Milton Keynes, UK.
Disodium hydrogen phosphate A & J Beveridge, Edinburgh, Lothian, UK.
Dithiothreitol Sigma, Poole, Dorset, UK.
DMSO Sigma (as above).
EDTA NBL, Cramlington, Northumberland, UK.
EGTA Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
Ethanol A.A.H. Pharmaceuticals Glasgow, Strathclyde.
Ethidium Bromide NBL, (as above).
Ficoll Pharmacia, Milton Keynes, UK.
Formamide MerkLtd, Lutterworth, Leices, UK.
Geneclean Kit Stratech Scientific Ltd, Luton, Bedfordshire, UK.
Glucose Sigma, Poole, Dorset, UK.
Glycerol A & J Beveridge, Edinburgh, Lothian, UK.
Glycine Sigma, Poole, Dorset, UK.
Glycogen Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
Hybond NC Amersham International Pic, Chalfont, Buckinghamshire, UK.
Hydrochloric acid A & J Beveridge, Edinburgh, Lothian, UK.
EPA Rathburn, Walkerburn, Peebleshire, UK.
EPTG Gibco BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Kanamycin Gibco-BRL (as above).
LMP agarose Gibco BRL (as above).
Lymphoprep Nycomed, Sheldon, Birmingham, UK.
Magnesium acetate Sigma, Poole, Dorset, UK.
Magnesium chloride MerkLtd, Lutterworth, Leices, UK.
Magnesium sulphate Sigma, Poole, Dorset, UK.
Mineral oil Sigma (as above).
Nitric acid A & J Beveridge, Edinburgh, Lothian, UK.
Nucleotides Pharmacia, Milton Keynes, UK.
Orange G MerkLtd, Lutterworth, Leices, UK.







Rathburn, Walkerburn, Peebleshire, UK.
Sigma, Poole, Dorset, UK.
Sigma (as above).
A & J Beveridge, Edinburgh, Lothian, UK.
Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
Amersham International Pic, Chalfont, Buckinghamshire, UK.
Random hexamer oligonucleotides Pharmacia, Milton Keyes, UK.
RecA protein Cambio Ltd, Cambridge, UK.
Salmon sperm DNA Sigma, Poole, Dorset, UK.
Scintran scintillation fluid Merk, Lutterworth, Leices, UK.
SDS Aldridge, Gillingham, Dorset, UK.
Sephadex Pharmacia, Milton Keynes, UK.
Silver nitrate Merk, Lutterworth, Leices, UK.
Sodium carbonate Merk (as above).
Sodium chloride A & J Beveridge, Edinburgh, Lothian, UK.
Sodium dihydrogen phosphate A & J Beveridge, Edinburgh, Lothian, UK.














Merk, Lutterworth, Leices, UK.
Sigma, Poole, Dorset, UK.
Sigma (as above).
A & J Beveridge, Edinburgh, Lothian, UK.
Sigma, Poole, Dorset, UK.
NBL, Cramlington, Northumberland, UK.
Merk, Lutterworth, Leices, UK.
Gibco BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Sigma, Poole, Dorset, UK.
Merk, Lutterworth, Leices, UK.
Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Sigma, Poole, Dorset, UK.
ICN Biomedicals,
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(ii) Suppliers of enzymes
Alw44I Promega, Milton Keynes, UK.
ApaLI Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
BamHI New England Biolabs, Hitchin, Hertfordshire, UK.
Bglll NBL, Cramlington, Northumberland, UK.
BspDI (isoschizomer of Clal) New England Biolabs, Hitchin, Hertfordshire, UK.
BstZI (isoschizomer of EagI) Promega, Milton Keynes, UK.
DNA polymerase I Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
DNase Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
EcoRI New England Biolabs, Hitchin, Hertfordshire, UK.
EcoRI methylase New England Biolabs (as above).
ExoIII nuclease Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Haelll Gibco-BRL (as above).
HincII NBL, Cramlington, Northumberland, UK.
Hindlll NBL (as above).
Klenow fragment (DNA polymerase I) NBL, (as above).
Kpnl NBL (as above).
Mlul NBL (as above).
Mspl NBL (as above).
Mung bean nuclease Boehringer Mannheim UK Ltd, Lewes, East Sussex, UK.
NotI New England Biolabs, Hitchin, Hertfordshire, UK.
Nrul New England Biolabs (as above).
PCR-script cloning kit Stratagene, Cambridge, UK.
Promega magic minipreps Promega, Milton Keynes, UK.
PstI NBL, Cramlington, Northumberland, UK.
Pvul Pharmacia, Milton Keynes, UK.
PvuII NBL, Cramlington, Northumberland, UK.
RNase Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Rsal Gibco-BRL (as above).
SacII New England Biolabs, Hitchin, Hertfordshire, UK.
Sail New England Biolabs (as above).
Sau3AI New England Biolabs (as above).
Sfil New England Biolabs (as above).
T4 kinase NBL, Cramlington, Northumberland, UK.
T4 ligase Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
TA cloning kit Invitrogen, Abingdon, UK.
Taq polymerase Perkin Elmer, Warrington, UK.
Xbal Gibco-BRL, Life Technologies Ltd, Inchinnan, Renfrewshire,UK.
Xhol Gibco-BRL (as above).












The first NIH-CEPH consortium map was based mainly
on anonymous RFLP markers and functional genes [17]. Pro¬
visional index maps presented at the First International Work¬
shop on Chromosome 7 Mapping 1993, by two groups,
attempted to integrate a number of the first generation micro-
satellite markers [2], typed on 8 of the CEPH families, with
other PCR-based markers like EGFR, GCK or TCRB,
MUC3, ERV3, TCRG, and IL6 [17,18],
The EUROGEM map is exclusively based on 30 mark¬
ers for which new data were generated by genotyping of the
40 CEPH families. It includes 10 Gdndthon markers, other
microsatellites and RFLP markers, selected by the Resource
Centre or the consortium, and 5 new dinucleotide microsatel-
lite markers identified in Marburg: D7S1491, D7S1492,
D7S1493, D7S1494, D7S1495. Details on the markers used
to build the map can be obtained from the Genome Data
Base (GDB).
All genotype information was error-checked visually
and entered into the GENBASE program. A second check
was made by running the L1NK2SUM program to test for
inconsistencies in the data (allelic exclusion and non-pater¬
nity). All possible errors were verified by retyping and either
corrected or the conflicting genotype was deleted from the
dataset before inclusion into the study. The analyses for map
building were carried out using CRI-MAP, starting from the
order predicted by the Gdndthon markers published by Weis¬
senbach et al. [2], and including the additional markers in a
stepwise fashion. For marker systems typed in the EURO-
GEM project for which there was already some data present
in the CEPH version 6 database, in our map building effort
this information was overruled by our new data. A first pre¬
liminary CRI-MAP 'build' was attempted on all newly geno-
typed markers and selected markers from the CEPH
database. Markers at odds of <1000:1 were excluded. Local
support for the preliminary map was assessed using the CRI-
MAP options 'flips2' and 'flips4'. Subsequently all non-
EUROGEM markers were eliminated.
THE EUROGEM Map of Human
Chromosome 7
Med. Zentrum Fur Humangenetik, Marburg, FRG;
MRC Human Biochemical Genetics Unit, University College London, UK;
Department of Medical Genetics, University of Groningen, The Netherlands;
Laboratoire de Gdndtique des Espbces, Institut de Biologie, Nantes, France;
MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK;
Centre d'Etudes du Bouchet, Vert le Petit, France;
Human Genetics Unit, Department of Medicine, University of Edinburgh, UK
The resulting EUROGEM map shown in the figure is a
baseline map of 30 markers (out of 40 typed by the EURO¬
GEM labs) for which new information was available ordered
in unique positions with odds of at least 1000; 1. The order of
markers which had also been used by other groups agrees
well with the one published previously [17,2]. In particular,
the order in 7q36 (cen - D7S468 - D7S22 - tel) which
seemed to be inverted in the map of Hill et al. [18] (cen -
D7S22 - D7S468 - tel) is back to the order indicated by
Helms et al. [17] and Gurreri et al. [19], probably due to the
availabilty of new data in the present study. The map is
268.3 cM (sex-averaged), 337.4 cM (female), and 209.3 cM
(male) in length. Physical locations had been described for 5
of the loci mapped in our study. In addition, we assigned the
5 microsatellite markers developed in our group by FISH
and analysis of a somatic cell hybrid panel (data not shown)
to regions of chromosome 7. As a result, 10 of the 30 mark¬
ers on the genetic map have a well-defined physical position
allowing the integration of genetic and physical maps:
PDGFA - 7p22; D7S1495 - 7p22; D7S1492 - 7p22; D7S513
- 7p21; D7S484 - 7pl4 to pl5; D7S506 - 7pll.2; MUC3 -
7q22; D7S1493 - 7q22; D7SI494 - 7q36; D7S1491 - 7q36.
Several important disease loci have been mapped to chromo¬
some 7 recently: Split hand/split foot malformation (SHFDI)
to 7q21-7q22; a deletion breakpoint interval in 7q22 in mye¬
loid disorder; Williams-Beuren-Syndrome (WBS) to
7q 11.23; two retinitis pigmentosa genes on 7q and 7p; a
"complex bilateral polysyndactyly"-gene and a gene for
triphalangeal thumb, both to the 7q36 region; a gene for holo-
prosencephaly to 7q36, and a gene for Saethre-Chotzen-type
of craniosynostosis to distal chromosome 7p.
The integration of the markers on the genetic maps of
this chromosome into physical maps and contiguous collec¬
tions of clones during the next round of EUROGEM will
define the position of these genes more precisely and thus
speed up their identification.









Fig. 7. The EUROGEM Map of Human Chromosome 7
